,date,title,url
0,2000-02-16,复星实业年报,/disclosure/listedinfo/announcement/c/600196_1999_0.pdf
1,2000-07-26,复星实业半年报,/disclosure/listedinfo/announcement/c/600196_2000_1.pdf
2,2001-03-23,复星实业年报,/disclosure/listedinfo/announcement/c/600196_2000_0.pdf
3,2001-04-12,复星实业上市公司章程,/disclosure/listedinfo/announcement/c/600196_2001_g.PDF
4,2001-08-18,复星实业半年报,/disclosure/listedinfo/announcement/c/600196_2001_1.pdf
5,2001-08-29,复星实业关联交易附录,/disclosure/listedinfo/announcement/c/600196_20010829_1.pdf
6,2001-09-05,复星实业关联交易,/disclosure/listedinfo/announcement/c/600196_20010905_1.pdf
7,2001-09-28,复星实业回访报告,/disclosure/listedinfo/announcement/c/600196_20010928_1.pdf
8,2002-03-21,复星实业年报,/disclosure/listedinfo/announcement/c/600196_2001_n.pdf
9,2002-04-26,复星实业第一季度季报,/disclosure/listedinfo/announcement/c/600196_2002_1.pdf
10,2002-07-10,复星实业股东大会会议资料,/disclosure/listedinfo/announcement/c/600196_20020710_1.pdf
11,2002-08-22,复星实业半年报,/disclosure/listedinfo/announcement/c/2002-08-22/600196_2002_z.pdf
12,2002-10-28,复星实业第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-28/600196_2002_3.pdf
13,2003-03-29,复星实业年报,/disclosure/listedinfo/announcement/c/2003-03-29/600196_2002_n.pdf
14,2003-04-12,复星实业第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-12/600196_2003_1.pdf
15,2003-04-22,复星实业关联交易备查,/disclosure/listedinfo/announcement/c/2003-04-22/600196_20030422_1.pdf
16,2003-04-22,复星实业股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-04-22/600196_20030422_2.pdf
17,2003-05-24,复星实业股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-05-24/600196_20030524_1.pdf
18,2003-06-25,复星实业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-06-25/600196_20030625_1.pdf
19,2003-07-11,复星实业半年报,/disclosure/listedinfo/announcement/c/2003-07-11/600196_2003_z.pdf
20,2003-08-20,复星实业股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-08-20/600196_20030820_1.pdf
21,2003-08-29,复星实业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-08-29/600196_20030829_1.pdf
22,2003-10-23,复星实业可转换公司债券募集说明书,/disclosure/listedinfo/announcement/c/2003-10-23/600196_20031023_1.pdf
23,2003-10-23,复星实业可转换公司债券发行公告,/disclosure/listedinfo/announcement/c/2003-10-23/600196_20031023_2.pdf
24,2003-10-31,复星实业第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-31/600196_2003_3.pdf
25,2003-11-12,复星实业可转换公司债券上市公告书,/disclosure/listedinfo/announcement/c/2003-11-12/600196_20031112_1.pdf
26,2004-01-02,复星实业控股子公司对外投资公告,/disclosure/listedinfo/announcement/c/2004-01-02/600196_20040102_1.pdf
27,2004-01-03,复星实业提示性公告,/disclosure/listedinfo/announcement/c/2004-01-03/600196_20040103_1.pdf
28,2004-01-12,复星实业重大事项公告,/disclosure/listedinfo/announcement/c/2004-01-12/600196_20040112_1.pdf
29,2004-02-05,复星实业关联交易公告,/disclosure/listedinfo/announcement/c/2004-02-05/600196_20040205_2.pdf
30,2004-02-05,复星实业关联交易备查,/disclosure/listedinfo/announcement/c/2004-02-05/600196_20040205_3.pdf
31,2004-02-05,复星实业董事会决议公告暨召开股东大会通知,/disclosure/listedinfo/announcement/c/2004-02-05/600196_20040205_1.pdf
32,2004-02-11,复星实业提示性公告,/disclosure/listedinfo/announcement/c/2004-02-11/600196_20040211_1.pdf
33,2004-02-28,复星实业召开股东大会会议地点公告,/disclosure/listedinfo/announcement/c/2004-02-28/600196_20040228_1.pdf
34,2004-03-02,复星实业股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-03-02/600196_20040302_1.pdf
35,2004-03-10,复星实业2004年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-03-10/600196_20040310_1.pdf
36,2004-04-06,复星实业2004年第一季度业绩预增提示性公告,/disclosure/listedinfo/announcement/c/2004-04-06/600196_20040406_1.pdf
37,2004-04-22,复星实业关于“复星转债”转股事宜公告,/disclosure/listedinfo/announcement/c/2004-04-22/600196_20040422_1.pdf
38,2004-04-24,复星实业年报,/disclosure/listedinfo/announcement/c/2004-04-24/600196_2003_n.pdf
39,2004-04-24,复星实业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-24/600196_20040424_2.pdf
40,2004-04-24,复星实业董事会决议公告暨召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-04-24/600196_20040424_1.pdf
41,2004-04-24,复星实业第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-24/600196_2004_1.pdf
42,2004-04-30,复星实业澄清公告,/disclosure/listedinfo/announcement/c/2004-04-30/600196_20040430_1.pdf
43,2004-05-20,复星实业发行可转换公司债券回访报告,/disclosure/listedinfo/announcement/c/2004-05-20/600196_20040520_1.pdf
44,2004-05-21,复星实业2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-05-21/600196_20040521_1.pdf
45,2004-05-22,复星实业2003年度股东大会会议地点公告,/disclosure/listedinfo/announcement/c/2004-05-22/600196_20040522_1.pdf
46,2004-05-29,复星实业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-05-29/600196_20040529_3.pdf
47,2004-05-29,复星实业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-05-29/600196_20040529_2.pdf
48,2004-05-29,复星实业2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-05-29/600196_20040529_1.pdf
49,2004-05-29,复星实业2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-05-29/600196_20040529_4.pdf
50,2004-06-10,复星实业澄清公告,/disclosure/listedinfo/announcement/c/2004-06-10/600196_20040610_1.pdf
51,2004-06-14,复星实业利润分配及资本公积金转增股本实施提示性公告,/disclosure/listedinfo/announcement/c/2004-06-14/600196_20040614_1.pdf
52,2004-06-18,复星实业利润分配及资本公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2004-06-18/600196_20040618_1.pdf
53,2004-06-18,复星实业关于复星转债初始转股价格调整特别提示公告,/disclosure/listedinfo/announcement/c/2004-06-18/600196_20040618_2.pdf
54,2004-07-02,复星实业关于股份变动的公告,/disclosure/listedinfo/announcement/c/2004-07-02/600196_20040702_1.pdf
55,2004-08-18,复星实业半年报摘要,/disclosure/listedinfo/announcement/c/2004-08-18/600196_2004_zzy.pdf
56,2004-08-18,复星实业半年报,/disclosure/listedinfo/announcement/c/2004-08-18/600196_2004_z.pdf
57,2004-09-14,复星实业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-09-14/600196_20040914_1.pdf
58,2004-09-27,复星实业新进入“医保目录”产品的提示性公告,/disclosure/listedinfo/announcement/c/2004-09-27/600196_20040927_1.pdf
59,2004-10-09,复星实业关于股份变动的公告,/disclosure/listedinfo/announcement/c/2004-10-09/600196_20041009_1.pdf
60,2004-10-21,复星实业关于可转换公司债券付息公告,/disclosure/listedinfo/announcement/c/2004-10-21/600196_20041021_1.pdf
61,2004-10-28,复星实业第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-28/600196_2004_3.pdf
62,2004-11-16,复星实业下属子公司关于受让“南京老山”部分股权的关联交易公告,/disclosure/listedinfo/announcement/c/2004-11-16/600196_20041116_3.pdf
63,2004-11-16,复星实业受让“复星医学”部分股权的关联交易公告,/disclosure/listedinfo/announcement/c/2004-11-16/600196_20041116_2.pdf
64,2004-11-16,复星实业董事会决议暨召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2004-11-16/600196_20041116_1.pdf
65,2004-12-04,复星实业关于召开临时股东大会会议地点的公告,/disclosure/listedinfo/announcement/c/2004-12-04/600196_20041204_2.pdf
66,2004-12-04,复星实业2004年度第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-12-04/600196_20041204_1.pdf
67,2004-12-18,复星实业2004年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-12-18/600196_20041218_1.pdf
68,2004-12-21,复星实业变更证券简称的公告,/disclosure/listedinfo/announcement/c/2004-12-21/600196_20041221_1.pdf
69,2004-12-23,复星实业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-12-23/600196_20041223_1.pdf
70,2004-12-24,复星医药关于股票简称变更的提示性公告,/disclosure/listedinfo/announcement/c/2004-12-24/600196_20041224_1.pdf
71,2004-12-31,复星医药名称变更的公告,/disclosure/listedinfo/announcement/c/2004-12-31/600196_20041231_1.pdf
72,2005-01-05,复星医药关于股份变动的公告,/disclosure/listedinfo/announcement/c/2005-01-05/600196_20050105_1.pdf
73,2005-01-08,复星医药信息披露制度,/disclosure/listedinfo/announcement/c/2005-01-08/600196_20050108_2.pdf
74,2005-01-08,复星医药投资者关系管理办法,/disclosure/listedinfo/announcement/c/2005-01-08/600196_20050108_1.pdf
75,2005-01-08,复星医药收购资产的公告,/disclosure/listedinfo/announcement/c/2005-01-08/600196_20050108_4.pdf
76,2005-01-08,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-01-08/600196_20050108_3.pdf
77,2005-01-12,复星医药关于控股股东受让部分非流通股股份的提示性公告,/disclosure/listedinfo/announcement/c/2005-01-12/600196_20050112_1.pdf
78,2005-01-20,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-01-20/600196_20050120_1.pdf
79,2005-01-25,复星医药控股子公司重大事项公告,/disclosure/listedinfo/announcement/c/2005-01-25/600196_20050125_1.pdf
80,2005-04-05,复星医药关于股份变动的公告,/disclosure/listedinfo/announcement/c/2005-04-05/600196_20050405_1.pdf
81,2005-04-09,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2005-04-09/600196_2004_nzy.pdf
82,2005-04-09,复星医药年报,/disclosure/listedinfo/announcement/c/2005-04-09/600196_2004_n.pdf
83,2005-04-09,复星医药累积投票制实施细则,/disclosure/listedinfo/announcement/c/2005-04-09/600196_20050409_3.pdf
84,2005-04-09,复星医药监事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-09/600196_20050409_2.pdf
85,2005-04-09,复星医药董事会决议暨召开2004年度股东大会的公告,/disclosure/listedinfo/announcement/c/2005-04-09/600196_20050409_1.pdf
86,2005-04-12,复星医药关于控股股东受让部分非流通股份过户的提示性公告,/disclosure/listedinfo/announcement/c/2005-04-12/600196_20050412_1.pdf
87,2005-04-22,复星医药2004年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-04-22/600196_20050422_1.pdf
88,2005-04-28,复星医药关于2004年度股东大会会议地点的公告,/disclosure/listedinfo/announcement/c/2005-04-28/600196_20050428_1.pdf
89,2005-04-28,复星医药第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-28/600196_2005_1.pdf
90,2005-05-11,复星医药2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-05-11/600196_20050511_1.pdf
91,2005-05-11,复星医药2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-05-11/600196_20050511_2.pdf
92,2005-05-18,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-05-18/600196_20050518_1.pdf
93,2005-06-09,复星医药利润分配实施提示性公告,/disclosure/listedinfo/announcement/c/2005-06-09/600196_20050609_1.pdf
94,2005-06-15,复星医药利润分配实施公告,/disclosure/listedinfo/announcement/c/2005-06-15/600196_20050615_1.pdf
95,2005-06-20,复星医药上市特别提示公告,/disclosure/listedinfo/announcement/c/2005-06-20/600196_20050620_1.pdf
96,2005-07-02,复星医药关于股份变动的公告,/disclosure/listedinfo/announcement/c/2005-07-02/600196_20050702_1.pdf
97,2005-08-09,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-08-09/600196_20050809_1.pdf
98,2005-08-09,复星医药半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-09/600196_2005_zzy.pdf
99,2005-08-09,复星医药半年报,/disclosure/listedinfo/announcement/c/2005-08-09/600196_2005_z.pdf
100,2005-10-11,复星医药关于股份变动的公告,/disclosure/listedinfo/announcement/c/2005-10-11/600196_20051011_1.pdf
101,2005-10-21,复星医药关于可转换公司债券付息公告,/disclosure/listedinfo/announcement/c/2005-10-21/600196_20051021_1.pdf
102,2005-10-29,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-10-29/600196_20051029_1.pdf
103,2005-10-29,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-29/600196_2005_3.pdf
104,2005-12-12,复星医药下属控股子公司重大事项公告,/disclosure/listedinfo/announcement/c/2005-12-12/600196_20051212_1.pdf
105,2006-01-05,复星医药关于股份变动的公告,/disclosure/listedinfo/announcement/c/2006-01-05/600196_20060105_1.pdf
106,2006-01-12,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-01-12/600196_20060112_1.pdf
107,2006-03-03,复星医药2005年度业绩快报,/disclosure/listedinfo/announcement/c/2006-03-03/600196_20060303_1.pdf
108,2006-03-06,复星医药关于股权分置改革的提示性公告,/disclosure/listedinfo/announcement/c/2006-03-06/600196_20060306_1.pdf
109,2006-03-15,复星医药关于召开2006年第一次临时股东大会暨相关股东会议的通知,/disclosure/listedinfo/announcement/c/2006-03-15/600196_20060315_1.pdf
110,2006-03-15,复星医药关于可转换公司债券转股的提示性公告,/disclosure/listedinfo/announcement/c/2006-03-15/600196_20060315_3.pdf
111,2006-03-15,复星医药股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-03-15/600196_20060315_6.pdf
112,2006-03-15,复星医药股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-03-15/600196_20060315_5.pdf
113,2006-03-15,复星医药股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-03-15/600196_20060315_4.pdf
114,2006-03-15,复星医药股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2006-03-15/600196_20060315_7.pdf
115,2006-03-15,复星医药独立董事关于股权分置改革之独立意见,/disclosure/listedinfo/announcement/c/2006-03-15/600196_20060315_8.pdf
116,2006-03-15,复星医药董事会委托投票征集函,/disclosure/listedinfo/announcement/c/2006-03-15/600196_20060315_9.pdf
117,2006-03-15,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-15/600196_20060315_2.pdf
118,2006-03-16,复星医药关于举办股权分置改革网上路演活动的提示性公告,/disclosure/listedinfo/announcement/c/2006-03-16/600196_20060316_1.pdf
119,2006-03-24,复星医药关于延迟披露股权分置改革方案沟通协商情况和结果的公告,/disclosure/listedinfo/announcement/c/2006-03-24/600196_20060324_1.pdf
120,2006-03-29,复星医药与控股股东及其他关联方之间占用资金问题的专项说明,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_6.pdf
121,2006-03-29,复星医药年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2006-03-29/600196_2005_nzy.pdf
122,2006-03-29,复星医药年报（修订版）,/disclosure/listedinfo/announcement/c/2006-03-29/600196_2005_n.pdf
123,2006-03-29,复星医药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_5.pdf
124,2006-03-29,复星医药关于可转换公司债券转股的提示性公告,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_3.pdf
125,2006-03-29,复星医药关于股权分置改革方案沟通协商情况暨调整股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_2.pdf
126,2006-03-29,复星医药股权分置改革之补充保荐意见,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_9.pdf
127,2006-03-29,复星医药股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_8.pdf
128,2006-03-29,复星医药股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_7.pdf
129,2006-03-29,复星医药股权分置改革的补充法律意见书,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_10.pdf
130,2006-03-29,复星医药独立董事关于股权分置改革之补充独立董事意见,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_11.pdf
131,2006-03-29,复星医药董事会决议及召开2005年度股东大会的公告,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_4.pdf
132,2006-03-29,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-29/600196_20060329_1.pdf
133,2006-03-31,复星医药更正公告,/disclosure/listedinfo/announcement/c/2006-03-31/600196_20060331_1.pdf
134,2006-04-05,复星医药关于股份变动的公告,/disclosure/listedinfo/announcement/c/2006-04-05/600196_20060405_1.pdf
135,2006-04-06,复星医药关于召开2006年第一次临时股东大会暨相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2006-04-06/600196_20060406_1.pdf
136,2006-04-13,复星医药关于召开2006年第一次临时股东大会暨相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2006-04-13/600196_20060413_1.pdf
137,2006-04-18,复星医药召开2006年第一次临时股东大会暨相关股东会议的法律意见书,/disclosure/listedinfo/announcement/c/2006-04-18/600196_20060418_2.pdf
138,2006-04-18,复星医药关于召开2006年第一次临时股东大会暨相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2006-04-18/600196_20060418_1.pdf
139,2006-04-21,复星医药关于股权分置改革方案实施的公告,/disclosure/listedinfo/announcement/c/2006-04-21/600196_20060421_4.pdf
140,2006-04-21,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2006-04-21/600196_20060421_2.pdf
141,2006-04-21,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-21/600196_20060421_1.pdf
142,2006-04-21,复星医药2005年度股东大会新增议案的公告,/disclosure/listedinfo/announcement/c/2006-04-21/600196_20060421_3.pdf
143,2006-04-22,复星医药2005年报补充公告,/disclosure/listedinfo/announcement/c/2006-04-22/600196_20060422_1.pdf
144,2006-04-25,复星医药2005年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-04-25/600196_20060425_1.pdf
145,2006-04-29,G复星关于2005年度股东大会会议地点的公告,/disclosure/listedinfo/announcement/c/2006-04-29/600196_20060429_1.pdf
146,2006-04-29,G复星第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-29/600196_2006_1.pdf
147,2006-05-11,G复星2005年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-05-11/600196_20060511_1.pdf
148,2006-05-11,G复星2005年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-05-11/600196_20060511_2.pdf
149,2006-05-19,G复星董事会决议公告,/disclosure/listedinfo/announcement/c/2006-05-19/600196_20060519_1.pdf
150,2006-05-31,G复星董事会决议公告,/disclosure/listedinfo/announcement/c/2006-05-31/600196_20060531_1.pdf
151,2006-06-24,G复星董事会决议公告,/disclosure/listedinfo/announcement/c/2006-06-24/600196_20060624_1.pdf
152,2006-06-27,G复星关于“复星转债”赎回的提示性公告,/disclosure/listedinfo/announcement/c/2006-06-27/600196_20060627_2.pdf
153,2006-06-27,G复星董事会决议公告,/disclosure/listedinfo/announcement/c/2006-06-27/600196_20060627_1.pdf
154,2006-06-28,G复星关于“复星转债”赎回事宜的第一次公告,/disclosure/listedinfo/announcement/c/2006-06-28/600196_20060628_1.pdf
155,2006-06-29,G复星关于“复星转债”赎回事宜的第二次公告,/disclosure/listedinfo/announcement/c/2006-06-29/600196_20060629_1.pdf
156,2006-06-30,G复星关于“复星转债”赎回事宜的第三次公告,/disclosure/listedinfo/announcement/c/2006-06-30/600196_20060630_1.pdf
157,2006-07-04,G复星关于股份变动的公告,/disclosure/listedinfo/announcement/c/2006-07-04/600196_20060704_1.pdf
158,2006-07-07,G复星下属控股子公司重大事项公告,/disclosure/listedinfo/announcement/c/2006-07-07/600196_20060707_1.pdf
159,2006-07-07,G复星关于“复星转债”停止交易的公告,/disclosure/listedinfo/announcement/c/2006-07-07/600196_20060707_2.pdf
160,2006-07-19,G复星关于“复星转债”赎回结果及摘牌的公告,/disclosure/listedinfo/announcement/c/2006-07-19/600196_20060719_1.pdf
161,2006-07-22,G复星董事会决议及召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2006-07-22/600196_20060722_1.pdf
162,2006-07-26,G复星2006年度第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-07-26/600196_20060726_1.pdf
163,2006-08-09,G复星2006年度第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-08-09/600196_20060809_1.pdf
164,2006-08-09,G复星2006年度第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-08-09/600196_20060809_2.pdf
165,2006-08-16,G复星董事会决议公告,/disclosure/listedinfo/announcement/c/2006-08-16/600196_20060816_1.pdf
166,2006-08-29,G复星半年报摘要,/disclosure/listedinfo/announcement/c/2006-08-29/600196_2006_zzy.pdf
167,2006-08-29,G复星半年报（修订版）,/disclosure/listedinfo/announcement/c/2006-08-29/600196_2006_z.pdf
168,2006-08-31,G复星更正公告,/disclosure/listedinfo/announcement/c/2006-08-31/600196_20060831_1.pdf
169,2006-09-19,G复星董事会决议公告,/disclosure/listedinfo/announcement/c/2006-09-19/600196_20060919_1.pdf
170,2006-09-23,G复星公告,/disclosure/listedinfo/announcement/c/2006-09-23/600196_20060923_1.pdf
171,2006-10-28,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-10-28/600196_20061028_1.pdf
172,2006-10-28,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-28/600196_2006_3.pdf
173,2006-11-25,复星医药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-11-25/600196_20061125_3.pdf
174,2006-11-25,复星医药关联交易公告,/disclosure/listedinfo/announcement/c/2006-11-25/600196_20061125_2.pdf
175,2006-11-25,复星医药董事会决议及召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2006-11-25/600196_20061125_1.pdf
176,2006-11-30,复星医药2006年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-11-30/600196_20061130_1.pdf
177,2006-12-12,复星医药2006年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-12-12/600196_20061212_1.pdf
178,2006-12-12,复星医药2006年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-12-12/600196_20061212_2.pdf
179,2007-01-06,复星医药关于受让上海复星医学科技发展有限公司3%股权的关联交易公告,/disclosure/listedinfo/announcement/c/2007-01-06/600196_20070106_2.pdf
180,2007-01-06,复星医药关于受让上海创新科技有限公司3%股权的关联交易公告,/disclosure/listedinfo/announcement/c/2007-01-06/600196_20070106_3.pdf
181,2007-01-06,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-01-06/600196_20070106_1.pdf
182,2007-01-16,复星医药网址域名变更公告,/disclosure/listedinfo/announcement/c/2007-01-16/600196_20070116_2.pdf
183,2007-01-16,复星医药2006年度业绩预告,/disclosure/listedinfo/announcement/c/2007-01-16/600196_20070116_1.pdf
184,2007-02-01,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-02-01/600196_20070201_1.pdf
185,2007-03-17,复星医药控股子公司出售资产公告,/disclosure/listedinfo/announcement/c/2007-03-17/600196_20070317_1.pdf
186,2007-03-28,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-03-28/600196_20070328_1.pdf
187,2007-04-10,复星医药关于股权分置改革追加对价承诺的第一次提示性公告,/disclosure/listedinfo/announcement/c/2007-04-10/600196_20070410_1.pdf
188,2007-04-11,复星医药关于股权分置改革追加对价承诺的第二次提示性公告,/disclosure/listedinfo/announcement/c/2007-04-11/600196_20070411_1.pdf
189,2007-04-23,复星医药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-04-23/600196_20070423_1.pdf
190,2007-04-30,复星医药日常关联交易公告,/disclosure/listedinfo/announcement/c/2007-04-30/600196_20070430_4.pdf
191,2007-04-30,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2007-04-30/600196_2006_nzy.pdf
192,2007-04-30,复星医药年报,/disclosure/listedinfo/announcement/c/2007-04-30/600196_2006_n.pdf
193,2007-04-30,复星医药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-30/600196_20070430_2.pdf
194,2007-04-30,复星医药董事会决议及召开2006年度股东大会的公告,/disclosure/listedinfo/announcement/c/2007-04-30/600196_20070430_1.pdf
195,2007-04-30,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-30/600196_20070430_3.pdf
196,2007-04-30,复星医药第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-30/600196_2007_1.pdf
197,2007-04-30,复星医药2006年度非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2007-04-30/600196_20070430_5.pdf
198,2007-05-19,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-05-19/600196_20070519_1.pdf
199,2007-05-19,复星医药2006年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-05-19/600196_20070519_2.pdf
200,2007-05-29,复星医药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-05-29/600196_20070529_3.pdf
201,2007-05-29,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-05-29/600196_20070529_2.pdf
202,2007-05-29,复星医药2006年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-05-29/600196_20070529_1.pdf
203,2007-05-29,复星医药2006年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-05-29/600196_20070529_4.pdf
204,2007-06-04,复星医药2006年度利润分配及资本公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2007-06-04/600196_20070604_1.pdf
205,2007-06-30,复星医药总经理工作细则,/disclosure/listedinfo/announcement/c/2007-06-30/600196_20070630_4.pdf
206,2007-06-30,复星医药治理专项活动自查报告和整改计划,/disclosure/listedinfo/announcement/c/2007-06-30/600196_20070630_2.pdf
207,2007-06-30,复星医药募集资金管理制度,/disclosure/listedinfo/announcement/c/2007-06-30/600196_20070630_5.pdf
208,2007-06-30,复星医药控股子公司担保公告,/disclosure/listedinfo/announcement/c/2007-06-30/600196_20070630_3.pdf
209,2007-06-30,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-30/600196_20070630_1.pdf
210,2007-08-28,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-28/600196_20070828_1.pdf
211,2007-08-28,复星医药半年报摘要,/disclosure/listedinfo/announcement/c/2007-08-28/600196_2007_zzy.pdf
212,2007-08-28,复星医药半年报,/disclosure/listedinfo/announcement/c/2007-08-28/600196_2007_z.pdf
213,2007-09-14,复星医药临时公告,/disclosure/listedinfo/announcement/c/2007-09-14/600196_20070914_1.pdf
214,2007-09-29,复星医药公司治理专项活动整改报告,/disclosure/listedinfo/announcement/c/2007-09-29/600196_20070929_2.pdf
215,2007-09-29,复星医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-09-29/600196_20070929_1.pdf
216,2007-10-22,复星医药业绩预增预告,/disclosure/listedinfo/announcement/c/2007-10-22/600196_20071022_1.pdf
217,2007-10-30,复星医药关于转让“友谊复星”48%股权关联交易公告,/disclosure/listedinfo/announcement/c/2007-10-30/600196_20071030_2.pdf
218,2007-10-30,复星医药董事会临时会议决议及召开临时股东大会的公告,/disclosure/listedinfo/announcement/c/2007-10-30/600196_20071030_1.pdf
219,2007-10-31,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-31/600196_20071031_1.pdf
220,2007-10-31,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-31/600196_2007_3.pdf
221,2007-11-07,复星医药2007年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-11-07/600196_20071107_1.pdf
222,2007-11-15,复星医药2007年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-11-15/600196_20071115_1.pdf
223,2007-11-15,复星医药2007年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-11-15/600196_20071115_2.pdf
224,2007-11-30,复星医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-11-30/600196_20071130_1.pdf
225,2007-12-19,复星医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-12-19/600196_20071219_1.pdf
226,2007-12-22,复星医药关于出资认购永安财产保险股份有限公司增发股份的关联交易公告,/disclosure/listedinfo/announcement/c/2007-12-22/600196_20071222_2.pdf
227,2007-12-22,复星医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-12-22/600196_20071222_1.pdf
228,2008-01-22,复星医药业绩预增预告,/disclosure/listedinfo/announcement/c/2008-01-22/600196_20080122_1.pdf
229,2008-01-22,复星医药控股子公司担保事项变更的公告,/disclosure/listedinfo/announcement/c/2008-01-22/600196_20080122_2.pdf
230,2008-01-30,复星医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-01-30/600196_20080130_1.pdf
231,2008-03-01,复星医药关于获准发行短期融资券的公告,/disclosure/listedinfo/announcement/c/2008-03-01/600196_20080301_1.pdf
232,2008-03-01,复星医药关于出资认购永安财产保险股份有限公司增发股份进展情况的公告,/disclosure/listedinfo/announcement/c/2008-03-01/600196_20080301_2.pdf
233,2008-03-08,复星医药独立董事年报工作制度,/disclosure/listedinfo/announcement/c/2008-03-08/600196_20080308_2.pdf
234,2008-03-08,复星医药董事会审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2008-03-08/600196_20080308_3.pdf
235,2008-03-08,复星医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-03-08/600196_20080308_1.pdf
236,2008-03-17,复星医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-03-17/600196_20080317_1.pdf
237,2008-03-18,复星医药澄清公告,/disclosure/listedinfo/announcement/c/2008-03-18/600196_20080318_1.pdf
238,2008-03-20,复星医药2007年度业绩快报,/disclosure/listedinfo/announcement/c/2008-03-20/600196_20080320_1.pdf
239,2008-03-28,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2008-03-28/600196_2007_nzy.pdf
240,2008-03-28,复星医药年报,/disclosure/listedinfo/announcement/c/2008-03-28/600196_2007_n.pdf
241,2008-03-28,复星医药监事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-28/600196_20080328_3.pdf
242,2008-03-28,复星医药董事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-28/600196_20080328_1.pdf
243,2008-03-28,复星医药2008年日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2008-03-28/600196_20080328_2.pdf
244,2008-03-28,复星医药2007年度非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2008-03-28/600196_20080328_4.pdf
245,2008-04-28,复星医药董事会决议及召开2007年度股东大会的公告,/disclosure/listedinfo/announcement/c/2008-04-28/600196_20080428_1.pdf
246,2008-04-28,复星医药第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-28/600196_2008_1.pdf
247,2008-05-16,复星医药2007年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-05-16/600196_20080516_1.pdf
248,2008-05-27,复星医药监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-05-27/600196_20080527_3.pdf
249,2008-05-27,复星医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-05-27/600196_20080527_2.pdf
250,2008-05-27,复星医药2007年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-05-27/600196_20080527_1.pdf
251,2008-05-27,复星医药2007年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-05-27/600196_20080527_4.pdf
252,2008-06-21,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2008-06-21/600196_20080621_2.pdf
253,2008-06-21,复星医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-06-21/600196_20080621_1.pdf
254,2008-07-04,复星医药2007年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2008-07-04/600196_20080704_1.pdf
255,2008-07-19,复星医药关于公司治理专项活动整改情况的说明,/disclosure/listedinfo/announcement/c/2008-07-19/600196_20080719_2.pdf
256,2008-07-19,复星医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-07-19/600196_20080719_1.pdf
257,2008-07-28,复星医药2008年中期业绩预增预告,/disclosure/listedinfo/announcement/c/2008-07-28/600196_20080728_1.pdf
258,2008-08-15,复星医药第四届董事会第二十七次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2008-08-15/600196_20080815_1.pdf
259,2008-08-15,复星医药半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-15/600196_2008_zzy.pdf
260,2008-08-15,复星医药半年报,/disclosure/listedinfo/announcement/c/2008-08-15/600196_2008_z.pdf
261,2008-08-23,复星医药关于2008年第一期短期融资券发行完成的公告,/disclosure/listedinfo/announcement/c/2008-08-23/600196_20080823_1.pdf
262,2008-08-29,复星医药第四届董事会第二十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2008-08-29/600196_20080829_1.pdf
263,2008-08-29,复星医药出售资产公告,/disclosure/listedinfo/announcement/c/2008-08-29/600196_20080829_2.pdf
264,2008-09-27,复星医药关联交易公告,/disclosure/listedinfo/announcement/c/2008-09-27/600196_20080927_2.pdf
265,2008-09-27,复星医药第四届董事会第三十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2008-09-27/600196_20080927_1.pdf
266,2008-10-18,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2008-10-18/600196_20081018_1.pdf
267,2008-10-28,复星医药第四届董事会第三十三次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2008-10-28/600196_20081028_1.pdf
268,2008-10-28,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-28/600196_2008_3.pdf
269,2008-11-01,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2008-11-01/600196_20081101_1.pdf
270,2008-11-19,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2008-11-19/600196_20081119_1.pdf
271,2008-12-02,复星医药第四届董事会第三十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2008-12-02/600196_20081202_1.pdf
272,2008-12-11,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2008-12-11/600196_20081211_1.pdf
273,2008-12-20,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2008-12-20/600196_20081220_1.pdf
274,2008-12-25,复星医药为下属控股公司江苏万邦生化医药股份有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2008-12-25/600196_20081225_2.pdf
275,2008-12-25,复星医药第四届董事会第三十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2008-12-25/600196_20081225_1.pdf
276,2008-12-30,复星医药关于公司邮箱域名变更的公告,/disclosure/listedinfo/announcement/c/2008-12-30/600196_20081230_1.pdf
277,2009-01-05,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2009-01-05/600196_20090105_1.pdf
278,2009-01-06,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2009-01-06/600196_20090106_1.pdf
279,2009-01-22,复星医药第四届董事会第三十九次会议（临时会议）决议及召开2009年第一次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2009-01-22/600196_20090122_1.pdf
280,2009-02-03,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2009-02-03/600196_20090203_1.pdf
281,2009-02-07,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2009-02-07/600196_20090207_1.pdf
282,2009-02-07,复星医药2009年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-02-07/600196_20090207_2.pdf
283,2009-02-17,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2009-02-17/600196_20090217_1.pdf
284,2009-02-17,复星医药2009年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-02-17/600196_20090217_2.pdf
285,2009-02-17,复星医药2009年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-02-17/600196_20090217_3.pdf
286,2009-03-06,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2009-03-06/600196_20090306_1.pdf
287,2009-03-09,复星医药2008年度业绩快报,/disclosure/listedinfo/announcement/c/2009-03-09/600196_20090309_1.pdf
288,2009-03-17,复星医药第四届董事会第四十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-03-17/600196_20090317_1.pdf
289,2009-03-17,复星医药2009年日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2009-03-17/600196_20090317_2.pdf
290,2009-03-21,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2009-03-21/600196_2008_nzy.pdf
291,2009-03-21,复星医药年报,/disclosure/listedinfo/announcement/c/2009-03-21/600196_2008_n.pdf
292,2009-03-21,复星医药董事会审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2009-03-21/600196_20090321_4.pdf
293,2009-03-21,复星医药第四届监事会2009年第一次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2009-03-21/600196_20090321_2.pdf
294,2009-03-21,复星医药第四届董事会第四十三次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2009-03-21/600196_20090321_1.pdf
295,2009-03-21,复星医药2008年度非经营性资金占用及其他关联资金往来情况的专项说明,/disclosure/listedinfo/announcement/c/2009-03-21/600196_20090321_3.pdf
296,2009-03-25,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2009-03-25/600196_20090325_1.pdf
297,2009-04-08,复星医药第四届董事会第四十四次会议（临时会议）决议及召开2009年第二次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2009-04-08/600196_20090408_1.pdf
298,2009-04-15,复星医药2009年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-04-15/600196_20090415_1.pdf
299,2009-04-21,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2009-04-21/600196_20090421_1.pdf
300,2009-04-22,复星医药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2009-04-22/600196_20090422_1.pdf
301,2009-04-24,复星医药2009年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-04-24/600196_20090424_1.pdf
302,2009-04-24,复星医药2009年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-04-24/600196_20090424_2.pdf
303,2009-04-25,复星医药第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-25/600196_2009_1.pdf
304,2009-04-25,复星医药第四届董事会第四十五次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2009-04-25/600196_20090425_1.pdf
305,2009-05-22,复星医药为下属控股公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2009-05-22/600196_20090522_2.pdf
306,2009-05-22,复星医药第四届董事会第四十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-05-22/600196_20090522_1.pdf
307,2009-06-01,复星医药第四届董事会第四十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-06-01/600196_20090601_1.pdf
308,2009-06-06,复星医药关于下属控股公司上海复星医药产业发展有限公司转让复地（集团）股份有限公司股份的关联交易公告,/disclosure/listedinfo/announcement/c/2009-06-06/600196_20090606_2.pdf
309,2009-06-06,复星医药第四届董事会第四十九次会议（临时会议）决议及召开2008年度股东大会的公告,/disclosure/listedinfo/announcement/c/2009-06-06/600196_20090606_1.pdf
310,2009-06-12,复星医药公告,/disclosure/listedinfo/announcement/c/2009-06-12/600196_20090612_1.pdf
311,2009-06-17,复星医药2008年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-06-17/600196_20090617_1.pdf
312,2009-06-23,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2009-06-23/600196_20090623_1.pdf
313,2009-06-27,复星医药关于非公开发行股票涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2009-06-27/600196_20090627_3.pdf
314,2009-06-27,复星医药第四届董事会第五十次会议（临时会议）决议暨召开2009年第三次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2009-06-27/600196_20090627_2.pdf
315,2009-06-27,复星医药2009年非公开发行A股股票预案,/disclosure/listedinfo/announcement/c/2009-06-27/600196_20090627_4.pdf
316,2009-06-27,复星医药2008年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-06-27/600196_20090627_1.pdf
317,2009-06-27,复星医药2008年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-06-27/600196_20090627_5.pdf
318,2009-07-02,复星医药为下属控股公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2009-07-02/600196_20090702_2.pdf
319,2009-07-02,复星医药第四届董事会第五十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-07-02/600196_20090702_1.pdf
320,2009-07-03,复星医药关于下属控股公司上海复星医药产业发展有限公司对江苏万邦生化医药股份有限公司增资的关联交易公告,/disclosure/listedinfo/announcement/c/2009-07-03/600196_20090703_2.pdf
321,2009-07-03,复星医药关于2009年第三次临时股东大会新增议案公告及2009年第三次临时股东大会的补充通知,/disclosure/listedinfo/announcement/c/2009-07-03/600196_20090703_1.pdf
322,2009-07-03,复星医药2009年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-07-03/600196_20090703_3.pdf
323,2009-07-08,复星医药关于甲型H1N1流感病毒试剂通过国家检测的公告,/disclosure/listedinfo/announcement/c/2009-07-08/600196_20090708_2.pdf
324,2009-07-08,复星医药关于2009年第三次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2009-07-08/600196_20090708_1.pdf
325,2009-07-14,复星医药2009年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-07-14/600196_20090714_1.pdf
326,2009-07-14,复星医药2009年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-07-14/600196_20090714_2.pdf
327,2009-07-30,复星医药第四届董事会第五十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-07-30/600196_20090730_1.pdf
328,2009-08-08,复星医药为下属控股公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2009-08-08/600196_20090808_2.pdf
329,2009-08-08,复星医药第四届董事会第五十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-08-08/600196_20090808_1.pdf
330,2009-08-13,复星医药关于控股公司复星实业（香港）有限公司购入同济堂药业股份的公告,/disclosure/listedinfo/announcement/c/2009-08-13/600196_20090813_2.pdf
331,2009-08-13,复星医药2008年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2009-08-13/600196_20090813_1.pdf
332,2009-08-19,复星医药为下属控股公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2009-08-19/600196_20090819_2.pdf
333,2009-08-19,复星医药第四届董事会第五十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-08-19/600196_20090819_1.pdf
334,2009-08-24,复星医药关于2008年第一期短期融资券兑付完成的公告,/disclosure/listedinfo/announcement/c/2009-08-24/600196_20090824_2.pdf
335,2009-08-24,复星医药2009年中期业绩快报,/disclosure/listedinfo/announcement/c/2009-08-24/600196_20090824_1.pdf
336,2009-08-28,复星医药第四届董事会第五十五次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2009-08-28/600196_20090828_1.pdf
337,2009-08-28,复星医药半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-28/600196_2009_zzy.pdf
338,2009-08-28,复星医药半年报,/disclosure/listedinfo/announcement/c/2009-08-28/600196_2009_z.pdf
339,2009-09-05,复星医药为下属控股公司上海科技进出口有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2009-09-05/600196_20090905_3.pdf
340,2009-09-05,复星医药关于公司与国药控股股份有限公司签订持续关联交易协议的公告,/disclosure/listedinfo/announcement/c/2009-09-05/600196_20090905_2.pdf
341,2009-09-05,复星医药第四届董事会第五十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-09-05/600196_20090905_1.pdf
342,2009-09-11,复星医药关于公司旗下参股投资的国药控股股份有限公司全球发售股份的提示性公告,/disclosure/listedinfo/announcement/c/2009-09-11/600196_20090911_1.pdf
343,2009-09-23,复星医药关于公司旗下参股投资的国药控股股份有限公司于香港联合交易所有限公司挂牌上市的提示性公告,/disclosure/listedinfo/announcement/c/2009-09-23/600196_20090923_1.pdf
344,2009-09-29,复星医药关于公司旗下参股投资的国药控股股份有限公司公布2009年中期业绩的提示性公告,/disclosure/listedinfo/announcement/c/2009-09-29/600196_20090929_1.pdf
345,2009-10-14,复星医药为下属控股公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2009-10-14/600196_20091014_2.pdf
346,2009-10-14,复星医药公告,/disclosure/listedinfo/announcement/c/2009-10-14/600196_20091014_3.pdf
347,2009-10-14,复星医药第四届董事会第五十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-10-14/600196_20091014_1.pdf
348,2009-10-20,复星医药关于旗下参股投资的国药控股股份有限公司全球发行稳定价格期结束及超额配股权实施完毕的提示性公告,/disclosure/listedinfo/announcement/c/2009-10-20/600196_20091020_2.pdf
349,2009-10-20,复星医药2009年前三季度业绩预增公告,/disclosure/listedinfo/announcement/c/2009-10-20/600196_20091020_1.pdf
350,2009-10-29,复星医药关于下属控股公司上海复星医药产业发展有限公司转让复地（集团）股份有限公司股份的关联交易公告,/disclosure/listedinfo/announcement/c/2009-10-29/600196_20091029_2.pdf
351,2009-10-29,复星医药关于下属控股公司上海复星平耀投资管理有限公司转让上海复星谱润股权投资企业(有限合伙)出资份额的关联交易公告,/disclosure/listedinfo/announcement/c/2009-10-29/600196_20091029_3.pdf
352,2009-10-29,复星医药第四届董事会第五十八次会议（定期会议）决议暨召开2009年第四次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2009-10-29/600196_20091029_1.pdf
353,2009-10-29,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-29/600196_2009_3.pdf
354,2009-11-07,复星医药2009年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-11-07/600196_20091107_1.pdf
355,2009-11-11,复星医药关于下属控股公司江苏万邦生化医药股份有限公司与D-Pharm Ltd.签署药物合作开发、许可及供货协议的公告,/disclosure/listedinfo/announcement/c/2009-11-11/600196_20091111_1.pdf
356,2009-11-11,复星医药关于下属控股公司减资的公告,/disclosure/listedinfo/announcement/c/2009-11-11/600196_20091111_2.pdf
357,2009-11-19,复星医药关于控股公司复星实业（香港）有限公司购入Chindex International Inc.股份的公告,/disclosure/listedinfo/announcement/c/2009-11-19/600196_20091119_2.pdf
358,2009-11-19,复星医药2009年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-11-19/600196_20091119_1.pdf
359,2009-11-19,复星医药2009年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-11-19/600196_20091119_3.pdf
360,2009-11-24,复星医药为下属控股公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2009-11-24/600196_20091124_2.pdf
361,2009-11-24,复星医药第四届董事会第五十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-11-24/600196_20091124_1.pdf
362,2009-12-12,复星医药关于公司向上海银行股份有限公司营业部借款的关联交易公告,/disclosure/listedinfo/announcement/c/2009-12-12/600196_20091212_2.pdf
363,2009-12-12,复星医药第四届董事会六十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2009-12-12/600196_20091212_1.pdf
364,2009-12-22,复星医药第四届董事会第六十三次会议（临时会议）决议暨召开2010年第一次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2009-12-22/600196_20091222_1.pdf
365,2009-12-22,复星医药2009年非公开发行A股股票预案（修订）,/disclosure/listedinfo/announcement/c/2009-12-22/600196_20091222_2.pdf
366,2009-12-30,复星医药2010年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-12-30/600196_20091230_1.pdf
367,2010-01-04,复星医药关于2010年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2010-01-04/600196_20100104_1.pdf
368,2010-01-09,复星医药2010年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-01-09/600196_20100109_1.pdf
369,2010-01-09,复星医药2010年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-01-09/600196_20100109_2.pdf
370,2010-01-12,复星医药2009年度业绩预增公告,/disclosure/listedinfo/announcement/c/2010-01-12/600196_20100112_1.pdf
371,2010-01-15,复星医药为下属控股公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-01-15/600196_20100115_2.pdf
372,2010-01-15,复星医药第四届董事会第六十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-01-15/600196_20100115_1.pdf
373,2010-01-28,复星医药关于公司非公开发行A股股票方案获中国证券监督管理委员会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2010-01-28/600196_20100128_1.pdf
374,2010-02-02,复星医药关于公司高管辞职的公告,/disclosure/listedinfo/announcement/c/2010-02-02/600196_20100202_1.pdf
375,2010-02-06,复星医药为下属控股公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-02-06/600196_20100206_2.pdf
376,2010-02-06,复星医药第四届董事会第六十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-02-06/600196_20100206_1.pdf
377,2010-02-12,复星医药公告,/disclosure/listedinfo/announcement/c/2010-02-12/600196_20100212_1.pdf
378,2010-02-27,复星医药为下属控股公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-02-27/600196_20100227_2.pdf
379,2010-02-27,复星医药第四届董事会第六十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-02-27/600196_20100227_1.pdf
380,2010-03-25,复星医药外部信息报送及使用管理制度,/disclosure/listedinfo/announcement/c/2010-03-25/600196_20100325_6.pdf
381,2010-03-25,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2010-03-25/600196_2009_nzy.pdf
382,2010-03-25,复星医药年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-03-25/600196_20100325_8.pdf
383,2010-03-25,复星医药年报,/disclosure/listedinfo/announcement/c/2010-03-25/600196_2009_n.pdf
384,2010-03-25,复星医药内幕信息知情人管理制度,/disclosure/listedinfo/announcement/c/2010-03-25/600196_20100325_7.pdf
385,2010-03-25,复星医药控股股东及其它关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2010-03-25/600196_20100325_5.pdf
386,2010-03-25,复星医药关于2009年日常关联交易报告及2010年日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2010-03-25/600196_20100325_3.pdf
387,2010-03-25,复星医药董事、监事和高级管理人员所持本公司股份及其变动管理办法,/disclosure/listedinfo/announcement/c/2010-03-25/600196_20100325_9.pdf
388,2010-03-25,复星医药第四届监事会2010年第一次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2010-03-25/600196_20100325_2.pdf
389,2010-03-25,复星医药第四届董事会第六十九次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2010-03-25/600196_20100325_1.pdf
390,2010-03-25,复星医药2010年第一季度业绩预增公告,/disclosure/listedinfo/announcement/c/2010-03-25/600196_20100325_4.pdf
391,2010-03-27,复星医药关于非公开发行股票申请获得中国证券监督管理委员会核准的公告,/disclosure/listedinfo/announcement/c/2010-03-27/600196_20100327_1.pdf
392,2010-04-09,复星医药公告,/disclosure/listedinfo/announcement/c/2010-04-09/600196_20100409_1.pdf
393,2010-04-10,复星医药第四届董事会第七十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-04-10/600196_20100410_1.pdf
394,2010-04-20,复星医药股改限售流通股上市公告,/disclosure/listedinfo/announcement/c/2010-04-20/600196_20100420_1.pdf
395,2010-04-22,复星医药为下属控股公司上海复星医药投资有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-04-22/600196_20100422_3.pdf
396,2010-04-22,复星医药为下属控股公司上海复星药业有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-04-22/600196_20100422_2.pdf
397,2010-04-22,复星医药第四届董事会第七十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-04-22/600196_20100422_1.pdf
398,2010-04-29,复星医药第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-29/600196_2010_1.pdf
399,2010-04-29,复星医药第四届董事会第七十四次会议（定期会议）决议暨召开2010年第二次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2010-04-29/600196_20100429_1.pdf
400,2010-05-06,复星医药非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2010-05-06/600196_20100506_2.pdf
401,2010-05-06,复星医药非公开发行股票发行结果暨股本变动公告,/disclosure/listedinfo/announcement/c/2010-05-06/600196_20100506_1.pdf
402,2010-05-06,复星医药2010年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-05-06/600196_20100506_3.pdf
403,2010-05-13,复星医药关于签署募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2010-05-13/600196_20100513_1.pdf
404,2010-05-15,复星医药第四届董事会第七十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-05-15/600196_20100515_2.pdf
405,2010-05-15,复星医药2010年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-05-15/600196_20100515_1.pdf
406,2010-05-15,复星医药2010年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-05-15/600196_20100515_3.pdf
407,2010-05-20,复星医药第四届监事会2010年第三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-05-20/600196_20100520_2.pdf
408,2010-05-20,复星医药第四届董事会第七十六次会议（临时会议）决议暨召开2009年度股东大会的公告,/disclosure/listedinfo/announcement/c/2010-05-20/600196_20100520_1.pdf
409,2010-05-25,复星医药关于公司旗下参股投资的湖南汉森制药股份有限公司首次公开发行股票于深圳证券交易所上市的提示性公告,/disclosure/listedinfo/announcement/c/2010-05-25/600196_20100525_1.pdf
410,2010-05-29,复星医药第四届董事会第七十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-05-29/600196_20100529_1.pdf
411,2010-06-02,复星医药2009年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-06-02/600196_20100602_1.pdf
412,2010-06-03,复星医药公告,/disclosure/listedinfo/announcement/c/2010-06-03/600196_20100603_1.pdf
413,2010-06-10,复星医药第五届监事会2010年第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-06-10/600196_20100610_3.pdf
414,2010-06-10,复星医药第五届董事会第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-06-10/600196_20100610_2.pdf
415,2010-06-10,复星医药2009年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-06-10/600196_20100610_1.pdf
416,2010-06-10,复星医药2009年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-06-10/600196_20100610_4.pdf
417,2010-06-17,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2010-06-17/600196_20100617_2.pdf
418,2010-06-17,复星医药第五届董事会第三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-06-17/600196_20100617_1.pdf
419,2010-06-30,复星医药关于控股孙公司重庆药友制药有限责任公司为其全资子公司重庆凯林制药有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-06-30/600196_20100630_2.pdf
420,2010-06-30,复星医药第五届董事会第四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-06-30/600196_20100630_1.pdf
421,2010-07-01,复星医药关于控股子公司复星实业（香港）有限公司购入Chindex International Inc.股份的公告,/disclosure/listedinfo/announcement/c/2010-07-01/600196_20100701_1.pdf
422,2010-07-03,复星医药关于控股子公司复星实业（香港）有限公司购入Chindex International Inc.股份的公告,/disclosure/listedinfo/announcement/c/2010-07-03/600196_20100703_1.pdf
423,2010-07-13,复星医药关于控股子公司复星实业（香港）有限公司购入Chindex International Inc.股份的公告,/disclosure/listedinfo/announcement/c/2010-07-13/600196_20100713_1.pdf
424,2010-07-20,复星医药2009年度利润分配及资本公积转增股本实施公告,/disclosure/listedinfo/announcement/c/2010-07-20/600196_20100720_1.pdf
425,2010-07-24,复星医药为下属控股子公司复星实业（香港）有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-07-24/600196_20100724_2.pdf
426,2010-07-24,复星医药第五届董事会第五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-07-24/600196_20100724_1.pdf
427,2010-07-30,复星医药2010年中期业绩预增公告,/disclosure/listedinfo/announcement/c/2010-07-30/600196_20100730_1.pdf
428,2010-07-31,复星医药关于控股子公司复星实业（香港）有限公司购入Chindex International Inc.股份的公告,/disclosure/listedinfo/announcement/c/2010-07-31/600196_20100731_1.pdf
429,2010-07-31,复星医药第五届监事会2010年第二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-07-31/600196_20100731_3.pdf
430,2010-07-31,复星医药第五届董事会第六次会议（临时会议）决议暨召开2010年第三次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2010-07-31/600196_20100731_2.pdf
431,2010-08-04,复星医药关于控股子公司复星实业（香港）有限公司购入Chindex International Inc.股份的公告,/disclosure/listedinfo/announcement/c/2010-08-04/600196_20100804_1.pdf
432,2010-08-07,复星医药第五届董事会第七次会议（临时会议）决议的公告,/disclosure/listedinfo/announcement/c/2010-08-07/600196_20100807_1.pdf
433,2010-08-07,复星医药2010年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-08-07/600196_20100807_2.pdf
434,2010-08-18,复星医药2010年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-08-18/600196_20100818_1.pdf
435,2010-08-18,复星医药2010年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-08-18/600196_20100818_2.pdf
436,2010-08-20,复星医药关于以募集资金置换预先投入募集资金投资项目自筹资金实施完成的公告,/disclosure/listedinfo/announcement/c/2010-08-20/600196_20100820_1.pdf
437,2010-08-26,复星医药关联交易及为全资子公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-08-26/600196_20100826_2.pdf
438,2010-08-26,复星医药第五届董事会第九次会议（定期会议）决议的公告,/disclosure/listedinfo/announcement/c/2010-08-26/600196_20100826_1.pdf
439,2010-08-26,复星医药半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-26/600196_2010_zzy.pdf
440,2010-08-26,复星医药半年报,/disclosure/listedinfo/announcement/c/2010-08-26/600196_2010_z.pdf
441,2010-08-26,复星医药2010年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2010-08-26/600196_20100826_3.pdf
442,2010-08-28,复星医药关于对外投资进展公告,/disclosure/listedinfo/announcement/c/2010-08-28/600196_20100828_1.pdf
443,2010-09-09,复星医药关于为全资子公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-09-09/600196_20100909_2.pdf
444,2010-09-09,复星医药第五届董事会第十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-09-09/600196_20100909_1.pdf
445,2010-09-30,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2010-09-30/600196_20100930_1.pdf
446,2010-10-12,复星医药关于中期票据获准注册的公告,/disclosure/listedinfo/announcement/c/2010-10-12/600196_20101012_3.pdf
447,2010-10-12,复星医药关于全资子公司上海复星医药投资有限公司对北京金象大药房医药连锁有限责任公司增资的关联交易公告,/disclosure/listedinfo/announcement/c/2010-10-12/600196_20101012_2.pdf
448,2010-10-12,复星医药第五届董事会第十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-10-12/600196_20101012_1.pdf
449,2010-10-14,复星医药更正公告,/disclosure/listedinfo/announcement/c/2010-10-14/600196_20101014_1.pdf
450,2010-10-16,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2010-10-16/600196_20101016_1.pdf
451,2010-10-28,复星医药第五届董事会第十五次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2010-10-28/600196_20101028_1.pdf
452,2010-10-28,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-28/600196_2010_3.pdf
453,2010-11-02,复星医药与周林林先生、金重仁先生对控股子公司上海复星化工医药投资有限公司同比例增资的关联交易公告,/disclosure/listedinfo/announcement/c/2010-11-02/600196_20101102_2.pdf
454,2010-11-02,复星医药第五届董事会第十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-11-02/600196_20101102_1.pdf
455,2010-11-05,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2010-11-05/600196_20101105_1.pdf
456,2010-11-11,复星医药2010年度第一期中期票据发行情况的公告,/disclosure/listedinfo/announcement/c/2010-11-11/600196_20101111_1.pdf
457,2010-11-16,复星医药关于控股孙公司江苏万邦生化医药股份有限公司为其控股子公司徐州万邦金桥制药有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-11-16/600196_20101116_2.pdf
458,2010-11-16,复星医药第五届董事会第十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-11-16/600196_20101116_1.pdf
459,2010-12-04,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2010-12-04/600196_20101204_1.pdf
460,2010-12-08,复星医药关于为全资子公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-12-08/600196_20101208_2.pdf
461,2010-12-08,复星医药第五届董事会第二十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-12-08/600196_20101208_1.pdf
462,2010-12-29,"复星医药关于公司与Chindex International,Inc.整合医疗器械业务的公告",/disclosure/listedinfo/announcement/c/2010-12-29/600196_20101229_2.pdf
463,2010-12-29,复星医药第五届董事会第二十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2010-12-29/600196_20101229_1.pdf
464,2010-12-31,复星医药关于公司高管辞职的公告,/disclosure/listedinfo/announcement/c/2010-12-31/600196_20101231_1.pdf
465,2011-01-29,复星医药关于下属全资子公司受让大连雅立峰生物制药有限公司股权的公告,/disclosure/listedinfo/announcement/c/2011-01-29/600196_20110129_3.pdf
466,2011-01-29,复星医药第五届董事会第二十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-01-29/600196_20110129_2.pdf
467,2011-01-29,复星医药2010年度业绩预告,/disclosure/listedinfo/announcement/c/2011-01-29/600196_20110129_1.pdf
468,2011-02-12,复星医药关于为全资子公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2011-02-12/600196_20110212_2.pdf
469,2011-02-12,复星医药第五届董事会第二十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-02-12/600196_20110212_1.pdf
470,2011-02-24,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2011-02-24/600196_20110224_1.pdf
471,2011-03-01,复星医药对控股孙公司重庆药友制药有限责任公司增资的公告,/disclosure/listedinfo/announcement/c/2011-03-01/600196_20110301_2.pdf
472,2011-03-01,复星医药第五届董事会第二十九次会议（临时会议）决议暨召开2011年第一次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2011-03-01/600196_20110301_1.pdf
473,2011-03-05,复星医药关于增加2011年第一次临时股东大会临时提案的公告及2011年第一次临时股东大会的补充通知,/disclosure/listedinfo/announcement/c/2011-03-05/600196_20110305_2.pdf
474,2011-03-05,复星医药第五届董事会第三十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-03-05/600196_20110305_1.pdf
475,2011-03-05,复星医药2011年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-03-05/600196_20110305_3.pdf
476,2011-03-15,复星医药关于全资子公司上海齐绅投资管理有限公司向国药产业投资有限公司提供委托贷款的关联交易公告,/disclosure/listedinfo/announcement/c/2011-03-15/600196_20110315_2.pdf
477,2011-03-15,复星医药第五届董事会第三十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-03-15/600196_20110315_1.pdf
478,2011-03-17,复星医药2011年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-03-17/600196_20110317_1.pdf
479,2011-03-17,复星医药2011年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-03-17/600196_20110317_2.pdf
480,2011-03-26,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2011-03-26/600196_2010_nzy.pdf
481,2011-03-26,复星医药年报,/disclosure/listedinfo/announcement/c/2011-03-26/600196_2010_n.pdf
482,2011-03-26,复星医药内部控制审核报告,/disclosure/listedinfo/announcement/c/2011-03-26/600196_20110326_5.pdf
483,2011-03-26,复星医药控股股东及其它关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2011-03-26/600196_20110326_4.pdf
484,2011-03-26,复星医药关于2010年日常关联交易报告及2011年日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2011-03-26/600196_20110326_2.pdf
485,2011-03-26,复星医药第五届监事会2011年第一次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2011-03-26/600196_20110326_3.pdf
486,2011-03-26,复星医药第五届董事会第三十二次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2011-03-26/600196_20110326_1.pdf
487,2011-03-26,复星医药2010年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2011-03-26/600196_20110326_6.pdf
488,2011-04-01,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2011-04-01/600196_20110401_2.pdf
489,2011-04-01,复星医药2011年度第一期中期票据发行情况的公告,/disclosure/listedinfo/announcement/c/2011-04-01/600196_20110401_1.pdf
490,2011-04-08,复星医药关于为控股孙公司上海复星药业有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2011-04-08/600196_20110408_2.pdf
491,2011-04-08,复星医药第五届董事会第三十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-04-08/600196_20110408_1.pdf
492,2011-04-19,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2011-04-19/600196_20110419_1.pdf
493,2011-04-20,复星医药股改限售流通股上市公告,/disclosure/listedinfo/announcement/c/2011-04-20/600196_20110420_1.pdf
494,2011-04-23,复星医药关于为全资子公司上海复星医药产业发展有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2011-04-23/600196_20110423_2.pdf
495,2011-04-23,复星医药第五届董事会第三十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-04-23/600196_20110423_1.pdf
496,2011-04-26,复星医药关于旗下参股投资的国药控股股份有限公司配售H股的提示性公告,/disclosure/listedinfo/announcement/c/2011-04-26/600196_20110426_1.pdf
497,2011-04-27,复星医药非公开发行限售流通股上市公告,/disclosure/listedinfo/announcement/c/2011-04-27/600196_20110427_1.pdf
498,2011-04-30,复星医药关于向国药产业投资有限公司提供委托贷款的关联交易公告,/disclosure/listedinfo/announcement/c/2011-04-30/600196_20110430_2.pdf
499,2011-04-30,复星医药关于为控股孙公司江苏万邦生化医药股份有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2011-04-30/600196_20110430_3.pdf
500,2011-04-30,复星医药第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-30/600196_2011_1.pdf
501,2011-04-30,复星医药第五届董事会第三十五次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2011-04-30/600196_20110430_1.pdf
502,2011-05-06,复星医药关于旗下参股投资的国药控股股份有限公司完成H股配售的提示性公告,/disclosure/listedinfo/announcement/c/2011-05-06/600196_20110506_1.pdf
503,2011-05-17,复星医药第五届董事会第三十六次会议（临时会议）决议暨召开2010年度股东大会的公告,/disclosure/listedinfo/announcement/c/2011-05-17/600196_20110517_1.pdf
504,2011-05-28,复星医药2010年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-05-28/600196_20110528_1.pdf
505,2011-06-09,复星医药2010年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-06-09/600196_20110609_1.pdf
506,2011-06-09,复星医药2010年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-06-09/600196_20110609_2.pdf
507,2011-06-11,复星医药董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2011-06-11/600196_20110611_2.pdf
508,2011-06-11,复星医药第五届董事会第三十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-06-11/600196_20110611_1.pdf
509,2011-06-21,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2011-06-21/600196_20110621_2.pdf
510,2011-06-21,复星医药第五届董事会第三十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-06-21/600196_20110621_1.pdf
511,2011-07-02,复星医药第五届董事会第四十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-07-02/600196_20110702_1.pdf
512,2011-07-05,复星医药2010年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2011-07-05/600196_20110705_1.pdf
513,2011-08-23,复星医药关于全资子公司上海复星医药投资有限公司转让浙江复星医药有限公司68.6%股权的关联交易公告,/disclosure/listedinfo/announcement/c/2011-08-23/600196_20110823_3.pdf
514,2011-08-23,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2011-08-23/600196_20110823_2.pdf
515,2011-08-23,复星医药第五届董事会第四十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-08-23/600196_20110823_1.pdf
516,2011-08-26,复星医药2011年中期业绩快报,/disclosure/listedinfo/announcement/c/2011-08-26/600196_20110826_1.pdf
517,2011-08-30,复星医药关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2011-08-30/600196_20110830_3.pdf
518,2011-08-30,复星医药关于全资子公司上海复星医药产业发展有限公司受让锦州奥鸿药业有限责任公司股权的公告,/disclosure/listedinfo/announcement/c/2011-08-30/600196_20110830_4.pdf
519,2011-08-30,复星医药关于全资子公司复星实业（香港）有限公司购入Simcere Pharmaceutical Group股份的公告,/disclosure/listedinfo/announcement/c/2011-08-30/600196_20110830_5.pdf
520,2011-08-30,复星医药第五届监事会2011年第三次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2011-08-30/600196_20110830_2.pdf
521,2011-08-30,复星医药第五届董事会第四十三次会议（定期会议）决议暨召开2011年第二次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2011-08-30/600196_20110830_1.pdf
522,2011-08-30,复星医药半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-30/600196_2011_zzy.pdf
523,2011-08-30,复星医药半年报,/disclosure/listedinfo/announcement/c/2011-08-30/600196_2011_z.pdf
524,2011-09-02,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2011-09-02/600196_20110902_1.pdf
525,2011-09-06,复星医药2011年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-09-06/600196_20110906_1.pdf
526,2011-09-16,复星医药2011年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-09-16/600196_20110916_1.pdf
527,2011-09-16,复星医药2011年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-09-16/600196_20110916_2.pdf
528,2011-09-29,复星医药关于公司投资者关系联系电话及传真变更的公告,/disclosure/listedinfo/announcement/c/2011-09-29/600196_20110929_1.pdf
529,2011-10-22,复星医药关于向湖北新生源生物工程股份有限公司提供委托贷款的关联交易公告,/disclosure/listedinfo/announcement/c/2011-10-22/600196_20111022_2.pdf
530,2011-10-22,复星医药第五届董事会第四十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-10-22/600196_20111022_1.pdf
531,2011-10-25,复星医药关于发行公司债券申请获得中国证券监督管理委员会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2011-10-25/600196_20111025_1.pdf
532,2011-10-31,复星医药第五届董事会第四十六次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2011-10-31/600196_20111031_1.pdf
533,2011-10-31,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-31/600196_2011_3.pdf
534,2011-11-03,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2011-11-03/600196_20111103_2.pdf
535,2011-11-03,复星医药第五届董事会第四十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-11-03/600196_20111103_1.pdf
536,2011-11-11,复星医药关于全资子公司复星实业（香港）有限公司购入Simcere Pharmaceutical Group股份的公告,/disclosure/listedinfo/announcement/c/2011-11-11/600196_20111111_1.pdf
537,2011-11-19,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2011-11-19/600196_20111119_2.pdf
538,2011-11-19,复星医药第五届董事会第四十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-11-19/600196_20111119_1.pdf
539,2011-11-25,复星医药关于公开发行公司债券获得中国证券监督管理委员会核准的公告,/disclosure/listedinfo/announcement/c/2011-11-25/600196_20111125_1.pdf
540,2011-12-03,复星医药关于与上海复星高科技集团财务有限公司签订《金融服务协议》的关联交易公告,/disclosure/listedinfo/announcement/c/2011-12-03/600196_20111203_2.pdf
541,2011-12-03,复星医药第五届董事会第五十次会议（临时会议）决议公告暨召开2011年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-12-03/600196_20111203_1.pdf
542,2011-12-10,复星医药关于增加2011年第三次临时股东大会临时提案的公告及2011年第三次临时股东大会的补充通知,/disclosure/listedinfo/announcement/c/2011-12-10/600196_20111210_2.pdf
543,2011-12-10,复星医药第五届董事会第五十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-12-10/600196_20111210_1.pdf
544,2011-12-13,复星医药2011年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-12-13/600196_20111213_1.pdf
545,2011-12-21,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2011-12-21/600196_20111221_3.pdf
546,2011-12-21,复星医药第五届董事会第五十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2011-12-21/600196_20111221_2.pdf
547,2011-12-21,复星医药2011年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-12-21/600196_20111221_1.pdf
548,2011-12-21,复星医药2011年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-12-21/600196_20111221_4.pdf
549,2012-01-14,复星医药关于变更部分募集资金投资项目的公告,/disclosure/listedinfo/announcement/c/2012-01-14/600196_20120114_4.pdf
550,2012-01-14,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2012-01-14/600196_20120114_3.pdf
551,2012-01-14,复星医药第五届监事会2012年第一次会议（临时会议）公告,/disclosure/listedinfo/announcement/c/2012-01-14/600196_20120114_2.pdf
552,2012-01-14,复星医药第五届董事会第五十四次会议（临时会议）决议公告暨召开2012年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-01-14/600196_20120114_1.pdf
553,2012-01-18,复星医药2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-01-18/600196_20120118_1.pdf
554,2012-02-01,复星医药2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-02-01/600196_20120201_1.pdf
555,2012-02-01,复星医药2012年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-02-01/600196_20120201_2.pdf
556,2012-02-23,复星医药关于控股股东增持本公司股份的公告,/disclosure/listedinfo/announcement/c/2012-02-23/600196_20120223_1.pdf
557,2012-02-25,复星医药关于闲置募集资金暂时补充流动资金到期归还的公告,/disclosure/listedinfo/announcement/c/2012-02-25/600196_20120225_1.pdf
558,2012-02-25,复星医药关联交易公告,/disclosure/listedinfo/announcement/c/2012-02-25/600196_20120225_3.pdf
559,2012-02-25,复星医药第五届董事会第五十五次会议（临时会议）决议公告暨召开2012年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-02-25/600196_20120225_2.pdf
560,2012-03-03,复星医药2012年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-03-03/600196_20120303_1.pdf
561,2012-03-07,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2012-03-07/600196_20120307_2.pdf
562,2012-03-07,复星医药第五届董事会第五十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-03-07/600196_20120307_1.pdf
563,2012-03-14,复星医药2012年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-03-14/600196_20120314_1.pdf
564,2012-03-14,复星医药2012年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-03-14/600196_20120314_2.pdf
565,2012-03-22,复星医药关于全资子公司复星实业（香港）有限公司购入Simcere Pharmaceutical Group股份的公告,/disclosure/listedinfo/announcement/c/2012-03-22/600196_20120322_1.pdf
566,2012-03-24,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2012-03-24/600196_2011_nzy.pdf
567,2012-03-24,复星医药年报,/disclosure/listedinfo/announcement/c/2012-03-24/600196_2011_n.pdf
568,2012-03-24,复星医药内部控制审核报告,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_10.pdf
569,2012-03-24,复星医药内部控制规范实施工作方案,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_11.pdf
570,2012-03-24,复星医药募集资金存放与实际使用情况专项审核报告,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_8.pdf
571,2012-03-24,复星医药控股股东及其它关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_7.pdf
572,2012-03-24,复星医药关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_4.pdf
573,2012-03-24,复星医药关于2011年日常关联交易执行情况及2012年日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_5.pdf
574,2012-03-24,复星医药关于2011年度计提资产减值准备的公告,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_3.pdf
575,2012-03-24,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_6.pdf
576,2012-03-24,复星医药独立董事2011年度述职报告,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_12.pdf
577,2012-03-24,复星医药第五届监事会2012年第二次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_2.pdf
578,2012-03-24,复星医药第五届董事会第五十七次会议（定期会议）决议公告暨召开2011年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_1.pdf
579,2012-03-24,复星医药2011年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_13.pdf
580,2012-03-24,复星医药2011年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2012-03-24/600196_20120324_9.pdf
581,2012-04-07,复星医药2011年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-04-07/600196_20120407_1.pdf
582,2012-04-10,复星医药第五届董事会第五十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-04-10/600196_20120410_1.pdf
583,2012-04-11,复星医药关于发行境外上市外资股获得中国证券监督管理委员会批复的公告,/disclosure/listedinfo/announcement/c/2012-04-11/600196_20120411_1.pdf
584,2012-04-18,复星医药2011年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-04-18/600196_20120418_1.pdf
585,2012-04-18,复星医药2011年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-04-18/600196_20120418_2.pdf
586,2012-04-23,复星医药公开发行2011年公司债券（第一期）募集说明书摘要,/disclosure/listedinfo/announcement/c/2012-04-23/600196_20120423_3.pdf
587,2012-04-23,复星医药公开发行2011年公司债券（第一期）募集说明书,/disclosure/listedinfo/announcement/c/2012-04-23/600196_20120423_2.pdf
588,2012-04-23,复星医药公开发行2011年公司债券（第一期）发行公告,/disclosure/listedinfo/announcement/c/2012-04-23/600196_20120423_1.pdf
589,2012-04-24,复星医药关于香港联合交易所有限公司审议公司境外发行上市外资股的公告,/disclosure/listedinfo/announcement/c/2012-04-24/600196_20120424_1.pdf
590,2012-04-25,复星医药2011年公司债券（第一期）票面利率公告,/disclosure/listedinfo/announcement/c/2012-04-25/600196_20120425_1.pdf
591,2012-04-28,复星医药第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-28/600196_2012_1.pdf
592,2012-04-28,复星医药第五届董事会第五十九次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2012-04-28/600196_20120428_1.pdf
593,2012-05-03,复星医药2011年公司债券（第一期）发行结果公告,/disclosure/listedinfo/announcement/c/2012-05-03/600196_20120503_1.pdf
594,2012-05-28,复星医药关于委托中国证券登记结算有限责任公司上海分公司代理债券兑付兑息相关事宜的公告,/disclosure/listedinfo/announcement/c/2012-05-28/600196_20120528_2.pdf
595,2012-05-28,复星医药2011年公司债券（第一期）上市公告书,/disclosure/listedinfo/announcement/c/2012-05-28/600196_20120528_1.pdf
596,2012-05-29,复星医药2011年公司债券（第一期）上市提示性公告,/disclosure/listedinfo/announcement/c/2012-05-29/600196_20120529_1.pdf
597,2012-06-05,复星医药2011年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2012-06-05/600196_20120605_1.pdf
598,2012-06-26,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2012-06-26/600196_20120626_2.pdf
599,2012-06-26,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2012-06-26/600196_20120626_3.pdf
600,2012-06-26,复星医药第五届董事会第六十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-06-26/600196_20120626_1.pdf
601,2012-06-30,复星医药关于向江苏万邦生化医药股份有限公司提供委托贷款的关联交易公告,/disclosure/listedinfo/announcement/c/2012-06-30/600196_20120630_2.pdf
602,2012-06-30,复星医药第五届董事会第六十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-06-30/600196_20120630_1.pdf
603,2012-07-10,复星医药关于向控股孙公司湖北新生源生物工程股份有限公司提供委托贷款的关联交易公告,/disclosure/listedinfo/announcement/c/2012-07-10/600196_20120710_2.pdf
604,2012-07-10,复星医药第五届董事会第六十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-07-10/600196_20120710_1.pdf
605,2012-07-21,复星医药关于转让永安财产保险股份有限公司股份的关联交易公告,/disclosure/listedinfo/announcement/c/2012-07-21/600196_20120721_2.pdf
606,2012-07-21,复星医药第五届董事会第六十四次会议（临时会议）决议公告暨召开2012年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-07-21/600196_20120721_1.pdf
607,2012-07-27,复星医药2012年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-07-27/600196_20120727_1.pdf
608,2012-08-07,复星医药2012年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-08-07/600196_20120807_1.pdf
609,2012-08-07,复星医药2012年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-08-07/600196_20120807_2.pdf
610,2012-08-23,复星医药关于控股孙公司江苏万邦生化医药股份有限公司增资的关联交易公告,/disclosure/listedinfo/announcement/c/2012-08-23/600196_20120823_2.pdf
611,2012-08-23,复星医药第五届董事会第六十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-08-23/600196_20120823_1.pdf
612,2012-08-28,复星医药新增日常关联交易的公告,/disclosure/listedinfo/announcement/c/2012-08-28/600196_20120828_3.pdf
613,2012-08-28,复星医药第五届监事会2012年第四次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2012-08-28/600196_20120828_2.pdf
614,2012-08-28,复星医药第五届董事会第六十七次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2012-08-28/600196_20120828_1.pdf
615,2012-08-28,复星医药半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-28/600196_2012_zzy.pdf
616,2012-08-28,复星医药半年报,/disclosure/listedinfo/announcement/c/2012-08-28/600196_2012_z.pdf
617,2012-08-28,复星医药2012年半年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2012-08-28/600196_20120828_5.pdf
618,2012-08-28,复星医药2012年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2012-08-28/600196_20120828_4.pdf
619,2012-09-15,复星医药关于药友制药注射用“炎琥宁”产品不良反应的公告,/disclosure/listedinfo/announcement/c/2012-09-15/600196_20120915_1.pdf
620,2012-09-22,复星医药关于闲置募集资金暂时补充流动资金到期归还的公告,/disclosure/listedinfo/announcement/c/2012-09-22/600196_20120922_1.pdf
621,2012-09-27,复星医药关于药友制药产品注射用“炎琥宁”不良反应的进展公告,/disclosure/listedinfo/announcement/c/2012-09-27/600196_20120927_1.pdf
622,2012-10-08,复星医药关于召开2012年第四次临时股东大会的通知公告,/disclosure/listedinfo/announcement/c/2012-10-08/600196_20121008_5.pdf
623,2012-10-08,复星医药关于与上海复星高科技集团财务有限公司续签《金融服务协议》的关联交易公告,/disclosure/listedinfo/announcement/c/2012-10-08/600196_20121008_4.pdf
624,2012-10-08,复星医药关联交易公告,/disclosure/listedinfo/announcement/c/2012-10-08/600196_20121008_2.pdf
625,2012-10-08,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2012-10-08/600196_20121008_3.pdf
626,2012-10-08,复星医药第五届董事会第六十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-10-08/600196_20121008_1.pdf
627,2012-10-09,复星医药关于刊发H股发行网上预览资料集的公告,/disclosure/listedinfo/announcement/c/2012-10-09/600196_20121009_2.pdf
628,2012-10-09,复星医药第五届董事会第七十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-10-09/600196_20121009_1.pdf
629,2012-10-13,复星医药2012年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-10-13/600196_20121013_1.pdf
630,2012-10-16,复星医药关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2012-10-16/600196_20121016_4.pdf
631,2012-10-16,复星医药关于刊发H股发行网上预览资料集（更新稿）的公告,/disclosure/listedinfo/announcement/c/2012-10-16/600196_20121016_1.pdf
632,2012-10-16,复星医药第五届监事会2012年第五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-10-16/600196_20121016_3.pdf
633,2012-10-16,复星医药第五届董事会第七十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-10-16/600196_20121016_2.pdf
634,2012-10-18,复星医药关于H股公开发售相关事宜的提示性公告,/disclosure/listedinfo/announcement/c/2012-10-18/600196_20121018_1.pdf
635,2012-10-18,复星医药H股--中文招股书,/disclosure/listedinfo/announcement/c/2012-10-18/600196_20121018_4.pdf
636,2012-10-18,复星医药H股--英文招股书,/disclosure/listedinfo/announcement/c/2012-10-18/600196_20121018_5.pdf
637,2012-10-18,复星医药H股--全球发售公告中文,/disclosure/listedinfo/announcement/c/2012-10-18/600196_20121018_2.pdf
638,2012-10-18,复星医药H股--全球发售公告英文,/disclosure/listedinfo/announcement/c/2012-10-18/600196_20121018_3.pdf
639,2012-10-25,复星医药关于公司投资者关系邮箱变更的公告,/disclosure/listedinfo/announcement/c/2012-10-25/600196_20121025_1.pdf
640,2012-10-25,复星医药2012年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-10-25/600196_20121025_2.pdf
641,2012-10-25,复星医药2012年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-10-25/600196_20121025_3.pdf
642,2012-10-30,复星医药关于境外上市外资股（H股）挂牌并上市交易的公告,/disclosure/listedinfo/announcement/c/2012-10-30/600196_20121030_2.pdf
643,2012-10-30,复星医药关于境外上市外资股（H股）公开发行价格的公告,/disclosure/listedinfo/announcement/c/2012-10-30/600196_20121030_1.pdf
644,2012-10-30,复星医药关于股东、关联方及上市公司承诺履行情况的公告,/disclosure/listedinfo/announcement/c/2012-10-30/600196_20121030_3.pdf
645,2012-10-31,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-31/600196_2012_3.pdf
646,2012-11-06,复星医药关于短期融资券获准注册的公告,/disclosure/listedinfo/announcement/c/2012-11-06/600196_20121106_1.pdf
647,2012-11-20,复星医药关于控股股东增持本公司股份的进展公告,/disclosure/listedinfo/announcement/c/2012-11-20/600196_20121120_1.pdf
648,2012-11-22,复星医药关于稳定价格期限结束、稳定价格行动及超额配股权失效的公告,/disclosure/listedinfo/announcement/c/2012-11-22/600196_20121122_1.pdf
649,2012-12-05,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2012-12-05/600196_20121205_2.pdf
650,2012-12-05,复星医药第五届董事会第七十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-12-05/600196_20121205_3.pdf
651,2012-12-05,复星医药H股公告,/disclosure/listedinfo/announcement/c/2012-12-05/600196_20121205_1.pdf
652,2012-12-20,复星医药关于2012年度第一期短期融资券发行完成的公告,/disclosure/listedinfo/announcement/c/2012-12-20/600196_20121220_1.pdf
653,2012-12-22,复星医药第五届董事会第七十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2012-12-22/600196_20121222_1.pdf
654,2013-01-05,复星医药日常关联（连）交易调整的公告,/disclosure/listedinfo/announcement/c/2013-01-04/600196_20130105_3.pdf
655,2013-01-05,复星医药第五届董事会第七十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-01-04/600196_20130105_2.pdf
656,2013-01-05,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-01-04/600196_20130105_1.pdf
657,2013-02-05,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-02-04/600196_20130205_1.pdf
658,2013-02-22,复星医药关于控股股东增持本公司股份计划实施完毕的公告,/disclosure/listedinfo/announcement/c/2013-02-21/600196_20130222_1.pdf
659,2013-02-22,复星医药：瑛明律师事务所关于上海复星高科技（集团）有限公司增持上海复星医药（集团）股份有限公司股份事宜之专项核查法律意见书,/disclosure/listedinfo/announcement/c/2013-02-21/600196_20130222_2.pdf
660,2013-03-01,复星医药第五届董事会第八十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-02-28/600196_20130301_1.pdf
661,2013-03-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-03-01/600196_20130302_1.pdf
662,2013-03-13,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-03-12/600196_20130313_1.pdf
663,2013-03-27,复星医药新增委托贷款额度公告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_5.pdf
664,2013-03-27,复星医药日常关联交易公告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_9.pdf
665,2013-03-27,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2013-03-26/600196_2012_nzy.pdf
666,2013-03-27,复星医药年报,/disclosure/listedinfo/announcement/c/2013-03-26/600196_2012_n.pdf
667,2013-03-27,复星医药内部控制审核报告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_13.pdf
668,2013-03-27,复星医药募集资金存放与实际使用情况专项审核报告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_18.pdf
669,2013-03-27,复星医药控股股东及其它关联方占用非经营性资金情况的专项说明,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_14.pdf
670,2013-03-27,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_7.pdf
671,2013-03-27,复星医药关于吸收合并全资子公司上海复星医药投资有限公司的公告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_6.pdf
672,2013-03-27,复星医药关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_16.pdf
673,2013-03-27,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_4.pdf
674,2013-03-27,复星医药独立非执行董事2012年度述职报告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_12.pdf
675,2013-03-27,复星医药第五届监事会2013年第一次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_3.pdf
676,2013-03-27,复星医药第五届董事会第八十五次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_2.pdf
677,2013-03-27,复星医药2012年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_11.pdf
678,2013-03-27,复星医药2012年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_17.pdf
679,2013-03-27,复星医药2012年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2013-03-26/600196_20130327_15.pdf
680,2013-04-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-04-02/600196_20130403_1.pdf
681,2013-04-12,复星医药关于闲置募集资金暂时补充流动资金到期归还的公告,/disclosure/listedinfo/announcement/c/2013-04-11/600196_20130412_1.pdf
682,2013-04-12,复星医药关于旗下参股投资的国药控股股份有限公司配售H股的提示性公告,/disclosure/listedinfo/announcement/c/2013-04-11/600196_20130412_2.pdf
683,2013-04-13,复星医药第五届董事会第八十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-04-12/600196_20130413_1.pdf
684,2013-04-16,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-04-15/600196_20130416_1.pdf
685,2013-04-19,复星医药2011年公司债券（第一期）2013年付息公告,/disclosure/listedinfo/announcement/c/2013-04-18/600196_20130419_1.pdf
686,2013-04-25,复星医药非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2013-04-24/600196_20130425_1.pdf
687,2013-04-26,复星医药使用闲置募集资金暂时补充流动资金的保荐意见,/disclosure/listedinfo/announcement/c/2013-04-25/600196_20130426_6.pdf
688,2013-04-26,复星医药关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2013-04-25/600196_20130426_4.pdf
689,2013-04-26,复星医药第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-25/600196_2013_1.pdf
690,2013-04-26,复星医药第五届监事会2013年第二次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2013-04-25/600196_20130426_3.pdf
691,2013-04-26,复星医药第五届董事会第九十次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2013-04-25/600196_20130426_2.pdf
692,2013-04-27,复星医药收购资产公告,/disclosure/listedinfo/announcement/c/2013-04-26/600196_20130427_2.pdf
693,2013-04-27,复星医药第五届董事会第九十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-04-26/600196_20130427_1.pdf
694,2013-05-07,复星医药关于“11复星债”2012年跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2013-05-06/600196_20130507_2.pdf
695,2013-05-07,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-05-06/600196_20130507_1.pdf
696,2013-05-07,复星医药2011年公司债券（第一期）跟踪评级报告,/disclosure/listedinfo/announcement/c/2013-05-06/600196_20130507_3.pdf
697,2013-05-13,复星医药关于召开2012年度股东大会的通知公告,/disclosure/listedinfo/announcement/c/2013-05-12/600196_20130513_3.pdf
698,2013-05-13,复星医药2012年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-05-12/600196_20130513_1.pdf
699,2013-05-13,复星医药2011年公司债券（第一期）受托管理事务报告（2012年度）,/disclosure/listedinfo/announcement/c/2013-05-12/600196_20130513_2.pdf
700,2013-05-17,复星医药关于选举职工监事的公告,/disclosure/listedinfo/announcement/c/2013-05-16/600196_20130517_1.pdf
701,2013-05-25,复星医药第五届董事会第九十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-05-24/600196_20130525_1.pdf
702,2013-05-25,复星医药出售资产公告,/disclosure/listedinfo/announcement/c/2013-05-24/600196_20130525_2.pdf
703,2013-05-29,复星医药收购资产进展公告,/disclosure/listedinfo/announcement/c/2013-05-28/600196_20130529_1.pdf
704,2013-06-07,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-06-06/600196_20130607_2.pdf
705,2013-06-07,复星医药2012年度第一期短期融资券兑付公告,/disclosure/listedinfo/announcement/c/2013-06-06/600196_20130607_1.pdf
706,2013-06-29,复星医药第六届监事会2013年第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-06-28/600196_20130629_3.pdf
707,2013-06-29,复星医药第六届董事会第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-06-28/600196_20130629_2.pdf
708,2013-06-29,复星医药2012年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-06-28/600196_20130629_1.pdf
709,2013-06-29,复星医药2012年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-06-28/600196_20130629_4.pdf
710,2013-07-02,复星医药出售资产进展公告,/disclosure/listedinfo/announcement/c/2013-07-01/600196_20130702_1.pdf
711,2013-07-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-07-02/600196_20130703_1.pdf
712,2013-07-26,复星医药2013年中期业绩预增公告,/disclosure/listedinfo/announcement/c/2013-07-25/600196_20130726_1.pdf
713,2013-08-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-08-01/600196_20130802_1.pdf
714,2013-08-13,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-08-12/600196_20130813_2.pdf
715,2013-08-13,复星医药2012年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2013-08-12/600196_20130813_1.pdf
716,2013-08-27,复星医药新增委托贷款额度公告,/disclosure/listedinfo/announcement/c/2013-08-26/600196_20130827_4.pdf
717,2013-08-27,复星医药关于与上海复星高科技集团财务有限公司续签《金融服务协议》的关联交易公告,/disclosure/listedinfo/announcement/c/2013-08-26/600196_20130827_6.pdf
718,2013-08-27,复星医药关于吸收合并全资子公司上海齐绅投资管理有限公司的公告,/disclosure/listedinfo/announcement/c/2013-08-26/600196_20130827_7.pdf
719,2013-08-27,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2013-08-26/600196_20130827_5.pdf
720,2013-08-27,复星医药第六届监事会2013年第二次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2013-08-26/600196_20130827_3.pdf
721,2013-08-27,复星医药第六届董事会第三次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2013-08-26/600196_20130827_2.pdf
722,2013-08-27,复星医药半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-26/600196_2013_zzy.pdf
723,2013-08-27,复星医药半年报,/disclosure/listedinfo/announcement/c/2013-08-26/600196_2013_z.pdf
724,2013-08-27,复星医药2013年半年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2013-08-26/600196_20130827_10.pdf
725,2013-08-27,复星医药2013年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2013-08-26/600196_20130827_9.pdf
726,2013-08-29,复星医药关于全资子公司复星实业（香港）有限公司参与Simcere Pharmaceutical Group私有化交易的公告,/disclosure/listedinfo/announcement/c/2013-08-28/600196_20130829_1.pdf
727,2013-09-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-09-02/600196_20130903_1.pdf
728,2013-09-07,复星医药第六届董事会第四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-09-06/600196_20130907_1.pdf
729,2013-09-27,复星医药限制性股票激励计划考核管理办法,/disclosure/listedinfo/announcement/c/2013-09-26/600196_20130927_6.pdf
730,2013-09-27,复星医药限制性股票激励计划（草案）摘要公告,/disclosure/listedinfo/announcement/c/2013-09-26/600196_20130927_3.pdf
731,2013-09-27,复星医药限制性股票激励计划（草案）,/disclosure/listedinfo/announcement/c/2013-09-26/600196_20130927_5.pdf
732,2013-09-27,复星医药实施限制性股票激励计划的法律意见书,/disclosure/listedinfo/announcement/c/2013-09-26/600196_20130927_7.pdf
733,2013-09-27,复星医药独立非执行董事关于本公司限制性股票激励计划的独立意见,/disclosure/listedinfo/announcement/c/2013-09-26/600196_20130927_4.pdf
734,2013-09-27,复星医药第六届监事会2013年第三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-09-26/600196_20130927_2.pdf
735,2013-09-27,复星医药第六届董事会第五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-09-26/600196_20130927_1.pdf
736,2013-10-09,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-10-08/600196_20131009_1.pdf
737,2013-10-10,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2013-10-09/600196_20131010_2.pdf
738,2013-10-10,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2013-10-09/600196_20131010_3.pdf
739,2013-10-10,复星医药第六届董事会第六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-10-09/600196_20131010_1.pdf
740,2013-10-16,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-10-15/600196_20131016_1.pdf
741,2013-10-21,复星医药拟出售资产的提示性公告,/disclosure/listedinfo/announcement/c/2013-10-20/600196_20131021_1.pdf
742,2013-10-24,复星医药关于知识产权及相关权利转让的公告,/disclosure/listedinfo/announcement/c/2013-10-23/600196_20131024_4.pdf
743,2013-10-24,复星医药关于闲置募集资金暂时补充流动资金到期归还的公告,/disclosure/listedinfo/announcement/c/2013-10-23/600196_20131024_1.pdf
744,2013-10-24,复星医药第六届董事会第八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-10-23/600196_20131024_3.pdf
745,2013-10-24,复星医药出售资产进展公告,/disclosure/listedinfo/announcement/c/2013-10-23/600196_20131024_2.pdf
746,2013-10-30,复星医药关于限制性股票激励计划（草案）获得中国证券监督管理委员会备案无异议的公告,/disclosure/listedinfo/announcement/c/2013-10-29/600196_20131030_1.pdf
747,2013-10-31,复星医药限制性股票激励计划（草案修订稿）摘要公告,/disclosure/listedinfo/announcement/c/2013-10-30/600196_20131031_3.pdf
748,2013-10-31,复星医药限制性股票激励计划（草案修订稿）,/disclosure/listedinfo/announcement/c/2013-10-30/600196_20131031_8.pdf
749,2013-10-31,复星医药实施限制性股票激励计划的补充法律意见书,/disclosure/listedinfo/announcement/c/2013-10-30/600196_20131031_6.pdf
750,2013-10-31,复星医药关于拟发行中期票据的公告,/disclosure/listedinfo/announcement/c/2013-10-30/600196_20131031_4.pdf
751,2013-10-31,复星医药独立非执行董事关于本公司限制性股票激励计划的补充意见,/disclosure/listedinfo/announcement/c/2013-10-30/600196_20131031_7.pdf
752,2013-10-31,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-30/600196_2013_3.pdf
753,2013-10-31,复星医药第六届监事会2013年第四次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2013-10-30/600196_20131031_2.pdf
754,2013-10-31,复星医药第六届董事会第九次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2013-10-30/600196_20131031_1.pdf
755,2013-11-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-11-01/600196_20131102_1.pdf
756,2013-11-04,复星医药关于召开2013年第一次临时股东大会、2013年第一次A股类别股东会的通知公告,/disclosure/listedinfo/announcement/c/2013-11-03/600196_20131104_2.pdf
757,2013-11-04,复星医药独立非执行董事征集投票权报告书,/disclosure/listedinfo/announcement/c/2013-11-03/600196_20131104_3.pdf
758,2013-11-04,复星医药2013年第一次临时股东大会、2013年第一次A股类别股东会会议资料,/disclosure/listedinfo/announcement/c/2013-11-03/600196_20131104_1.pdf
759,2013-11-06,复星医药关于召开2013年第一次临时股东大会、2013年第一次A股类别股东会通知的更正公告,/disclosure/listedinfo/announcement/c/2013-11-05/600196_20131106_1.pdf
760,2013-11-23,复星医药澄清公告,/disclosure/listedinfo/announcement/c/2013-11-22/600196_20131123_1.pdf
761,2013-12-03,复星医药关于召开2013年第一次临时股东大会、2013年第一次A股类别股东会的再次通知,/disclosure/listedinfo/announcement/c/2013-12-02/600196_20131203_2.pdf
762,2013-12-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2013-12-02/600196_20131203_1.pdf
763,2013-12-10,复星医药使用闲置募集资金暂时补充流动资金的保荐意见,/disclosure/listedinfo/announcement/c/2013-12-09/600196_20131210_4.pdf
764,2013-12-10,复星医药关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2013-12-09/600196_20131210_3.pdf
765,2013-12-10,复星医药第六届监事会2013年第五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-12-09/600196_20131210_2.pdf
766,2013-12-10,复星医药第六届董事会第十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-12-09/600196_20131210_1.pdf
767,2013-12-21,复星医药2013年第一次临时股东大会、2013年第一次A股类别股东会和2013年第一次H股类别股东会决议的公告,/disclosure/listedinfo/announcement/c/2013-12-20/600196_20131221_1.pdf
768,2013-12-21,复星医药2013年第一次临时股东大会、2013年第一次A股类别股东会、2013年第一次H股类别股东会的法律意见书,/disclosure/listedinfo/announcement/c/2013-12-20/600196_20131221_2.pdf
769,2013-12-25,复星医药关于与上海复星高科技（集团）有限公司、南京钢铁联合有限公司对上海复星高科技集团财务有限公司同比例增资的关联交易公告,/disclosure/listedinfo/announcement/c/2013-12-24/600196_20131225_2.pdf
770,2013-12-25,复星医药关于全资子公司复星实业（香港）有限公司参与 Simcere Pharmaceutical Group 私有化交易的进展公告,/disclosure/listedinfo/announcement/c/2013-12-24/600196_20131225_3.pdf
771,2013-12-25,复星医药第六届董事会第十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2013-12-24/600196_20131225_1.pdf
772,2014-01-08,复星医药限制性股票激励计划激励对象名单,/disclosure/listedinfo/announcement/c/2014-01-07/600196_20140108_6.pdf
773,2014-01-08,复星医药关于限制性股票激励计划授予相关事项的公告,/disclosure/listedinfo/announcement/c/2014-01-07/600196_20140108_3.pdf
774,2014-01-08,复星医药独立非执行董事关于本公司限制性股票激励计划授予相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-01-07/600196_20140108_4.pdf
775,2014-01-08,复星医药第六届监事会2014年第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-01-07/600196_20140108_2.pdf
776,2014-01-08,复星医药第六届董事会第十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-01-07/600196_20140108_1.pdf
777,2014-01-08,复星医药：瑛明律师事务所关于上海复星医药（集团）股份有限公司授予限制性股票的法律意见书,/disclosure/listedinfo/announcement/c/2014-01-07/600196_20140108_5.pdf
778,2014-01-08,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-01-07/600196_20140108_7.pdf
779,2014-01-15,复星医药关于与上海复星高科技（集团）有限公司、南京钢铁联合有限公司对上海复星高科技集团财务有限公司同比例增资的关联交易进展公告,/disclosure/listedinfo/announcement/c/2014-01-14/600196_20140115_1.pdf
780,2014-01-21,复星医药第六届董事会第十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-01-20/600196_20140121_1.pdf
781,2014-01-21,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-01-20/600196_20140121_2.pdf
782,2014-01-22,复星医药章程修正案,/disclosure/listedinfo/announcement/c/2014-01-21/600196_20140122_5.pdf
783,2014-01-22,复星医药限制性股票激励计划限制性股票授予结果公告,/disclosure/listedinfo/announcement/c/2014-01-21/600196_20140122_1.pdf
784,2014-01-22,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2014-01-21/600196_20140122_3.pdf
785,2014-01-22,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2014-01-21/600196_20140122_4.pdf
786,2014-01-22,复星医药第六届董事会第十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-01-21/600196_20140122_2.pdf
787,2014-01-25,复星医药关于向控股孙公司提供委托贷款的关联交易公告,/disclosure/listedinfo/announcement/c/2014-01-24/600196_20140125_2.pdf
788,2014-01-25,复星医药第六届董事会第十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-01-24/600196_20140125_1.pdf
789,2014-01-29,复星医药第六届董事会第十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-01-28/600196_20140129_1.pdf
790,2014-02-08,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-02-07/600196_20140208_1.pdf
791,2014-02-14,复星医药关于实际控制人、股东、关联方以及本公司承诺及履行情况的公告,/disclosure/listedinfo/announcement/c/2014-02-13/600196_20140214_1.pdf
792,2014-02-17,复星医药关于停牌的提示性公告,/disclosure/listedinfo/announcement/c/2014-02-16/600196_20140217_1.pdf
793,2014-02-18,复星医药关于复牌的提示性公告,/disclosure/listedinfo/announcement/c/2014-02-17/600196_20140218_1.pdf
794,2014-02-18,复星医药对外投资及关联交易公告,/disclosure/listedinfo/announcement/c/2014-02-17/600196_20140218_3.pdf
795,2014-02-18,复星医药第六届董事会第十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-02-17/600196_20140218_2.pdf
796,2014-03-01,复星医药关于受让锦州奥鸿药业有限责任公司部分股权暨关联交易公告,/disclosure/listedinfo/announcement/c/2014-02-28/600196_20140301_2.pdf
797,2014-03-01,复星医药第六届董事会第十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-02-28/600196_20140301_1.pdf
798,2014-03-06,复星医药关于获中国证监会批复核准增发境外上市外资股的公告,/disclosure/listedinfo/announcement/c/2014-03-05/600196_20140306_2.pdf
799,2014-03-06,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-03-05/600196_20140306_1.pdf
800,2014-03-11,复星医药关于闲置募集资金暂时补充流动资金到期归还的公告,/disclosure/listedinfo/announcement/c/2014-03-10/600196_20140311_1.pdf
801,2014-03-11,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-03-10/600196_20140311_2.pdf
802,2014-03-25,复星医药新增委托贷款额度及关联交易公告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_5.pdf
803,2014-03-25,复星医药审计报告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_9.pdf
804,2014-03-25,复星医药日常关联交易公告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_4.pdf
805,2014-03-25,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2014-03-24/600196_2013_nzy.pdf
806,2014-03-25,复星医药年报,/disclosure/listedinfo/announcement/c/2014-03-24/600196_2013_n.pdf
807,2014-03-25,复星医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_14.pdf
808,2014-03-25,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_6.pdf
809,2014-03-25,复星医药独立非执行董事关于对外担保情况的专项说明及意见,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_8.pdf
810,2014-03-25,复星医药独立非执行董事2013年度述职报告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_11.pdf
811,2014-03-25,复星医药董事会审计委员会2013年度履职报告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_17.pdf
812,2014-03-25,复星医药第六届监事会2014年第二次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_3.pdf
813,2014-03-25,复星医药第六届董事会第二十一次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_2.pdf
814,2014-03-25,复星医药：海通证券股份有限公司关于上海复星医药（集团）股份有限公司2013年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_15.pdf
815,2014-03-25,复星医药：海通证券股份有限公司关于上海复星医药（集团）股份有限公司2013年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_18.pdf
816,2014-03-25,复星医药：关于公司控股股东及其他关联方占用非经营性资金情况的专项说明,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_10.pdf
817,2014-03-25,复星医药2013年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_13.pdf
818,2014-03-25,复星医药2013年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2014-03-24/600196_20140325_12.pdf
819,2014-03-27,复星医药关于根据一般授权配售新H股的公告,/disclosure/listedinfo/announcement/c/2014-03-26/600196_20140327_1.pdf
820,2014-04-04,复星医药关于完成根据一般授权配售新H股的公告,/disclosure/listedinfo/announcement/c/2014-04-03/600196_20140404_3.pdf
821,2014-04-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-04-03/600196_20140404_2.pdf
822,2014-04-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-04-03/600196_20140404_1.pdf
823,2014-04-09,复星医药关于召开2014年第一次临时股东大会的通知公告,/disclosure/listedinfo/announcement/c/2014-04-08/600196_20140409_1.pdf
824,2014-04-09,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2014-04-08/600196_20140409_2.pdf
825,2014-04-09,复星医药2014年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-04-08/600196_20140409_3.pdf
826,2014-04-15,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2014-04-14/600196_20140415_2.pdf
827,2014-04-15,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-04-14/600196_20140415_1.pdf
828,2014-04-19,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2014-04-18/600196_20140419_3.pdf
829,2014-04-19,复星医药第六届董事会第二十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-04-18/600196_20140419_1.pdf
830,2014-04-19,复星医药2011年公司债券（第一期）2014年付息公告,/disclosure/listedinfo/announcement/c/2014-04-18/600196_20140419_2.pdf
831,2014-04-21,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2014-04-20/600196_20140421_1.pdf
832,2014-04-30,复星医药章程修正案,/disclosure/listedinfo/announcement/c/2014-04-29/600196_20140430_5.pdf
833,2014-04-30,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2014-04-29/600196_20140430_3.pdf
834,2014-04-30,复星医药第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-29/600196_2014_1.pdf
835,2014-04-30,复星医药第六届监事会2014年第三次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2014-04-29/600196_20140430_2.pdf
836,2014-04-30,复星医药第六届董事会第二十三次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2014-04-29/600196_20140430_1.pdf
837,2014-05-06,复星医药关于2011年公司债券（第一期）跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2014-05-05/600196_20140506_2.pdf
838,2014-05-06,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-05-05/600196_20140506_1.pdf
839,2014-05-06,复星医药2011年公司债券（第一期）受托管理事务报告（2013年度）,/disclosure/listedinfo/announcement/c/2014-05-05/600196_20140506_4.pdf
840,2014-05-06,复星医药2011年公司债券（第一期）跟踪评级报告,/disclosure/listedinfo/announcement/c/2014-05-05/600196_20140506_3.pdf
841,2014-05-13,复星医药关于召开2014年第一次临时股东大会的再次通知,/disclosure/listedinfo/announcement/c/2014-05-12/600196_20140513_1.pdf
842,2014-05-13,复星医药关于召开2013年度股东大会的通知公告,/disclosure/listedinfo/announcement/c/2014-05-12/600196_20140513_2.pdf
843,2014-05-13,复星医药2013年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-05-12/600196_20140513_3.pdf
844,2014-05-16,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2014-05-15/600196_20140516_2.pdf
845,2014-05-16,复星医药第六届董事会第二十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-05-15/600196_20140516_1.pdf
846,2014-05-30,复星医药第六届董事会第二十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-05-29/600196_20140530_1.pdf
847,2014-05-30,复星医药2014年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-29/600196_20140530_2.pdf
848,2014-05-30,复星医药2014年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-05-29/600196_20140530_3.pdf
849,2014-06-06,复星医药关于闲置募集资金暂时补充流动资金到期归还的公告,/disclosure/listedinfo/announcement/c/2014-06-05/600196_20140606_2.pdf
850,2014-06-06,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-06-05/600196_20140606_1.pdf
851,2014-06-12,复星医药关于召开2013年度股东大会的再次通知,/disclosure/listedinfo/announcement/c/2014-06-11/600196_20140612_1.pdf
852,2014-06-27,复星医药对外投资暨关联交易公告,/disclosure/listedinfo/announcement/c/2014-06-26/600196_20140627_2.pdf
853,2014-06-27,复星医药第六届董事会第二十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-06-26/600196_20140627_1.pdf
854,2014-07-01,复星医药出售资产进展公告,/disclosure/listedinfo/announcement/c/2014-06-30/600196_20140701_2.pdf
855,2014-07-01,复星医药2013年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-06-30/600196_20140701_1.pdf
856,2014-07-01,复星医药2013年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-06-30/600196_20140701_3.pdf
857,2014-07-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-07-02/600196_20140703_1.pdf
858,2014-07-15,复星医药关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2014-07-14/600196_20140715_3.pdf
859,2014-07-15,复星医药第六届监事会2014年第四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-07-14/600196_20140715_2.pdf
860,2014-07-15,复星医药第六届董事会第二十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-07-14/600196_20140715_1.pdf
861,2014-07-15,复星医药：海通证券股份有限公司关于上海复星医药（集团）股份有限公司使用闲置募集资金暂时补充流动资金的保荐意见,/disclosure/listedinfo/announcement/c/2014-07-14/600196_20140715_4.pdf
862,2014-07-18,复星医药第六届董事会第二十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-07-17/600196_20140718_1.pdf
863,2014-07-31,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2014-07-30/600196_20140731_1.pdf
864,2014-08-05,复星医药第六届董事会第三十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-08-04/600196_20140805_2.pdf
865,2014-08-05,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-08-04/600196_20140805_1.pdf
866,2014-08-12,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-08-11/600196_20140812_2.pdf
867,2014-08-12,复星医药2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-08-11/600196_20140812_1.pdf
868,2014-08-27,复星医药第六届监事会2014年第五次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2014-08-26/600196_20140827_3.pdf
869,2014-08-27,复星医药第六届董事会第三十一次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2014-08-26/600196_20140827_2.pdf
870,2014-08-27,复星医药半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-26/600196_2014_zzy.pdf
871,2014-08-27,复星医药半年报,/disclosure/listedinfo/announcement/c/2014-08-26/600196_2014_z.pdf
872,2014-08-27,复星医药2014年半年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2014-08-26/600196_20140827_6.pdf
873,2014-08-27,复星医药2014年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2014-08-26/600196_20140827_4.pdf
874,2014-09-02,复星医药第六届董事会第三十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-09-01/600196_20140902_1.pdf
875,2014-09-05,复星医药关于办公地址和投资者联系方式变更的公告,/disclosure/listedinfo/announcement/c/2014-09-04/600196_20140905_1.pdf
876,2014-09-05,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-09-04/600196_20140905_2.pdf
877,2014-09-27,复星医药关于2014年度第一期短期融资券发行完成的公告,/disclosure/listedinfo/announcement/c/2014-09-26/600196_20140927_1.pdf
878,2014-10-01,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2014-09-30/600196_20141001_1.pdf
879,2014-10-09,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-10-08/600196_20141009_1.pdf
880,2014-10-14,复星医药关于闲置募集资金暂时补充流动资金到期归还的公告,/disclosure/listedinfo/announcement/c/2014-10-13/600196_20141014_1.pdf
881,2014-10-17,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-10-16/600196_20141017_1.pdf
882,2014-10-29,复星医药关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2014-10-28/600196_20141029_3.pdf
883,2014-10-29,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-28/600196_2014_3.pdf
884,2014-10-29,复星医药第六届监事会2014年第六次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2014-10-28/600196_20141029_2.pdf
885,2014-10-29,复星医药第六届董事会第三十四次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2014-10-28/600196_20141029_1.pdf
886,2014-10-29,复星医药：安永华明会计师事务所（特殊普通合伙）关于上海复星医药（集团）股份有限公司2014年三季度报告会计政策变更事项的专项说明的报告,/disclosure/listedinfo/announcement/c/2014-10-28/600196_20141029_5.pdf
887,2014-11-04,复星医药第六届董事会第三十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-11-03/600196_20141104_1.pdf
888,2014-11-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-11-03/600196_20141104_2.pdf
889,2014-11-13,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2014-11-12/600196_20141113_1.pdf
890,2014-11-28,复星医药交易事项进展暨复牌公告,/disclosure/listedinfo/announcement/c/2014-11-27/600196_20141128_1.pdf
891,2014-12-05,复星医药关于投资苏州二叶制药有限公司的公告,/disclosure/listedinfo/announcement/c/2014-12-04/600196_20141205_4.pdf
892,2014-12-05,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2014-12-04/600196_20141205_3.pdf
893,2014-12-05,复星医药第六届董事会第三十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-12-04/600196_20141205_2.pdf
894,2014-12-05,复星医药H股公告,/disclosure/listedinfo/announcement/c/2014-12-04/600196_20141205_1.pdf
895,2014-12-11,复星医药关联交易公告,/disclosure/listedinfo/announcement/c/2014-12-10/600196_20141211_2.pdf
896,2014-12-11,复星医药第六届董事会第三十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-12-10/600196_20141211_1.pdf
897,2014-12-18,复星医药关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2014-12-17/600196_20141218_3.pdf
898,2014-12-18,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2014-12-17/600196_20141218_4.pdf
899,2014-12-18,复星医药第六届监事会2014年第七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-12-17/600196_20141218_2.pdf
900,2014-12-18,复星医药第六届董事会第三十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-12-17/600196_20141218_1.pdf
901,2014-12-18,复星医药：海通证券股份有限公司关于上海复星医药（集团）股份有限公司使用闲置募集资金暂时补充流动资金的保荐意见,/disclosure/listedinfo/announcement/c/2014-12-17/600196_20141218_5.pdf
902,2014-12-30,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2014-12-29/600196_20141230_2.pdf
903,2014-12-30,复星医药第六届董事会第三十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2014-12-29/600196_20141230_1.pdf
904,2015-01-06,复星医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2015-01-05/600196_20150106_2.pdf
905,2015-01-06,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-01-05/600196_20150106_1.pdf
906,2015-01-20,复星医药关于回购注销部分限制性A股股票通知债权人公告,/disclosure/listedinfo/announcement/c/2015-01-19/600196_20150120_4.pdf
907,2015-01-20,复星医药关于回购注销部分未解锁限制性A股股票的公告,/disclosure/listedinfo/announcement/c/2015-01-19/600196_20150120_3.pdf
908,2015-01-20,复星医药第六届监事会2015年第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-01-19/600196_20150120_2.pdf
909,2015-01-20,复星医药第六届董事会第四十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-01-19/600196_20150120_1.pdf
910,2015-01-20,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司限制性股票激励计划所涉限制性股票第一期解锁及回购注销部分限制性股票相关事宜之法律意见书,/disclosure/listedinfo/announcement/c/2015-01-19/600196_20150120_5.pdf
911,2015-01-21,复星医药独立非执行董事关于本公司第二期限制性股票激励计划的独立意见,/disclosure/listedinfo/announcement/c/2015-01-20/600196_20150121_7.pdf
912,2015-01-21,复星医药第六届监事会2015年第二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-01-20/600196_20150121_2.pdf
913,2015-01-21,复星医药第六届董事会第四十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-01-20/600196_20150121_1.pdf
914,2015-01-21,复星医药第二期限制性股票激励计划考核管理办法,/disclosure/listedinfo/announcement/c/2015-01-20/600196_20150121_5.pdf
915,2015-01-21,复星医药第二期限制性股票激励计划的激励对象名单,/disclosure/listedinfo/announcement/c/2015-01-20/600196_20150121_6.pdf
916,2015-01-21,复星医药第二期限制性股票激励计划（草案）摘要公告,/disclosure/listedinfo/announcement/c/2015-01-20/600196_20150121_3.pdf
917,2015-01-21,复星医药第二期限制性股票激励计划（草案）,/disclosure/listedinfo/announcement/c/2015-01-20/600196_20150121_8.pdf
918,2015-01-21,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司第二期限制性股票激励计划（草案）的法律意见书,/disclosure/listedinfo/announcement/c/2015-01-20/600196_20150121_4.pdf
919,2015-01-22,复星医药已解锁限制性股票减持管理制度,/disclosure/listedinfo/announcement/c/2015-01-21/600196_20150122_1.pdf
920,2015-01-22,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司限制性股票激励计划所涉限制性股票第一期解锁及回购注销部分限制性股票相关事宜之法律意见书,/disclosure/listedinfo/announcement/c/2015-01-21/600196_20150122_2.pdf
921,2015-01-28,复星医药关于拟合作设立齐齐哈尔市第一医院南院（暂定名）公告,/disclosure/listedinfo/announcement/c/2015-01-27/600196_20150128_1.pdf
922,2015-01-31,复星医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2015-01-30/600196_20150131_1.pdf
923,2015-02-05,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-02-04/600196_20150205_1.pdf
924,2015-02-11,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-02-10/600196_20150211_1.pdf
925,2015-02-12,复星医药关于注销已回购限制性A股股票的公告,/disclosure/listedinfo/announcement/c/2015-02-11/600196_20150212_1.pdf
926,2015-02-13,复星医药章程修正案,/disclosure/listedinfo/announcement/c/2015-02-12/600196_20150213_5.pdf
927,2015-02-13,复星医药限制性A股股票第一期解锁暨上市的公告,/disclosure/listedinfo/announcement/c/2015-02-12/600196_20150213_3.pdf
928,2015-02-13,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2015-02-12/600196_20150213_4.pdf
929,2015-02-13,复星医药公司章程（A+H股）,/disclosure/listedinfo/announcement/c/2015-02-12/600196_20150213_6.pdf
930,2015-02-13,复星医药第六届董事会第四十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-02-12/600196_20150213_2.pdf
931,2015-02-13,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-02-12/600196_20150213_1.pdf
932,2015-03-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-03-02/600196_20150303_1.pdf
933,2015-03-05,复星医药关于第二期限制性股票激励计划（草案）获得中国证券监督管理委员会备案无异议的公告,/disclosure/listedinfo/announcement/c/2015-03-04/600196_20150305_1.pdf
934,2015-03-11,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-03-10/600196_20150311_1.pdf
935,2015-03-17,复星医药关于获中国证监会批复核准增发境外上市外资股的公告,/disclosure/listedinfo/announcement/c/2015-03-16/600196_20150317_1.pdf
936,2015-03-25,复星医药续展及新增委托贷款额度暨关联交易公告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_4.pdf
937,2015-03-25,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2015-03-24/600196_2014_nzy.pdf
938,2015-03-25,复星医药年报,/disclosure/listedinfo/announcement/c/2015-03-24/600196_2014_n.pdf
939,2015-03-25,复星医药内部控制自我评价手册,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_11.pdf
940,2015-03-25,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_7.pdf
941,2015-03-25,复星医药公司章程修正案（尚须股东大会审议）,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_24.pdf
942,2015-03-25,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_5.pdf
943,2015-03-25,复星医药独立非执行董事提名人声明,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_9.pdf
944,2015-03-25,复星医药独立非执行董事候选人声明（江宪）,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_10.pdf
945,2015-03-25,复星医药独立非执行董事关于对外担保情况的专项说明及意见,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_13.pdf
946,2015-03-25,复星医药独立非执行董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_16.pdf
947,2015-03-25,复星医药董事会审计委员会2014年度履职报告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_23.pdf
948,2015-03-25,复星医药第六届监事会2015年第三次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_2.pdf
949,2015-03-25,复星医药第六届董事会第四十四次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_1.pdf
950,2015-03-25,复星医药参与对上海复星高科技集团财务有限公司增资的关联交易公告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_6.pdf
951,2015-03-25,复星医药：海通证券股份有限公司关于上海复星医药（集团）股份有限公司2014年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_22.pdf
952,2015-03-25,复星医药：关于公司控股股东及其他关联方占用非经营性资金情况的专项说明,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_15.pdf
953,2015-03-25,复星医药2014年日常关联交易报告及2015年日常关联交易预计公告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_3.pdf
954,2015-03-25,复星医药2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_14.pdf
955,2015-03-25,复星医药2014年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_19.pdf
956,2015-03-25,复星医药2014年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_17.pdf
957,2015-03-25,复星医药2014年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_21.pdf
958,2015-03-25,复星医药2014年度募集资金存放与实际使用情况专项审核报告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_20.pdf
959,2015-03-25,复星医药2014年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-03-24/600196_20150325_18.pdf
960,2015-03-27,复星医药2014年日常关联交易报告及2015年日常关联交易预计公告的补充公告,/disclosure/listedinfo/announcement/c/2015-03-26/600196_20150327_1.pdf
961,2015-03-30,复星医药关于筹划非公开发行股票停牌公告,/disclosure/listedinfo/announcement/c/2015-03-29/600196_20150330_1.pdf
962,2015-04-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-04-01/600196_20150402_1.pdf
963,2015-04-03,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2015-04-02/600196_20150403_2.pdf
964,2015-04-03,复星医药第六届董事会第四十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-04-02/600196_20150403_1.pdf
965,2015-04-04,复星医药关于中国银行间市场交易商协会接受本公司中期票据注册的公告,/disclosure/listedinfo/announcement/c/2015-04-03/600196_20150404_2.pdf
966,2015-04-04,复星医药关于非公开发行股票事项进展公告,/disclosure/listedinfo/announcement/c/2015-04-03/600196_20150404_1.pdf
967,2015-04-14,复星医药关于筹划非公开发行股票事项进展暨延期复牌的公告,/disclosure/listedinfo/announcement/c/2015-04-13/600196_20150414_1.pdf
968,2015-04-16,复星医药关于2011年公司债券（第一期）跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2015-04-15/600196_20150416_2.pdf
969,2015-04-16,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-04-15/600196_20150416_1.pdf
970,2015-04-16,复星医药2011年公司债券（第一期）跟踪评级报告,/disclosure/listedinfo/announcement/c/2015-04-15/600196_20150416_4.pdf
971,2015-04-16,复星医药2011年公司债券（第一期）2015年付息公告,/disclosure/listedinfo/announcement/c/2015-04-15/600196_20150416_3.pdf
972,2015-04-17,复星医药章程修正案（尚须股东大会审议）,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_11.pdf
973,2015-04-17,复星医药未来三年（2015-2017年）股东分红回报规划,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_8.pdf
974,2015-04-17,复星医药前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_12.pdf
975,2015-04-17,复星医药前次募集资金使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_6.pdf
976,2015-04-17,复星医药关于与本次非公开发行对象签署附条件生效股份认购合同的公告,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_7.pdf
977,2015-04-17,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_4.pdf
978,2015-04-17,复星医药关于股票复牌的提示性公告,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_1.pdf
979,2015-04-17,复星医药关于非公开发行A股股票摊薄即期回报对主要财务指标的影响及所采取措施的公告,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_5.pdf
980,2015-04-17,复星医药关于本公司2015年非公开发行A股股票募集资金使用的可行性报告,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_13.pdf
981,2015-04-17,复星医药非公开发行A股股票预案,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_9.pdf
982,2015-04-17,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_10.pdf
983,2015-04-17,复星医药第六届监事会2015年第四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_3.pdf
984,2015-04-17,复星医药第六届董事会第四十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-04-16/600196_20150417_2.pdf
985,2015-04-24,复星医药关于控股孙公司Sisram Medical Limited雇员薪酬激励计划以及关于根据该等计划授予相关人士购股权的公告,/disclosure/listedinfo/announcement/c/2015-04-23/600196_20150424_1.pdf
986,2015-04-25,复星医药2011年公司债券（第一期）受托管理事务报告（2014年度）,/disclosure/listedinfo/announcement/c/2015-04-24/600196_20150425_1.pdf
987,2015-04-29,复星医药第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-28/600196_2015_1.pdf
988,2015-05-06,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-05-05/600196_20150506_1.pdf
989,2015-05-12,复星医药关于召开2014年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-05-11/600196_20150512_1.pdf
990,2015-05-12,复星医药2014年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-05-11/600196_20150512_2.pdf
991,2015-05-13,复星医药年报（修订版）,/disclosure/listedinfo/announcement/c/2015-05-12/600196_2014_n.pdf
992,2015-05-13,复星医药关于对2014年年报事后审核意见回复的公告,/disclosure/listedinfo/announcement/c/2015-05-12/600196_20150513_1.pdf
993,2015-05-13,复星医药关于2014年年报全文修订的说明,/disclosure/listedinfo/announcement/c/2015-05-12/600196_20150513_3.pdf
994,2015-05-13,复星医药：关于上海复星医药（集团）股份有限公司2014年年报的事后审核意见函中涉及的财务报表项目附注信息的专项说明,/disclosure/listedinfo/announcement/c/2015-05-12/600196_20150513_2.pdf
995,2015-05-15,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2015-05-14/600196_20150515_1.pdf
996,2015-05-29,复星医药关于与挂号网（杭州）科技有限公司签订《战略合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2015-05-28/600196_20150529_1.pdf
997,2015-06-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-06-01/600196_20150602_1.pdf
998,2015-06-03,复星医药关于与玉林市医疗集团签订《合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2015-06-02/600196_20150603_1.pdf
999,2015-06-11,复星医药关于召开2014年度股东大会的再次通知,/disclosure/listedinfo/announcement/c/2015-06-10/600196_20150611_1.pdf
1000,2015-06-17,复星医药关于闲置募集资金暂时补充流动资金到期归还的公告,/disclosure/listedinfo/announcement/c/2015-06-16/600196_20150617_1.pdf
1001,2015-06-19,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2015-06-18/600196_20150619_2.pdf
1002,2015-06-19,复星医药第六届董事会第四十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-06-18/600196_20150619_1.pdf
1003,2015-06-24,复星医药关于召开2014年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-06-23/600196_20150624_1.pdf
1004,2015-06-24,复星医药关于对外担保事项变更的公告,/disclosure/listedinfo/announcement/c/2015-06-23/600196_20150624_2.pdf
1005,2015-06-30,复星医药公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-06-29/600196_20150630_4.pdf
1006,2015-06-30,复星医药第六届董事会第五十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-06-29/600196_20150630_1.pdf
1007,2015-06-30,复星医药2014年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-06-29/600196_20150630_2.pdf
1008,2015-06-30,复星医药2014年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-06-29/600196_20150630_3.pdf
1009,2015-07-08,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2015-07-07/600196_20150708_2.pdf
1010,2015-07-08,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-07-07/600196_20150708_1.pdf
1011,2015-07-17,复星医药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2015-07-16/600196_20150717_3.pdf
1012,2015-07-17,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2015-07-16/600196_20150717_2.pdf
1013,2015-07-17,复星医药第六届董事会第五十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-07-16/600196_20150717_1.pdf
1014,2015-07-22,复星医药关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2015-07-21/600196_20150722_3.pdf
1015,2015-07-22,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2015-07-21/600196_20150722_5.pdf
1016,2015-07-22,复星医药第六届监事会2015年第六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-07-21/600196_20150722_2.pdf
1017,2015-07-22,复星医药第六届董事会第五十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-07-21/600196_20150722_1.pdf
1018,2015-07-22,复星医药：海通证券股份有限公司关于上海复星医药（集团）股份有限公司使用闲置募集资金暂时补充流动资金的保荐意见,/disclosure/listedinfo/announcement/c/2015-07-21/600196_20150722_4.pdf
1019,2015-07-29,复星医药关于变更保荐机构及保荐代表人的公告,/disclosure/listedinfo/announcement/c/2015-07-28/600196_20150729_1.pdf
1020,2015-07-31,复星医药关于参与认购重庆医药（集团）股份有限公司增发股份暨关联交易的公告,/disclosure/listedinfo/announcement/c/2015-07-30/600196_20150731_2.pdf
1021,2015-07-31,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2015-07-30/600196_20150731_3.pdf
1022,2015-07-31,复星医药第六届董事会第五十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-07-30/600196_20150731_1.pdf
1023,2015-08-04,复星医药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2015-08-04/600196_20150804_3.pdf
1024,2015-08-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-08-04/600196_20150804_1.pdf
1025,2015-08-04,复星医药2014年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2015-08-04/600196_20150804_2.pdf
1026,2015-08-05,复星医药：重庆医药（集团）股份有限公司拟引入战略投资者所涉及的其股东全部权益的资产评估项目资产评估报告书,/disclosure/listedinfo/announcement/c/2015-08-05/600196_20150805_1.pdf
1027,2015-08-06,复星医药关于中国证券监督管理委员会受理本公司非公开发行A股股票申请的公告,/disclosure/listedinfo/announcement/c/2015-08-06/600196_20150806_1.pdf
1028,2015-08-11,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-08-11/600196_20150811_1.pdf
1029,2015-08-26,复星医药监事会关于本公司第二期限制性股票激励计划激励对象名单（修订稿）的核查意见,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_11.pdf
1030,2015-08-26,复星医药关于实施2014年度利润分配方案后调整非公开发行A股股票发行价格和发行数量的公告,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_5.pdf
1031,2015-08-26,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_1.pdf
1032,2015-08-26,复星医药独立非执行董事关于本公司限制性股票激励计划的补充意见,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_15.pdf
1033,2015-08-26,复星医药第六届监事会2015年第七次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_3.pdf
1034,2015-08-26,复星医药第六届董事会第五十四次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_2.pdf
1035,2015-08-26,复星医药第二期限制性股票激励计划考核管理办法,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_9.pdf
1036,2015-08-26,复星医药第二期限制性股票激励计划的激励对象名单（修订稿）,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_10.pdf
1037,2015-08-26,复星医药第二期限制性股票激励计划（草案修订稿）摘要公告,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_6.pdf
1038,2015-08-26,复星医药第二期限制性股票激励计划（草案修订稿）摘要,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_14.pdf
1039,2015-08-26,复星医药第二期限制性股票激励计划（草案修订稿）,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_13.pdf
1040,2015-08-26,复星医药半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-26/600196_2015_zzy.pdf
1041,2015-08-26,复星医药半年报,/disclosure/listedinfo/announcement/c/2015-08-26/600196_2015_z.pdf
1042,2015-08-26,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司第二期限制性股票激励计划（草案修订稿）的法律意见书,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_12.pdf
1043,2015-08-26,复星医药2015年半年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_8.pdf
1044,2015-08-26,复星医药2015年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-08-26/600196_20150826_4.pdf
1045,2015-08-28,复星医药公司债券发行预案公告,/disclosure/listedinfo/announcement/c/2015-08-28/600196_20150828_2.pdf
1046,2015-08-28,复星医药第六届董事会第五十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-08-28/600196_20150828_1.pdf
1047,2015-09-08,复星医药关于变更保荐机构后重新签订募集资金三方监管协议的公告,/disclosure/listedinfo/announcement/c/2015-09-08/600196_20150908_1.pdf
1048,2015-09-08,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-09-08/600196_20150908_2.pdf
1049,2015-09-11,复星医药2015年度第一期中期票据发行结果的公告,/disclosure/listedinfo/announcement/c/2015-09-11/600196_20150911_1.pdf
1050,2015-09-18,复星医药关于参与对上海复星高科技集团财务有限公司增资的关联交易的进展公告,/disclosure/listedinfo/announcement/c/2015-09-18/600196_20150918_1.pdf
1051,2015-09-23,复星医药关于召开2015年第一次临时股东大会、2015年第一次A股类别股东会的通知,/disclosure/listedinfo/announcement/c/2015-09-23/600196_20150923_3.pdf
1052,2015-09-23,复星医药独立非执行董事征集投票权报告书,/disclosure/listedinfo/announcement/c/2015-09-23/600196_20150923_2.pdf
1053,2015-09-23,复星医药2015年第一次临时股东大会、2015年第一次A股类别股东会会议资料,/disclosure/listedinfo/announcement/c/2015-09-23/600196_20150923_1.pdf
1054,2015-10-09,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-10-09/600196_20151009_1.pdf
1055,2015-10-13,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2015-10-13/600196_20151013_1.pdf
1056,2015-10-13,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-10-13/600196_20151013_2.pdf
1057,2015-10-16,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2015-10-16/600196_20151016_1.pdf
1058,2015-10-17,复星医药关于与发行对象签订股份认购合同之补充协议和股份认购合同之终止协议的公告,/disclosure/listedinfo/announcement/c/2015-10-17/600196_20151017_6.pdf
1059,2015-10-17,复星医药关于非公开发行A股股票预案修订情况说明的公告,/disclosure/listedinfo/announcement/c/2015-10-17/600196_20151017_5.pdf
1060,2015-10-17,复星医药关于非公开发行A股股票摊薄即期回报对主要财务指标的影响及所采取措施的公告（修订稿）,/disclosure/listedinfo/announcement/c/2015-10-17/600196_20151017_2.pdf
1061,2015-10-17,复星医药关于调整非公开发行A股股票发行方案的公告,/disclosure/listedinfo/announcement/c/2015-10-17/600196_20151017_4.pdf
1062,2015-10-17,复星医药关于本公司2015年非公开发行A股股票募集资金使用的可行性报告（修订稿）,/disclosure/listedinfo/announcement/c/2015-10-17/600196_20151017_7.pdf
1063,2015-10-17,复星医药非公开发行A股股票预案（修订稿）,/disclosure/listedinfo/announcement/c/2015-10-17/600196_20151017_8.pdf
1064,2015-10-17,复星医药第六届监事会2015年第八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-10-17/600196_20151017_1.pdf
1065,2015-10-17,复星医药第六届董事会第五十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-10-17/600196_20151017_3.pdf
1066,2015-10-23,复星医药对外投资暨关联交易公告,/disclosure/listedinfo/announcement/c/2015-10-23/600196_20151023_2.pdf
1067,2015-10-23,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2015-10-23/600196_20151023_3.pdf
1068,2015-10-23,复星医药第六届董事会第五十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-10-23/600196_20151023_1.pdf
1069,2015-10-27,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2015-10-27/600196_20151027_1.pdf
1070,2015-10-29,复星医药关于召开2015年第一次临时股东大会、2015年第一次A股类别股东会的再次通知,/disclosure/listedinfo/announcement/c/2015-10-29/600196_20151029_1.pdf
1071,2015-10-29,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2015-10-29/600196_20151029_2.pdf
1072,2015-10-29,复星医药关于控股子公司获药品临床申请受理的公告,/disclosure/listedinfo/announcement/c/2015-10-29/600196_20151029_3.pdf
1073,2015-10-30,复星医药第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-30/600196_2015_3.pdf
1074,2015-10-31,复星医药关于控股子公司获药品临床试验批准的补充公告,/disclosure/listedinfo/announcement/c/2015-10-31/600196_20151031_1.pdf
1075,2015-10-31,复星医药关于控股子公司获药品临床申请受理的补充公告,/disclosure/listedinfo/announcement/c/2015-10-31/600196_20151031_2.pdf
1076,2015-11-05,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-11-05/600196_20151105_1.pdf
1077,2015-11-07,复星医药关于召开2015年第一次临时股东大会、2015年第一次A股类别股东会的提示性公告,/disclosure/listedinfo/announcement/c/2015-11-07/600196_20151107_1.pdf
1078,2015-11-17,复星医药2015年第一次临时股东大会、2015年第一次A股类别股东会及2015年第一次H股类别股东会决议公告,/disclosure/listedinfo/announcement/c/2015-11-17/600196_20151117_1.pdf
1079,2015-11-17,复星医药2015年第一次临时股东大会、2015年第一次A股类别股东会、2015年第一次H股类别股东会的法律意见书,/disclosure/listedinfo/announcement/c/2015-11-17/600196_20151117_2.pdf
1080,2015-11-19,复星医药对外投资暨关联交易进展公告,/disclosure/listedinfo/announcement/c/2015-11-19/600196_20151119_1.pdf
1081,2015-11-20,复星医药关于第二期限制性股票激励计划授予相关事项的公告,/disclosure/listedinfo/announcement/c/2015-11-20/600196_20151120_3.pdf
1082,2015-11-20,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2015-11-20/600196_20151120_4.pdf
1083,2015-11-20,复星医药独立非执行董事关于本公司第二期限制性股票激励计划授予相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-11-20/600196_20151120_5.pdf
1084,2015-11-20,复星医药第六届监事会2015年第十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-11-20/600196_20151120_2.pdf
1085,2015-11-20,复星医药第六届董事会第六十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-11-20/600196_20151120_1.pdf
1086,2015-11-20,复星医药第二期限制性股票激励计划激励对象名单,/disclosure/listedinfo/announcement/c/2015-11-20/600196_20151120_7.pdf
1087,2015-11-20,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司第二期限制性股票激励计划限制性股票授予相关事项的法律意见书,/disclosure/listedinfo/announcement/c/2015-11-20/600196_20151120_6.pdf
1088,2015-11-25,复星医药关于控股子公司撤回法罗培南钠片申报生产申请的公告,/disclosure/listedinfo/announcement/c/2015-11-25/600196_20151125_1.pdf
1089,2015-12-01,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2015-12-01/600196_20151201_4.pdf
1090,2015-12-01,复星医药关于收到《中国证监会行政许可项目审查反馈意见通知书》的公告,/disclosure/listedinfo/announcement/c/2015-12-01/600196_20151201_6.pdf
1091,2015-12-01,复星医药关于第二期限制性股票激励计划限制性股票授予结果的公告,/disclosure/listedinfo/announcement/c/2015-12-01/600196_20151201_3.pdf
1092,2015-12-01,复星医药公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-12-01/600196_20151201_7.pdf
1093,2015-12-01,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2015-12-01/600196_20151201_5.pdf
1094,2015-12-01,复星医药第六届董事会第六十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-12-01/600196_20151201_2.pdf
1095,2015-12-01,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-12-01/600196_20151201_1.pdf
1096,2015-12-03,复星医药关于控股子公司撤回盐酸度洛西汀肠溶片申报生产申请的公告,/disclosure/listedinfo/announcement/c/2015-12-03/600196_20151203_1.pdf
1097,2015-12-04,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2015-12-04/600196_20151204_1.pdf
1098,2015-12-04,复星医药第六届董事会第六十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-12-04/600196_20151204_2.pdf
1099,2015-12-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2015-12-04/600196_20151204_3.pdf
1100,2015-12-09,复星医药关于超短期融资券获得注册的公告,/disclosure/listedinfo/announcement/c/2015-12-09/600196_20151209_1.pdf
1101,2015-12-12,复星医药关于本公司股票复牌的提示性公告,/disclosure/listedinfo/announcement/c/2015-12-12/600196_20151212_1.pdf
1102,2015-12-16,复星医药关于控股子公司撤回盐酸帕洛诺司琼注射液申报生产申请的公告,/disclosure/listedinfo/announcement/c/2015-12-16/600196_20151216_1.pdf
1103,2015-12-17,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2015-12-17/600196_20151217_2.pdf
1104,2015-12-17,复星医药第六届董事会第六十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-12-17/600196_20151217_1.pdf
1105,2015-12-21,复星医药第六届董事会第六十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-12-21/600196_20151221_1.pdf
1106,2015-12-23,复星医药关于控股子公司亚能生物技术（深圳）有限公司拟境外上市的补充公告,/disclosure/listedinfo/announcement/c/2015-12-23/600196_20151223_1.pdf
1107,2015-12-24,复星医药关于申请延期提交非公开发行A股股票申请文件反馈意见书面回复的公告,/disclosure/listedinfo/announcement/c/2015-12-24/600196_20151224_3.pdf
1108,2015-12-24,复星医药对外投资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2015-12-24/600196_20151224_2.pdf
1109,2015-12-24,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2015-12-24/600196_20151224_4.pdf
1110,2015-12-24,复星医药第六届董事会第六十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-12-24/600196_20151224_1.pdf
1111,2016-01-06,复星医药关于向合格投资者公开发行公司债券申请获中国证券监督管理委员会核准的公告,/disclosure/listedinfo/announcement/c/2016-01-06/600196_20160106_1.pdf
1112,2016-01-06,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-01-06/600196_20160106_2.pdf
1113,2016-01-08,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-01-08/600196_20160108_1.pdf
1114,2016-01-08,复星医药独立非执行董事关于《上海复星医药（集团）股份有限公司限制性股票激励计划》所涉限制性A股股票第二期解锁事项的独立意见,/disclosure/listedinfo/announcement/c/2016-01-08/600196_20160108_6.pdf
1115,2016-01-08,复星医药第一期激励计划所涉限制性A股股票第二期解锁暨上市的公告,/disclosure/listedinfo/announcement/c/2016-01-08/600196_20160108_4.pdf
1116,2016-01-08,复星医药第六届监事会2016年第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-01-08/600196_20160108_3.pdf
1117,2016-01-08,复星医药第六届董事会第六十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-01-08/600196_20160108_2.pdf
1118,2016-01-08,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司第一期限制性股票激励计划所涉限制性A股股票第二期解锁之法律意见书,/disclosure/listedinfo/announcement/c/2016-01-08/600196_20160108_5.pdf
1119,2016-01-13,复星医药关于闲置募集资金暂时补充流动资金到期归还的公告,/disclosure/listedinfo/announcement/c/2016-01-13/600196_20160113_1.pdf
1120,2016-01-15,复星医药董事会审计委员会职权范围及实施细则,/disclosure/listedinfo/announcement/c/2016-01-15/600196_20160115_2.pdf
1121,2016-01-15,复星医药第六届董事会第六十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-01-15/600196_20160115_1.pdf
1122,2016-01-19,复星医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2016-01-19/600196_20160119_1.pdf
1123,2016-01-21,复星医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2016-01-21/600196_20160121_1.pdf
1124,2016-01-22,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-01-22/600196_20160122_1.pdf
1125,2016-01-23,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2016-01-23/600196_20160123_2.pdf
1126,2016-01-23,复星医药第六届董事会第七十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-01-23/600196_20160123_1.pdf
1127,2016-01-29,复星医药关于控股股东增持本公司股份的公告,/disclosure/listedinfo/announcement/c/2016-01-29/600196_20160129_1.pdf
1128,2016-02-02,复星医药媒体报道相关情况的进展公告,/disclosure/listedinfo/announcement/c/2016-02-02/600196_20160202_2.pdf
1129,2016-02-02,复星医药关于控股股东增持本公司股份的补充公告,/disclosure/listedinfo/announcement/c/2016-02-02/600196_20160202_3.pdf
1130,2016-02-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-02-02/600196_20160202_1.pdf
1131,2016-02-04,复星医药媒体报道相关情况进展的补充公告,/disclosure/listedinfo/announcement/c/2016-02-04/600196_20160204_2.pdf
1132,2016-02-04,复星医药关于控股股东增持本公司股份的说明公告,/disclosure/listedinfo/announcement/c/2016-02-04/600196_20160204_1.pdf
1133,2016-02-05,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-02-05/600196_20160205_1.pdf
1134,2016-02-06,复星医药关于控股子公司撤回重组赖脯胰岛素注射液及其原料药申报生产申请的公告,/disclosure/listedinfo/announcement/c/2016-02-06/600196_20160206_1.pdf
1135,2016-02-16,复星医药关于控股子公司签署许可协议的公告,/disclosure/listedinfo/announcement/c/2016-02-16/600196_20160216_2.pdf
1136,2016-02-16,复星医药第六届董事会第七十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-02-16/600196_20160216_1.pdf
1137,2016-02-23,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2016-02-23/600196_20160223_2.pdf
1138,2016-02-23,复星医药第六届董事会第七十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-02-23/600196_20160223_1.pdf
1139,2016-02-24,复星医药关于再次调整非公开发行A股股票发行方案的公告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_4.pdf
1140,2016-02-24,复星医药关于与发行对象签订《股份认购合同之终止协议》、《股份认购合同及补充协议之终止协议》的公告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_5.pdf
1141,2016-02-24,复星医药关于控股股东、实际控制人签署《承诺函》的公告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_8.pdf
1142,2016-02-24,复星医药关于就非公开发行A股股票相关事项签署《承诺函》的公告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_7.pdf
1143,2016-02-24,复星医药关于近五年被证券监管部门和交易所采取监管措施或处罚及整改情况的公告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_11.pdf
1144,2016-02-24,复星医药关于非公开发行A股股票预案二次修订说明的公告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_3.pdf
1145,2016-02-24,复星医药关于非公开发行A股股票摊薄即期回报对主要财务指标的影响及所采取措施的公告（第二次修订稿）,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_6.pdf
1146,2016-02-24,复星医药关于对《中国证监会行政许可项目审查反馈意见通知书》回复的公告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_10.pdf
1147,2016-02-24,复星医药关于本公司非公开发行A股股票募集资金使用的可行性报告（第二次修订稿）,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_13.pdf
1148,2016-02-24,复星医药非公开发行A股股票预案（第二次修订稿）,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_12.pdf
1149,2016-02-24,复星医药非公开发行A股股票申请文件之反馈意见答复,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_14.pdf
1150,2016-02-24,复星医药董事、高级管理人员关于非公开发行A股股票摊薄即期回报采取填补措施的承诺的公告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_9.pdf
1151,2016-02-24,复星医药第六届监事会2016年第二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_2.pdf
1152,2016-02-24,复星医药第六届董事会第七十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_1.pdf
1153,2016-02-24,复星医药：保荐机构关于《上海复星医药（集团）股份有限公司非公开发行A股股票申请文件之反馈意见答复》的核查报告,/disclosure/listedinfo/announcement/c/2016-02-24/600196_20160224_15.pdf
1154,2016-03-01,复星医药2016年公开发行公司债券募集说明书摘要（面向合格投资者）（第一期）,/disclosure/listedinfo/announcement/c/2016-03-01/600196_20160301_2.pdf
1155,2016-03-01,复星医药2016年公开发行公司债券募集说明书（面向合格投资者）（第一期）,/disclosure/listedinfo/announcement/c/2016-03-01/600196_20160301_4.pdf
1156,2016-03-01,复星医药2016年公开发行公司债券（面向合格投资者）（第一期）信用评级报告,/disclosure/listedinfo/announcement/c/2016-03-01/600196_20160301_3.pdf
1157,2016-03-01,复星医药2016年公开发行公司债券（面向合格投资者）（第一期）发行公告,/disclosure/listedinfo/announcement/c/2016-03-01/600196_20160301_1.pdf
1158,2016-03-03,复星医药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2016-03-03/600196_20160303_1.pdf
1159,2016-03-03,复星医药关于董事辞职的公告,/disclosure/listedinfo/announcement/c/2016-03-03/600196_20160303_2.pdf
1160,2016-03-03,复星医药第六届董事会第七十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-03-03/600196_20160303_3.pdf
1161,2016-03-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-03-03/600196_20160303_4.pdf
1162,2016-03-03,复星医药2016年公开发行公司债券（面向合格投资者）（第一期）票面利率公告,/disclosure/listedinfo/announcement/c/2016-03-03/600196_20160303_5.pdf
1163,2016-03-07,复星医药2016年公开发行公司债券（面向合格投资者）（第一期）发行结果公告,/disclosure/listedinfo/announcement/c/2016-03-07/600196_20160307_1.pdf
1164,2016-03-11,复星医药关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-03-11/600196_20160311_1.pdf
1165,2016-03-11,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2016-03-11/600196_20160311_4.pdf
1166,2016-03-11,复星医药第六届董事会第七十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-03-11/600196_20160311_3.pdf
1167,2016-03-11,复星医药2016年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-03-11/600196_20160311_2.pdf
1168,2016-03-15,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-03-15/600196_20160315_1.pdf
1169,2016-03-16,复星医药关于受让锦州奥鸿药业有限责任公司股权的公告,/disclosure/listedinfo/announcement/c/2016-03-16/600196_20160316_2.pdf
1170,2016-03-16,复星医药第六届董事会第七十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-03-16/600196_20160316_1.pdf
1171,2016-03-21,复星医药关于非公开发行A股股票申请获得中国证监会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2016-03-21/600196_20160321_1.pdf
1172,2016-03-30,复星医药已审财务报表（2015年12月31日）,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_14.pdf
1173,2016-03-30,复星医药续展及新增委托贷款/借款额度暨关联交易公告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_5.pdf
1174,2016-03-30,复星医药年报摘要,/disclosure/listedinfo/announcement/c/2016-03-30/600196_2015_nzy.pdf
1175,2016-03-30,复星医药年报,/disclosure/listedinfo/announcement/c/2016-03-30/600196_2015_n.pdf
1176,2016-03-30,复星医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_19.pdf
1177,2016-03-30,复星医药募集资金存放与实际使用情况专项审核报告（2015年12月31日）,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_11.pdf
1178,2016-03-30,复星医药关于控股子公司获药品临床试验申请受理的公告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_8.pdf
1179,2016-03-30,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_4.pdf
1180,2016-03-30,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_9.pdf
1181,2016-03-30,复星医药独立非执行董事关于对外担保情况的专项说明及意见,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_13.pdf
1182,2016-03-30,复星医药独立非执行董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_16.pdf
1183,2016-03-30,复星医药董事会审计委员会2015年度履职报告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_20.pdf
1184,2016-03-30,复星医药第六届监事会2016年第三次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_1.pdf
1185,2016-03-30,复星医药第六届董事会第七十七次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_2.pdf
1186,2016-03-30,复星医药：瑞银证券有限责任公司、德邦证券股份有限公司关于上海复星医药（集团）股份有限公司2015年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_10.pdf
1187,2016-03-30,复星医药：关于上海复星医药（集团）股份有限公司控股股东及其它关联方占用非经营性资金情况的专项说明,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_15.pdf
1188,2016-03-30,复星医药2015年日常关联交易报告及2016年日常关联交易预计公告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_3.pdf
1189,2016-03-30,复星医药2015年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_18.pdf
1190,2016-03-30,复星医药2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_17.pdf
1191,2016-03-30,复星医药2015年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-03-30/600196_20160330_6.pdf
1192,2016-03-31,复星医药关于拟委托中国证券登记结算有限责任公司上海分公司代理债券兑付兑息相关事宜的公告,/disclosure/listedinfo/announcement/c/2016-03-31/600196_20160331_2.pdf
1193,2016-03-31,复星医药公开发行2016年公司债券（面向合格投资者）（第一期）上市公告书,/disclosure/listedinfo/announcement/c/2016-03-31/600196_20160331_1.pdf
1194,2016-04-02,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2016-04-02/600196_20160402_1.pdf
1195,2016-04-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-04-02/600196_20160402_2.pdf
1196,2016-04-06,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-04-06/600196_20160406_1.pdf
1197,2016-04-08,复星医药关于召开2016年第一次临时股东大会的再次通知,/disclosure/listedinfo/announcement/c/2016-04-08/600196_20160408_1.pdf
1198,2016-04-09,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-04-09/600196_20160409_1.pdf
1199,2016-04-12,复星医药可续期公司债券发行预案公告,/disclosure/listedinfo/announcement/c/2016-04-12/600196_20160412_3.pdf
1200,2016-04-12,复星医药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2016-04-12/600196_20160412_4.pdf
1201,2016-04-12,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2016-04-12/600196_20160412_5.pdf
1202,2016-04-12,复星医药独立非执行董事提名人声明,/disclosure/listedinfo/announcement/c/2016-04-12/600196_20160412_10.pdf
1203,2016-04-12,复星医药独立非执行董事候选人声明（韦少琨）,/disclosure/listedinfo/announcement/c/2016-04-12/600196_20160412_9.pdf
1204,2016-04-12,复星医药独立非执行董事候选人声明（江宪）,/disclosure/listedinfo/announcement/c/2016-04-12/600196_20160412_8.pdf
1205,2016-04-12,复星医药独立非执行董事候选人声明（黄天祐）,/disclosure/listedinfo/announcement/c/2016-04-12/600196_20160412_7.pdf
1206,2016-04-12,复星医药独立非执行董事候选人声明（曹惠民）,/disclosure/listedinfo/announcement/c/2016-04-12/600196_20160412_6.pdf
1207,2016-04-12,复星医药第六届监事会2016年第四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-04-12/600196_20160412_2.pdf
1208,2016-04-12,复星医药第六届董事会第七十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-04-12/600196_20160412_1.pdf
1209,2016-04-15,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-04-15/600196_20160415_1.pdf
1210,2016-04-16,复星医药关联交易公告,/disclosure/listedinfo/announcement/c/2016-04-16/600196_20160416_2.pdf
1211,2016-04-16,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2016-04-16/600196_20160416_3.pdf
1212,2016-04-16,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2016-04-16/600196_20160416_4.pdf
1213,2016-04-16,复星医药第六届董事会第七十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-04-16/600196_20160416_1.pdf
1214,2016-04-19,复星医药关于召开2015年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-19/600196_20160419_2.pdf
1215,2016-04-19,复星医药2015年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-04-19/600196_20160419_1.pdf
1216,2016-04-21,复星医药关于召开2016年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-04-21/600196_20160421_1.pdf
1217,2016-04-21,复星医药2011年公司债券（第一期）2016年付息公告,/disclosure/listedinfo/announcement/c/2016-04-21/600196_20160421_2.pdf
1218,2016-04-27,复星医药2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-04-27/600196_20160427_1.pdf
1219,2016-04-27,复星医药2016年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-04-27/600196_20160427_2.pdf
1220,2016-04-29,复星医药2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-29/600196_2016_1.pdf
1221,2016-05-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-05-04/600196_20160504_1.pdf
1222,2016-05-07,复星医药关于选举职工监事的公告,/disclosure/listedinfo/announcement/c/2016-05-07/600196_20160507_1.pdf
1223,2016-05-12,复星医药关于2011年公司债券（第一期）及2016年公开发行公司债券（第一期）跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2016-05-12/600196_20160512_1.pdf
1224,2016-05-12,复星医药2011年公司债券（第一期）及2016年公开发行公司债券（第一期）跟踪评级报告,/disclosure/listedinfo/announcement/c/2016-05-12/600196_20160512_2.pdf
1225,2016-05-16,复星医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2016-05-16/600196_20160516_1.pdf
1226,2016-05-18,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-05-18/600196_20160518_2.pdf
1227,2016-05-18,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-05-18/600196_20160518_3.pdf
1228,2016-05-18,复星医药关于控股子公司撤回沙库比曲缬沙坦片及其原料药申报临床申请的公告,/disclosure/listedinfo/announcement/c/2016-05-18/600196_20160518_4.pdf
1229,2016-05-18,复星医药关于控股子公司撤回阿戈美拉汀片申报生产申请的公告,/disclosure/listedinfo/announcement/c/2016-05-18/600196_20160518_1.pdf
1230,2016-05-20,复星医药关于召开2015年度股东大会的再次通知,/disclosure/listedinfo/announcement/c/2016-05-20/600196_20160520_1.pdf
1231,2016-05-24,复星医药关于2016年度第一期超短期融资券发行完成的公告,/disclosure/listedinfo/announcement/c/2016-05-24/600196_20160524_1.pdf
1232,2016-05-28,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-05-28/600196_20160528_1.pdf
1233,2016-06-03,复星医药关于召开2015年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-06-03/600196_20160603_1.pdf
1234,2016-06-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-06-03/600196_20160603_2.pdf
1235,2016-06-07,复星医药关于当年累计新增借款及担保情况的公告,/disclosure/listedinfo/announcement/c/2016-06-07/600196_20160607_1.pdf
1236,2016-06-07,复星医药：瑞银证券有限责任公司关于上海复星医药（集团）股份有限公司2011年公司债券重大事项受托管理事务临时报告,/disclosure/listedinfo/announcement/c/2016-06-07/600196_20160607_2.pdf
1237,2016-06-07,复星医药2016年公开发行公司债券（面向合格投资者）（第一期）2016年度受托管理事务临时报告,/disclosure/listedinfo/announcement/c/2016-06-07/600196_20160607_4.pdf
1238,2016-06-07,复星医药2011年公司债券受托管理事务报告（2015年度）,/disclosure/listedinfo/announcement/c/2016-06-07/600196_20160607_3.pdf
1239,2016-06-08,复星医药独立非执行董事关于聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2016-06-08/600196_20160608_5.pdf
1240,2016-06-08,复星医药第七届监事会2016年第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-06-08/600196_20160608_3.pdf
1241,2016-06-08,复星医药第七届董事会第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-06-08/600196_20160608_2.pdf
1242,2016-06-08,复星医药2015年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-06-08/600196_20160608_1.pdf
1243,2016-06-08,复星医药2015年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-06-08/600196_20160608_4.pdf
1244,2016-06-09,复星医药进展公告,/disclosure/listedinfo/announcement/c/2016-06-09/600196_20160609_1.pdf
1245,2016-06-14,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2016-06-14/600196_20160614_1.pdf
1246,2016-06-17,复星医药2015年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2016-06-17/600196_20160617_1.pdf
1247,2016-06-18,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-06-18/600196_20160618_1.pdf
1248,2016-06-30,复星医药关于董事辞职的公告,/disclosure/listedinfo/announcement/c/2016-06-30/600196_20160630_1.pdf
1249,2016-06-30,复星医药第七届董事会第二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-06-30/600196_20160630_2.pdf
1250,2016-07-01,复星医药关于签订日常关联交易框架协议的公告,/disclosure/listedinfo/announcement/c/2016-07-01/600196_20160701_1.pdf
1251,2016-07-01,复星医药关于控股子公司Sisram Medical Ltd.或其上市主体拟境外上市的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-01/600196_20160701_2.pdf
1252,2016-07-05,复星医药关于与支付宝（中国）网络技术有限公司签订《业务合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2016-07-05/600196_20160705_1.pdf
1253,2016-07-05,复星医药关于与支付宝（中国）网络技术有限公司签订《业务合作框架协议》的补充公告,/disclosure/listedinfo/announcement/c/2016-07-05/600196_20160705_3.pdf
1254,2016-07-05,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-07-05/600196_20160705_2.pdf
1255,2016-07-06,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-07-06/600196_20160706_1.pdf
1256,2016-07-08,复星医药对外投资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-07-08/600196_20160708_2.pdf
1257,2016-07-08,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2016-07-08/600196_20160708_4.pdf
1258,2016-07-08,复星医药独立非执行董事关于聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2016-07-08/600196_20160708_3.pdf
1259,2016-07-08,复星医药第七届董事会第四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-07-08/600196_20160708_1.pdf
1260,2016-07-11,复星医药关于非公开发行股票获得中国证监会核准批文的公告,/disclosure/listedinfo/announcement/c/2016-07-11/600196_20160711_1.pdf
1261,2016-07-15,复星医药关于召开2016年第二次临时股东大会、2016年第一次A股类别股东会的通知,/disclosure/listedinfo/announcement/c/2016-07-15/600196_20160715_2.pdf
1262,2016-07-15,复星医药关于实施2015年度利润分配方案后调整非公开发行A股股票发行价格和发行数量的公告,/disclosure/listedinfo/announcement/c/2016-07-15/600196_20160715_3.pdf
1263,2016-07-15,复星医药对外投资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-07-15/600196_20160715_5.pdf
1264,2016-07-15,复星医药独立非执行董事意见（提名执行董事）,/disclosure/listedinfo/announcement/c/2016-07-15/600196_20160715_6.pdf
1265,2016-07-15,复星医药独立非执行董事意见（国药健康在线）,/disclosure/listedinfo/announcement/c/2016-07-15/600196_20160715_7.pdf
1266,2016-07-15,复星医药第七届董事会第五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-07-15/600196_20160715_4.pdf
1267,2016-07-15,复星医药2016年第二次临时股东大会、2016年第一次A股类别股东会会议资料,/disclosure/listedinfo/announcement/c/2016-07-15/600196_20160715_1.pdf
1268,2016-07-16,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-07-16/600196_20160716_1.pdf
1269,2016-07-20,复星医药关于举行集体接待日的公告,/disclosure/listedinfo/announcement/c/2016-07-20/600196_20160720_1.pdf
1270,2016-07-29,复星医药新增担保额度公告,/disclosure/listedinfo/announcement/c/2016-07-29/600196_20160729_4.pdf
1271,2016-07-29,复星医药关于本公司股票复牌的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-29/600196_20160729_1.pdf
1272,2016-07-29,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2016-07-29/600196_20160729_3.pdf
1273,2016-07-29,复星医药第七届董事会第六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-07-29/600196_20160729_2.pdf
1274,2016-07-29,复星医药：鉴证报告以及准则差异调节表（截至2016年3月31日止12个月）,/disclosure/listedinfo/announcement/c/2016-07-29/600196_20160729_5.pdf
1275,2016-08-04,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2016-08-04/600196_20160804_2.pdf
1276,2016-08-04,复星医药：GLAND PHARMA LIMITED已审财务报表（2016年3月31日以及2015年12月31日）,/disclosure/listedinfo/announcement/c/2016-08-04/600196_20160804_3.pdf
1277,2016-08-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-08-04/600196_20160804_1.pdf
1278,2016-08-05,复星医药关于更换持续督导保荐代表人的公告,/disclosure/listedinfo/announcement/c/2016-08-05/600196_20160805_1.pdf
1279,2016-08-06,复星医药对外投资暨关联交易进展公告,/disclosure/listedinfo/announcement/c/2016-08-06/600196_20160806_1.pdf
1280,2016-08-06,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2016-08-06/600196_20160806_2.pdf
1281,2016-08-09,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-08-09/600196_20160809_1.pdf
1282,2016-08-11,复星医药信息披露暂缓与豁免业务管理制度,/disclosure/listedinfo/announcement/c/2016-08-11/600196_20160811_5.pdf
1283,2016-08-11,复星医药关于召开2016年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-08-11/600196_20160811_3.pdf
1284,2016-08-11,复星医药关于控股子公司上海复宏汉霖生物技术有限公司拟改制并申请在全国中小企业股份转让系统挂牌的提示性公告,/disclosure/listedinfo/announcement/c/2016-08-11/600196_20160811_4.pdf
1285,2016-08-11,复星医药第七届董事会第七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-08-11/600196_20160811_2.pdf
1286,2016-08-11,复星医药2016年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-08-11/600196_20160811_1.pdf
1287,2016-08-12,复星医药关于召开2016年第二次临时股东大会、2016年第一次A股类别股东会的再次通知,/disclosure/listedinfo/announcement/c/2016-08-12/600196_20160812_1.pdf
1288,2016-08-16,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-08-16/600196_20160816_2.pdf
1289,2016-08-16,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-08-16/600196_20160816_1.pdf
1290,2016-08-16,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-08-16/600196_20160816_3.pdf
1291,2016-08-20,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600196_20160820_3.pdf
1292,2016-08-20,复星医药关于2016年度第二期超短期融资券发行完成的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600196_20160820_1.pdf
1293,2016-08-20,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2016-08-20/600196_20160820_2.pdf
1294,2016-08-24,复星医药独立非执行董事关于聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2016-08-24/600196_20160824_6.pdf
1295,2016-08-24,复星医药第七届监事会2016年第二次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2016-08-24/600196_20160824_2.pdf
1296,2016-08-24,复星医药第七届董事会第八次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2016-08-24/600196_20160824_1.pdf
1297,2016-08-24,复星医药2016年半年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2016-08-24/600196_20160824_5.pdf
1298,2016-08-24,复星医药2016年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-08-24/600196_20160824_4.pdf
1299,2016-08-24,复星医药2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-24/600196_2016_zzy.pdf
1300,2016-08-24,复星医药2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-24/600196_2016_z.pdf
1301,2016-08-27,复星医药关于召开2016年第二次临时股东大会、2016年第一次A股类别股东会的提示性公告,/disclosure/listedinfo/announcement/c/2016-08-27/600196_20160827_1.pdf
1302,2016-08-30,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-08-30/600196_20160830_2.pdf
1303,2016-08-30,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2016-08-30/600196_20160830_1.pdf
1304,2016-08-31,复星医药关于当年累计新增借款及担保情况的公告,/disclosure/listedinfo/announcement/c/2016-08-31/600196_20160831_1.pdf
1305,2016-08-31,复星医药：瑞银证券有限责任公司关于上海复星医药（集团）股份有限公司2011年公司债券2016年度第二次重大事项受托管理事务临时报告,/disclosure/listedinfo/announcement/c/2016-08-31/600196_20160831_3.pdf
1306,2016-08-31,复星医药2016年公开发行公司债券（面向合格投资者）（第一期）2016年度第二次受托管理事务临时报告,/disclosure/listedinfo/announcement/c/2016-08-31/600196_20160831_2.pdf
1307,2016-09-01,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-09-01/600196_20160901_2.pdf
1308,2016-09-01,复星医药2016年第二次临时股东大会、2016年第一次A股类别股东会及2016年第一次H股类别股东会决议公告,/disclosure/listedinfo/announcement/c/2016-09-01/600196_20160901_1.pdf
1309,2016-09-01,复星医药2016年第二次临时股东大会、2016年第一次A股类别股东会、2016年第一次H股类别股东会的法律意见书,/disclosure/listedinfo/announcement/c/2016-09-01/600196_20160901_3.pdf
1310,2016-09-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-09-02/600196_20160902_1.pdf
1311,2016-09-03,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-09-03/600196_20160903_1.pdf
1312,2016-09-07,复星医药关于与南华大学附属第二医院签订《投资合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2016-09-07/600196_20160907_1.pdf
1313,2016-09-07,复星医药关于与广州中医药大学签订《合作框架协议书》的公告,/disclosure/listedinfo/announcement/c/2016-09-07/600196_20160907_2.pdf
1314,2016-09-12,复星医药关于参与重庆建峰化工股份有限公司重大资产重组的提示性公告,/disclosure/listedinfo/announcement/c/2016-09-12/600196_20160912_2.pdf
1315,2016-09-12,复星医药第七届董事会第十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-09-12/600196_20160912_1.pdf
1316,2016-09-13,复星医药关于召开2016年第三次临时股东大会的再次通知,/disclosure/listedinfo/announcement/c/2016-09-13/600196_20160913_1.pdf
1317,2016-09-15,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-09-15/600196_20160915_2.pdf
1318,2016-09-15,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-09-15/600196_20160915_1.pdf
1319,2016-09-27,复星医药关于召开2016年第三次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-09-27/600196_20160927_1.pdf
1320,2016-09-30,复星医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2016-09-30/600196_20160930_4.pdf
1321,2016-09-30,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2016-09-30/600196_20160930_3.pdf
1322,2016-09-30,复星医药2016年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-09-30/600196_20160930_1.pdf
1323,2016-09-30,复星医药2016年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-09-30/600196_20160930_2.pdf
1324,2016-10-11,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-10-11/600196_20161011_1.pdf
1325,2016-10-14,复星医药关于控股子公司获药品注册批件的公告,/disclosure/listedinfo/announcement/c/2016-10-14/600196_20161014_1.pdf
1326,2016-10-14,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-10-14/600196_20161014_2.pdf
1327,2016-10-14,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-10-14/600196_20161014_3.pdf
1328,2016-10-14,复星医药关于控股子公司获美国FDA药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-10-14/600196_20161014_4.pdf
1329,2016-10-18,复星医药关于与上海复星高科技集团财务有限公司续签《金融服务协议》的关联交易公告,/disclosure/listedinfo/announcement/c/2016-10-18/600196_20161018_3.pdf
1330,2016-10-18,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2016-10-18/600196_20161018_4.pdf
1331,2016-10-18,复星医药第七届董事会第十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-10-18/600196_20161018_2.pdf
1332,2016-10-18,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-10-18/600196_20161018_1.pdf
1333,2016-10-19,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-10-19/600196_20161019_1.pdf
1334,2016-10-20,复星医药关于控股子公司药品临床试验进展的公告,/disclosure/listedinfo/announcement/c/2016-10-20/600196_20161020_1.pdf
1335,2016-10-26,复星医药章程修正案（尚须股东大会审议）,/disclosure/listedinfo/announcement/c/2016-10-26/600196_20161026_4.pdf
1336,2016-10-26,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2016-10-26/600196_20161026_2.pdf
1337,2016-10-26,复星医药第七届监事会2016年第三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-10-26/600196_20161026_1.pdf
1338,2016-10-26,复星医药第七届董事会第十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-10-26/600196_20161026_3.pdf
1339,2016-10-27,复星医药募集资金管理制度（尚须股东大会审议）,/disclosure/listedinfo/announcement/c/2016-10-27/600196_20161027_6.pdf
1340,2016-10-27,复星医药累积投票制实施细则（尚须股东大会审议）,/disclosure/listedinfo/announcement/c/2016-10-27/600196_20161027_5.pdf
1341,2016-10-27,复星医药监事会议事规则（尚须股东大会审议）,/disclosure/listedinfo/announcement/c/2016-10-27/600196_20161027_3.pdf
1342,2016-10-27,复星医药关联交易管理制度（尚须股东大会审议）,/disclosure/listedinfo/announcement/c/2016-10-27/600196_20161027_4.pdf
1343,2016-10-27,复星医药股东大会议事规则（尚须股东大会审议）,/disclosure/listedinfo/announcement/c/2016-10-27/600196_20161027_2.pdf
1344,2016-10-27,复星医药董事会议事规则（尚须股东大会审议）,/disclosure/listedinfo/announcement/c/2016-10-27/600196_20161027_1.pdf
1345,2016-10-28,复星医药关于与湖北省黄冈市蕲春县人民政府签订《战略合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2016-10-28/600196_20161028_1.pdf
1346,2016-10-29,复星医药关于控股子公司签署许可协议的公告,/disclosure/listedinfo/announcement/c/2016-10-29/600196_20161029_1.pdf
1347,2016-10-29,复星医药第七届董事会第十四次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2016-10-29/600196_20161029_3.pdf
1348,2016-10-29,复星医药2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-29/600196_2016_3.pdf
1349,2016-11-03,复星医药关于控股子公司签署许可协议的公告,/disclosure/listedinfo/announcement/c/2016-11-03/600196_20161103_2.pdf
1350,2016-11-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-11-03/600196_20161103_1.pdf
1351,2016-11-04,复星医药关于召开2016年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-11-04/600196_20161104_2.pdf
1352,2016-11-04,复星医药2016年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-11-04/600196_20161104_1.pdf
1353,2016-11-10,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_6.pdf
1354,2016-11-10,复星医药关于使用募集资金置换预先投入募投项目的自筹资金的公告,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_5.pdf
1355,2016-11-10,复星医药关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_2.pdf
1356,2016-11-10,复星医药公司章程,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_11.pdf
1357,2016-11-10,复星医药非公开发行A股股票之发行情况报告书,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_14.pdf
1358,2016-11-10,复星医药非公开发行A股股票发行结果暨股本变动公告,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_7.pdf
1359,2016-11-10,复星医药独立非执行董事关于使用募集资金置换预先投入募投项目的自筹资金的独立意见,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_10.pdf
1360,2016-11-10,复星医药第七届监事会2016年第五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_4.pdf
1361,2016-11-10,复星医药第七届董事会第十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_3.pdf
1362,2016-11-10,复星医药：验资报告,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_12.pdf
1363,2016-11-10,复星医药：瑞银证券有限责任公司、德邦证券股份有限公司关于上海复星医药（集团）股份有限公司使用募集资金置换预先投入募集资金投资项目的自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_8.pdf
1364,2016-11-10,复星医药：瑞银证券有限责任公司、德邦证券股份有限公司关于上海复星医药（集团）股份有限公司非公开发行股票发行过程和认购对象合规性的报告,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_15.pdf
1365,2016-11-10,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司非公开发行股票发行过程和认购对象合规性之法律意见书,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_13.pdf
1366,2016-11-10,复星医药：安永华明会计师事务所（特殊普通合伙）关于上海复星医药（集团）股份有限公司以自筹资金预先投入募集资金投资项目的专项审核报告,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_9.pdf
1367,2016-11-10,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-11-10/600196_20161110_16.pdf
1368,2016-11-11,复星医药关于控股股东增持本公司股份计划的提示性公告,/disclosure/listedinfo/announcement/c/2016-11-11/600196_20161111_5.pdf
1369,2016-11-11,复星医药关于回购注销部分限制性A股股票通知债权人公告,/disclosure/listedinfo/announcement/c/2016-11-11/600196_20161111_4.pdf
1370,2016-11-11,复星医药关于回购注销部分未解锁限制性A股股票的公告,/disclosure/listedinfo/announcement/c/2016-11-11/600196_20161111_3.pdf
1371,2016-11-11,复星医药独立非执行董事关于回购注销部分未解锁限制性A股股票的独立意见,/disclosure/listedinfo/announcement/c/2016-11-11/600196_20161111_6.pdf
1372,2016-11-11,复星医药第七届监事会2016年第六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-11-11/600196_20161111_2.pdf
1373,2016-11-11,复星医药第七届董事会第十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-11-11/600196_20161111_1.pdf
1374,2016-11-11,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司回购注销第二期限制性股票激励计划部分限制性A股股票之法律意见书,/disclosure/listedinfo/announcement/c/2016-11-11/600196_20161111_7.pdf
1375,2016-11-18,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-11-18/600196_20161118_1.pdf
1376,2016-11-18,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-11-18/600196_20161118_2.pdf
1377,2016-11-22,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-11-22/600196_20161122_5.pdf
1378,2016-11-22,复星医药独立非执行董事关于《上海复星医药（集团）股份有限公司第二期限制性股票激励计划（修订稿）》所涉限制性A股股票第一期解锁事项的独立意见,/disclosure/listedinfo/announcement/c/2016-11-22/600196_20161122_4.pdf
1379,2016-11-22,复星医药第七届监事会2016年第七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-11-22/600196_20161122_2.pdf
1380,2016-11-22,复星医药第七届董事会第十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-11-22/600196_20161122_1.pdf
1381,2016-11-22,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司第二期限制性股票激励计划所涉限制性A股股票第一期解锁之法律意见书,/disclosure/listedinfo/announcement/c/2016-11-22/600196_20161122_3.pdf
1382,2016-11-24,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-11-24/600196_20161124_1.pdf
1383,2016-11-24,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-11-24/600196_20161124_2.pdf
1384,2016-11-25,复星医药关于参与重庆建峰化工股份有限公司重大资产重组的进展公告,/disclosure/listedinfo/announcement/c/2016-11-25/600196_20161125_1.pdf
1385,2016-11-26,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-11-26/600196_20161126_1.pdf
1386,2016-11-30,复星医药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2016-11-30/600196_20161130_2.pdf
1387,2016-11-30,复星医药第二期激励计划所涉限制性A股股票第一期解锁暨上市的公告,/disclosure/listedinfo/announcement/c/2016-11-30/600196_20161130_1.pdf
1388,2016-12-01,复星医药关于获中国证监会批复核准增发境外上市外资股的公告,/disclosure/listedinfo/announcement/c/2016-12-01/600196_20161201_1.pdf
1389,2016-12-02,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2016-12-02/600196_20161202_1.pdf
1390,2016-12-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2016-12-02/600196_20161202_2.pdf
1391,2016-12-06,复星医药关于召开2016年第四次临时股东大会的再次通知,/disclosure/listedinfo/announcement/c/2016-12-06/600196_20161206_1.pdf
1392,2016-12-07,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-12-07/600196_20161207_1.pdf
1393,2016-12-09,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-12-09/600196_20161209_1.pdf
1394,2016-12-13,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-12-13/600196_20161213_1.pdf
1395,2016-12-15,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-12-15/600196_20161215_1.pdf
1396,2016-12-15,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2016-12-15/600196_20161215_2.pdf
1397,2016-12-20,复星医药关于召开2016年第四次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-12-20/600196_20161220_1.pdf
1398,2016-12-23,复星医药募集资金管理制度（2016年修订）,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_13.pdf
1399,2016-12-23,复星医药累积投票制实施细则（2016年修订）,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_12.pdf
1400,2016-12-23,复星医药监事会议事规则（2016年修订）,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_11.pdf
1401,2016-12-23,复星医药关于参与发起设立私募基金的公告,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_3.pdf
1402,2016-12-23,复星医药关联交易管理制度（2016年修订）,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_10.pdf
1403,2016-12-23,复星医药股东大会议事规则（2016年修订）,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_9.pdf
1404,2016-12-23,复星医药公司章程,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_14.pdf
1405,2016-12-23,复星医药反腐败条例,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_6.pdf
1406,2016-12-23,复星医药对外投资暨关联交易公告,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_2.pdf
1407,2016-12-23,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_5.pdf
1408,2016-12-23,复星医药董事会议事规则（2016年修订）,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_8.pdf
1409,2016-12-23,复星医药第七届董事会第十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_1.pdf
1410,2016-12-23,复星医药2016年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_4.pdf
1411,2016-12-23,复星医药2016年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-12-23/600196_20161223_7.pdf
1412,2016-12-24,复星医药关于收到中国证监会关于本公司分拆下属公司境外上市有关事宜的函的公告,/disclosure/listedinfo/announcement/c/2016-12-24/600196_20161224_1.pdf
1413,2016-12-24,复星医药关于控股子公司药品临床试验进展的公告,/disclosure/listedinfo/announcement/c/2016-12-24/600196_20161224_3.pdf
1414,2016-12-24,复星医药关于控股子公司药品临床试验进展的公告,/disclosure/listedinfo/announcement/c/2016-12-24/600196_20161224_4.pdf
1415,2016-12-24,复星医药关于控股子公司药品临床试验进展的公告,/disclosure/listedinfo/announcement/c/2016-12-24/600196_20161224_2.pdf
1416,2016-12-28,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2016-12-28/600196_20161228_1.pdf
1417,2016-12-29,复星医药关于控股子公司改制及申请于全国中小企业股份转让系统挂牌的进展公告,/disclosure/listedinfo/announcement/c/2016-12-29/600196_20161229_1.pdf
1418,2017-01-03,复星医药关于董事、高级管理人员增持本公司股份计划的公告,/disclosure/listedinfo/announcement/c/2017-01-03/600196_20170103_1.pdf
1419,2017-01-04,复星医药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2017-01-04/600196_20170104_3.pdf
1420,2017-01-04,复星医药第七届董事会第二十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-01-04/600196_20170104_2.pdf
1421,2017-01-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-01-04/600196_20170104_1.pdf
1422,2017-01-05,复星医药更正公告,/disclosure/listedinfo/announcement/c/2017-01-05/600196_20170105_1.pdf
1423,2017-01-05,复星医药：瑞银证券有限责任公司、德邦证券股份有限公司关于上海复星医药（集团）股份有限公司非公开发行A股股票2016年度持续督导现场检查报告,/disclosure/listedinfo/announcement/c/2017-01-05/600196_20170105_2.pdf
1424,2017-01-11,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2017-01-11/600196_20170111_2.pdf
1425,2017-01-11,复星医药第七届董事会第二十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-01-11/600196_20170111_1.pdf
1426,2017-01-12,复星医药关于与淮安市第二人民医院签订《投资合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2017-01-12/600196_20170112_2.pdf
1427,2017-01-12,复星医药对外投资公告的补充公告,/disclosure/listedinfo/announcement/c/2017-01-12/600196_20170112_1.pdf
1428,2017-01-13,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2017-01-13/600196_20170113_4.pdf
1429,2017-01-13,复星医药独立非执行董事关于《上海复星医药（集团）股份有限公司限制性股票激励计划（修订稿）》所涉限制性A股股票第三期解锁事项的独立意见,/disclosure/listedinfo/announcement/c/2017-01-13/600196_20170113_5.pdf
1430,2017-01-13,复星医药第一期激励计划所涉限制性A股股票第三期解锁暨上市的公告,/disclosure/listedinfo/announcement/c/2017-01-13/600196_20170113_3.pdf
1431,2017-01-13,复星医药第七届监事会2017年第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-01-13/600196_20170113_2.pdf
1432,2017-01-13,复星医药第七届董事会第二十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-01-13/600196_20170113_1.pdf
1433,2017-01-13,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司第一期限制性股票激励计划所涉限制性A股股票第三期解锁之法律意见书,/disclosure/listedinfo/announcement/c/2017-01-13/600196_20170113_6.pdf
1434,2017-01-16,复星医药独立非执行董事关于聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2017-01-16/600196_20170116_2.pdf
1435,2017-01-16,复星医药第七届董事会第二十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-01-16/600196_20170116_1.pdf
1436,2017-01-19,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-01-19/600196_20170119_1.pdf
1437,2017-01-20,复星医药关于董事、高级管理人员增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-01-20/600196_20170120_1.pdf
1438,2017-01-26,复星医药对外投资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2017-01-26/600196_20170126_2.pdf
1439,2017-01-26,复星医药对外投资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2017-01-26/600196_20170126_3.pdf
1440,2017-01-26,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2017-01-26/600196_20170126_4.pdf
1441,2017-01-26,复星医药第七届董事会第二十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-01-26/600196_20170126_1.pdf
1442,2017-02-04,复星医药关于控股子公司获药品临床试验申请受理的公告,/disclosure/listedinfo/announcement/c/2017-02-04/600196_20170204_2.pdf
1443,2017-02-04,复星医药关于控股股东增持本公司股份计划实施期限届满的公告,/disclosure/listedinfo/announcement/c/2017-02-04/600196_20170204_1.pdf
1444,2017-02-04,复星医药：国浩律师（上海）事务所关于上海复星高科技（集团）有限公司增持上海复星医药（集团）股份有限公司股份之专项核查意见,/disclosure/listedinfo/announcement/c/2017-02-04/600196_20170204_3.pdf
1445,2017-02-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-02-04/600196_20170204_4.pdf
1446,2017-02-24,复星医药关于回购注销限制性A股股票进展的公告,/disclosure/listedinfo/announcement/c/2017-02-24/600196_20170224_2.pdf
1447,2017-02-24,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-02-24/600196_20170224_1.pdf
1448,2017-02-25,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600196_20170225_2.pdf
1449,2017-02-25,复星医药公司章程,/disclosure/listedinfo/announcement/c/2017-02-25/600196_20170225_5.pdf
1450,2017-02-25,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2017-02-25/600196_20170225_4.pdf
1451,2017-02-25,复星医药第七届董事会第二十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-02-25/600196_20170225_1.pdf
1452,2017-02-25,复星医药2016年公开发行公司债券（面向合格投资者）（第一期）2017年付息公告,/disclosure/listedinfo/announcement/c/2017-02-25/600196_20170225_3.pdf
1453,2017-02-27,复星医药关于产品新纳入国家医保目录的公告,/disclosure/listedinfo/announcement/c/2017-02-27/600196_20170227_1.pdf
1454,2017-03-02,复星医药关于募集资金专户销户的公告,/disclosure/listedinfo/announcement/c/2017-03-02/600196_20170302_2.pdf
1455,2017-03-02,复星医药关于FDA对控股子公司原料药检查出具警告信的公告,/disclosure/listedinfo/announcement/c/2017-03-02/600196_20170302_3.pdf
1456,2017-03-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-03-02/600196_20170302_1.pdf
1457,2017-03-09,复星医药2017年公开发行公司债券募集说明书摘要（面向合格投资者）（第一期）,/disclosure/listedinfo/announcement/c/2017-03-09/600196_20170309_3.pdf
1458,2017-03-09,复星医药2017年公开发行公司债券募集说明书（面向合格投资者）（第一期）,/disclosure/listedinfo/announcement/c/2017-03-09/600196_20170309_1.pdf
1459,2017-03-09,复星医药2017年公开发行公司债券（面向合格投资者）（第一期）信用评级报告,/disclosure/listedinfo/announcement/c/2017-03-09/600196_20170309_4.pdf
1460,2017-03-09,复星医药2017年公开发行公司债券（面向合格投资者）（第一期）发行公告,/disclosure/listedinfo/announcement/c/2017-03-09/600196_20170309_2.pdf
1461,2017-03-11,复星医药关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2017-03-11/600196_20170311_1.pdf
1462,2017-03-13,复星医药2017年公开发行公司债券（面向合格投资者）（第一期）票面利率公告,/disclosure/listedinfo/announcement/c/2017-03-13/600196_20170313_1.pdf
1463,2017-03-15,复星医药2017年公开发行公司债券（面向合格投资者）（第一期）发行结果公告,/disclosure/listedinfo/announcement/c/2017-03-15/600196_20170315_1.pdf
1464,2017-03-16,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-03-16/600196_20170316_1.pdf
1465,2017-03-22,复星医药2017年公开发行公司债券（面向合格投资者）（第一期）在上海证券交易所上市的公告,/disclosure/listedinfo/announcement/c/2017-03-22/600196_20170322_1.pdf
1466,2017-03-29,复星医药续展及新增委托贷款/借款额度公告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_7.pdf
1467,2017-03-29,复星医药关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_4.pdf
1468,2017-03-29,复星医药关于签订日常关联交易框架协议的公告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_5.pdf
1469,2017-03-29,复星医药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_3.pdf
1470,2017-03-29,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_6.pdf
1471,2017-03-29,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_11.pdf
1472,2017-03-29,复星医药独立非执行董事关于对外担保情况的专项说明及意见,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_13.pdf
1473,2017-03-29,复星医药独立非执行董事2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_16.pdf
1474,2017-03-29,复星医药董事会审计委员会2016年度履职报告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_22.pdf
1475,2017-03-29,复星医药第七届监事会2017年第二次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_29.pdf
1476,2017-03-29,复星医药第七届董事会第二十七次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_28.pdf
1477,2017-03-29,复星医药：已审财务报表（2016年12月31日）,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_14.pdf
1478,2017-03-29,复星医药：瑞银证券有限责任公司、德邦证券股份有限公司关于上海复星医药（集团）股份有限公司2016年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_21.pdf
1479,2017-03-29,复星医药：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_20.pdf
1480,2017-03-29,复星医药：募集资金存放与实际使用情况专项审核报告（2016年12月31日）,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_19.pdf
1481,2017-03-29,复星医药：关于上海复星医药（集团）股份有限公司控股股东及其它关联方占用非经营性资金情况的专项说明,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_15.pdf
1482,2017-03-29,复星医药2016年日常关联交易报告及2017年日常关联交易预计公告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_10.pdf
1483,2017-03-29,复星医药2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-03-29/600196_2016_nzy.pdf
1484,2017-03-29,复星医药2016年年度报告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_2016_n.pdf
1485,2017-03-29,复星医药2016年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_18.pdf
1486,2017-03-29,复星医药2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_17.pdf
1487,2017-03-29,复星医药2016年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-03-29/600196_20170329_9.pdf
1488,2017-03-30,复星医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2017-03-30/600196_20170330_2.pdf
1489,2017-03-30,复星医药：瑞银证券有限责任公司、德邦证券股份有限公司关于上海复星医药（集团）股份有限公司非公开发行A股股票2016年度持续督导报告书,/disclosure/listedinfo/announcement/c/2017-03-30/600196_20170330_1.pdf
1490,2017-04-01,复星医药总裁工作细则,/disclosure/listedinfo/announcement/c/2017-04-01/600196_20170401_8.pdf
1491,2017-04-01,复星医药关于公司债券发行预案的公告,/disclosure/listedinfo/announcement/c/2017-04-01/600196_20170401_2.pdf
1492,2017-04-01,复星医药关联交易管理制度（尚须股东大会审议）,/disclosure/listedinfo/announcement/c/2017-04-01/600196_20170401_3.pdf
1493,2017-04-01,复星医药独立非执行董事制度,/disclosure/listedinfo/announcement/c/2017-04-01/600196_20170401_4.pdf
1494,2017-04-01,复星医药独立非执行董事年报工作制度,/disclosure/listedinfo/announcement/c/2017-04-01/600196_20170401_5.pdf
1495,2017-04-01,复星医药董事会审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2017-04-01/600196_20170401_6.pdf
1496,2017-04-01,复星医药董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2017-04-01/600196_20170401_7.pdf
1497,2017-04-01,复星医药第七届董事会第二十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-04-01/600196_20170401_1.pdf
1498,2017-04-06,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-04-06/600196_20170406_1.pdf
1499,2017-04-07,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-04-07/600196_20170407_1.pdf
1500,2017-04-08,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2017-04-08/600196_20170408_1.pdf
1501,2017-04-13,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-04-13/600196_20170413_1.pdf
1502,2017-04-14,复星医药2011年公司债券（第一期）本息兑付和摘牌公告,/disclosure/listedinfo/announcement/c/2017-04-14/600196_20170414_1.pdf
1503,2017-04-19,复星医药关于公司债券发行预案修订的提示性公告,/disclosure/listedinfo/announcement/c/2017-04-19/600196_20170419_2.pdf
1504,2017-04-19,复星医药关于公司债券发行预案（修订稿）的公告,/disclosure/listedinfo/announcement/c/2017-04-19/600196_20170419_3.pdf
1505,2017-04-19,复星医药第七届董事会第二十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-04-19/600196_20170419_1.pdf
1506,2017-04-22,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2017-04-22/600196_20170422_1.pdf
1507,2017-04-25,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2017-04-25/600196_20170425_2.pdf
1508,2017-04-25,复星医药第七届董事会第三十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-04-25/600196_20170425_1.pdf
1509,2017-04-28,复星医药对外投资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2017-04-28/600196_20170428_3.pdf
1510,2017-04-28,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2017-04-28/600196_20170428_5.pdf
1511,2017-04-28,复星医药第七届董事会第三十一次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2017-04-28/600196_20170428_1.pdf
1512,2017-04-28,复星医药2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-28/600196_2017_1.pdf
1513,2017-04-29,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2017-04-29/600196_20170429_1.pdf
1514,2017-05-03,复星医药关于认购私募基金份额的公告,/disclosure/listedinfo/announcement/c/2017-05-03/600196_20170503_1.pdf
1515,2017-05-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-05-03/600196_20170503_2.pdf
1516,2017-05-05,复星医药关于认购私募基金份额的补充公告,/disclosure/listedinfo/announcement/c/2017-05-05/600196_20170505_1.pdf
1517,2017-05-05,复星医药关于董事、高级管理人员增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-05/600196_20170505_2.pdf
1518,2017-05-10,复星医药关于控股股东增持股份暨增持计划的公告,/disclosure/listedinfo/announcement/c/2017-05-10/600196_20170510_1.pdf
1519,2017-05-11,复星医药关于召开2016年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-05-11/600196_20170511_1.pdf
1520,2017-05-11,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-11/600196_20170511_3.pdf
1521,2017-05-11,复星医药2016年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-05-11/600196_20170511_2.pdf
1522,2017-05-12,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-12/600196_20170512_1.pdf
1523,2017-05-17,复星医药关于根据一般授权配售新H股的公告,/disclosure/listedinfo/announcement/c/2017-05-17/600196_20170517_1.pdf
1524,2017-05-19,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-05-19/600196_20170519_1.pdf
1525,2017-05-24,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-24/600196_20170524_4.pdf
1526,2017-05-24,复星医药关于董事、高级管理人员增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-24/600196_20170524_3.pdf
1527,2017-05-24,复星医药关于2016年公开发行公司债券（第一期）及2017年公开发行公司债券（第一期）跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2017-05-24/600196_20170524_1.pdf
1528,2017-05-24,复星医药2016年公开发行公司债券（第一期）及2017年公开发行公司债券（第一期）跟踪评级报告,/disclosure/listedinfo/announcement/c/2017-05-24/600196_20170524_2.pdf
1529,2017-05-25,复星医药关于完成根据一般授权配售新H股的公告,/disclosure/listedinfo/announcement/c/2017-05-25/600196_20170525_1.pdf
1530,2017-05-25,复星医药关于控股股东继续增持本公司股份暨增持计划的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-25/600196_20170525_2.pdf
1531,2017-05-25,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-05-25/600196_20170525_3.pdf
1532,2017-05-26,复星医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2017-05-26/600196_20170526_2.pdf
1533,2017-05-26,复星医药公司章程,/disclosure/listedinfo/announcement/c/2017-05-26/600196_20170526_3.pdf
1534,2017-05-26,复星医药第七届董事会第三十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-05-26/600196_20170526_1.pdf
1535,2017-06-01,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-06-01/600196_20170601_1.pdf
1536,2017-06-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-06-02/600196_20170602_1.pdf
1537,2017-06-07,复星医药关于控股子公司获乌克兰卫生部药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2017-06-07/600196_20170607_2.pdf
1538,2017-06-07,复星医药关于建议分拆 SISRAM MEDICAL LTD 并于香港联合交易所有限公司主板独立上市的进展公告,/disclosure/listedinfo/announcement/c/2017-06-07/600196_20170607_1.pdf
1539,2017-06-09,复星医药关于转让北京滨复华耀资本投资管理中心（有限合伙）出资份额的公告,/disclosure/listedinfo/announcement/c/2017-06-09/600196_20170609_1.pdf
1540,2017-06-10,复星医药关于控股子公司获药品临床试验申请受理的公告,/disclosure/listedinfo/announcement/c/2017-06-10/600196_20170610_1.pdf
1541,2017-06-13,复星医药关于召开2016年度股东大会的再次通知,/disclosure/listedinfo/announcement/c/2017-06-13/600196_20170613_1.pdf
1542,2017-06-20,复星医药2016年公开发行公司债券（面向合格投资者）（第一期）受托管理事务报告（2016年度）,/disclosure/listedinfo/announcement/c/2017-06-20/600196_20170620_1.pdf
1543,2017-06-23,复星医药公告,/disclosure/listedinfo/announcement/c/2017-06-23/600196_20170623_1.pdf
1544,2017-06-27,复星医药关于召开2016年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-06-27/600196_20170627_1.pdf
1545,2017-06-27,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-06-27/600196_20170627_2.pdf
1546,2017-06-28,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-06-28/600196_20170628_1.pdf
1547,2017-06-30,复星医药关联交易管理制度（2017年修订）,/disclosure/listedinfo/announcement/c/2017-06-30/600196_20170630_3.pdf
1548,2017-06-30,复星医药2016年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-30/600196_20170630_1.pdf
1549,2017-06-30,复星医药2016年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-30/600196_20170630_2.pdf
1550,2017-07-04,复星医药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2017-07-04/600196_20170704_1.pdf
1551,2017-07-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-07-04/600196_20170704_2.pdf
1552,2017-07-06,复星医药澄清公告,/disclosure/listedinfo/announcement/c/2017-07-06/600196_20170706_1.pdf
1553,2017-07-07,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-07-07/600196_20170707_3.pdf
1554,2017-07-07,复星医药关于出资设立科技创新孵化平台的公告,/disclosure/listedinfo/announcement/c/2017-07-07/600196_20170707_2.pdf
1555,2017-07-07,复星医药第七届董事会第三十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-07-07/600196_20170707_1.pdf
1556,2017-07-11,复星医药关于控股子公司获药品临床试验申请受理的公告,/disclosure/listedinfo/announcement/c/2017-07-11/600196_20170711_1.pdf
1557,2017-07-11,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-07-11/600196_20170711_2.pdf
1558,2017-07-14,复星医药关于控股子公司获药品临床试验申请受理的公告,/disclosure/listedinfo/announcement/c/2017-07-14/600196_20170714_1.pdf
1559,2017-07-19,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-07-19/600196_20170719_1.pdf
1560,2017-07-21,复星医药关于控股股东继续增持本公司股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-07-21/600196_20170721_1.pdf
1561,2017-07-22,复星医药信息披露制度,/disclosure/listedinfo/announcement/c/2017-07-22/600196_20170722_3.pdf
1562,2017-07-22,复星医药外部信息报送及使用管理制度,/disclosure/listedinfo/announcement/c/2017-07-22/600196_20170722_5.pdf
1563,2017-07-22,复星医药内幕信息知情人管理制度,/disclosure/listedinfo/announcement/c/2017-07-22/600196_20170722_4.pdf
1564,2017-07-22,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-07-22/600196_20170722_1.pdf
1565,2017-07-22,复星医药第七届董事会第三十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-07-22/600196_20170722_2.pdf
1566,2017-07-25,复星医药关于参与重庆建峰化工股份有限公司重大资产重组的进展公告,/disclosure/listedinfo/announcement/c/2017-07-25/600196_20170725_1.pdf
1567,2017-07-26,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2017-07-26/600196_20170726_1.pdf
1568,2017-07-28,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2017-07-28/600196_20170728_2.pdf
1569,2017-07-28,复星医药第七届董事会第三十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-07-28/600196_20170728_1.pdf
1570,2017-08-01,复星医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2017-08-01/600196_20170801_1.pdf
1571,2017-08-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-08-02/600196_20170802_1.pdf
1572,2017-08-02,复星医药2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-08-02/600196_20170802_2.pdf
1573,2017-08-03,复星医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2017-08-03/600196_20170803_1.pdf
1574,2017-08-14,复星医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2017-08-14/600196_20170814_1.pdf
1575,2017-08-15,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-08-15/600196_20170815_1.pdf
1576,2017-08-16,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2017-08-16/600196_20170816_1.pdf
1577,2017-08-21,复星医药关于建议分拆SISRAM MEDICAL LTD并于香港联合交易所有限公司主板独立上市提交聆讯后资料集的公告,/disclosure/listedinfo/announcement/c/2017-08-21/600196_20170821_1.pdf
1578,2017-08-22,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2017-08-22/600196_20170822_1.pdf
1579,2017-08-25,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-08-25/600196_20170825_1.pdf
1580,2017-08-29,复星医药关于控股子公司获药品临床试验申请受理的公告,/disclosure/listedinfo/announcement/c/2017-08-29/600196_20170829_1.pdf
1581,2017-08-30,复星医药关于控股子公司购买产品包的公告,/disclosure/listedinfo/announcement/c/2017-08-30/600196_20170830_8.pdf
1582,2017-08-30,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2017-08-30/600196_20170830_7.pdf
1583,2017-08-30,复星医药第七届监事会2017年第四次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2017-08-30/600196_20170830_3.pdf
1584,2017-08-30,复星医药第七届董事会第三十七次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2017-08-30/600196_20170830_1.pdf
1585,2017-08-30,复星医药2017年半年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2017-08-30/600196_20170830_2.pdf
1586,2017-08-30,复星医药2017年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-30/600196_20170830_4.pdf
1587,2017-08-30,复星医药2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-30/600196_2017_zzy.pdf
1588,2017-08-30,复星医药2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-30/600196_2017_z.pdf
1589,2017-08-31,复星医药关于建议分拆SISRAM MEDICAL LTD并于香港联合交易所有限公司主板独立上市提交经更新聆讯后资料集的公告,/disclosure/listedinfo/announcement/c/2017-08-31/600196_20170831_1.pdf
1590,2017-09-01,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2017-09-01/600196_20170901_2.pdf
1591,2017-09-01,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2017-09-01/600196_20170901_1.pdf
1592,2017-09-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-09-02/600196_20170902_1.pdf
1593,2017-09-04,复星医药对外投资公告的补充公告,/disclosure/listedinfo/announcement/c/2017-09-04/600196_20170904_1.pdf
1594,2017-09-05,复星医药关于SISRAM MEDICAL LTD刊发招股章程及终止SISRAM MEDICAL LTD购股权计划的公告,/disclosure/listedinfo/announcement/c/2017-09-05/600196_20170905_1.pdf
1595,2017-09-07,复星医药关于控股子公司签署许可协议的公告,/disclosure/listedinfo/announcement/c/2017-09-07/600196_20170907_2.pdf
1596,2017-09-07,复星医药关于控股子公司获美国FDA药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2017-09-07/600196_20170907_3.pdf
1597,2017-09-07,复星医药第七届董事会第三十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-09-07/600196_20170907_1.pdf
1598,2017-09-09,复星医药关于控股子公司签署许可协议的补充公告,/disclosure/listedinfo/announcement/c/2017-09-09/600196_20170909_1.pdf
1599,2017-09-12,复星医药关于控股子公司获波兰药品注册办公室药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2017-09-12/600196_20170912_1.pdf
1600,2017-09-12,复星医药关于SISRAM MEDICAL LTD建议分拆上市全球发售最终发售价的公告,/disclosure/listedinfo/announcement/c/2017-09-12/600196_20170912_2.pdf
1601,2017-09-14,复星医药关于更换持续督导保荐代表人的公告,/disclosure/listedinfo/announcement/c/2017-09-14/600196_20170914_1.pdf
1602,2017-09-18,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2017-09-18/600196_20170918_2.pdf
1603,2017-09-18,复星医药第七届董事会第三十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-09-18/600196_20170918_1.pdf
1604,2017-09-20,复星医药关于 SISRAM MEDICAL LTD 上市及股份开始买卖的提示性公告,/disclosure/listedinfo/announcement/c/2017-09-20/600196_20170920_1.pdf
1605,2017-09-22,复星医药关于控股子公司获《药品生产许可证》的公告,/disclosure/listedinfo/announcement/c/2017-09-22/600196_20170922_1.pdf
1606,2017-09-23,复星医药关于与绵阳市第三人民医院签订《投资合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2017-09-23/600196_20170923_1.pdf
1607,2017-09-26,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-09-26/600196_20170926_1.pdf
1608,2017-09-26,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-09-26/600196_20170926_2.pdf
1609,2017-09-27,复星医药关于控股子公司获美国FDA药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2017-09-27/600196_20170927_1.pdf
1610,2017-09-30,复星医药关于与重庆市渝北区人民政府签订《战略合作协议》的公告,/disclosure/listedinfo/announcement/c/2017-09-30/600196_20170930_1.pdf
1611,2017-10-09,复星医药关于SISRAM MEDICAL LTD部分行使超额配股权的提示性公告,/disclosure/listedinfo/announcement/c/2017-10-09/600196_20171009_2.pdf
1612,2017-10-09,复星医药对外投资进展公告,/disclosure/listedinfo/announcement/c/2017-10-09/600196_20171009_1.pdf
1613,2017-10-10,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-10-10/600196_20171010_1.pdf
1614,2017-10-11,复星医药关于当年累计新增借款情况的公告,/disclosure/listedinfo/announcement/c/2017-10-11/600196_20171011_1.pdf
1615,2017-10-13,复星医药关于参与重庆建峰化工股份有限公司重大资产重组的进展公告,/disclosure/listedinfo/announcement/c/2017-10-13/600196_20171013_1.pdf
1616,2017-10-17,复星医药2016年公开发行公司债券（面向合格投资者）（第一期）、2017年公开发行公司债券（面向合格投资者）（第一期）2017年度第一次受托管理事务临时报告,/disclosure/listedinfo/announcement/c/2017-10-17/600196_20171017_1.pdf
1617,2017-10-18,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-10-18/600196_20171018_1.pdf
1618,2017-10-27,复星医药关于与常德经济开发区管理委员会签订《战略合作投资协议》的公告,/disclosure/listedinfo/announcement/c/2017-10-27/600196_20171027_1.pdf
1619,2017-10-28,复星医药关于控股子公司获美国FDA药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2017-10-28/600196_20171028_1.pdf
1620,2017-10-30,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2017-10-30/600196_20171030_2.pdf
1621,2017-10-30,复星医药第七届董事会第四十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-10-30/600196_20171030_1.pdf
1622,2017-10-31,复星医药关于控股子公司药品临床试验进展的公告,/disclosure/listedinfo/announcement/c/2017-10-31/600196_20171031_10.pdf
1623,2017-10-31,复星医药关于控股子公司获药品注册申请受理的公告,/disclosure/listedinfo/announcement/c/2017-10-31/600196_20171031_11.pdf
1624,2017-10-31,复星医药关于回购注销部分限制性A股股票通知债权人公告,/disclosure/listedinfo/announcement/c/2017-10-31/600196_20171031_7.pdf
1625,2017-10-31,复星医药关于回购注销部分未解锁限制性A股股票的公告,/disclosure/listedinfo/announcement/c/2017-10-31/600196_20171031_5.pdf
1626,2017-10-31,复星医药独立非执行董事关于聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2017-10-31/600196_20171031_3.pdf
1627,2017-10-31,复星医药独立非执行董事关于回购注销部分未解锁限制性A股股票的独立意见,/disclosure/listedinfo/announcement/c/2017-10-31/600196_20171031_2.pdf
1628,2017-10-31,复星医药第七届监事会2017年第五次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2017-10-31/600196_20171031_4.pdf
1629,2017-10-31,复星医药第七届董事会第四十三次会议（定期会议）决议公告,/disclosure/listedinfo/announcement/c/2017-10-31/600196_20171031_1.pdf
1630,2017-10-31,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司回购注销第二期限制性股票激励计划部分限制性A股股票之法律意见书,/disclosure/listedinfo/announcement/c/2017-10-31/600196_20171031_6.pdf
1631,2017-10-31,复星医药2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-31/600196_2017_3.pdf
1632,2017-11-02,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-11-02/600196_20171102_1.pdf
1633,2017-11-03,复星医药对外投资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2017-11-03/600196_20171103_2.pdf
1634,2017-11-03,复星医药独立非执行董事关于受让汉霖生技股份有限公司股份的独立意见,/disclosure/listedinfo/announcement/c/2017-11-03/600196_20171103_3.pdf
1635,2017-11-03,复星医药第七届董事会第四十四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-11-03/600196_20171103_1.pdf
1636,2017-11-07,复星医药：汉霖生技股份有限公司资产评估报告书摘要,/disclosure/listedinfo/announcement/c/2017-11-07/600196_20171107_2.pdf
1637,2017-11-08,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-11-08/600196_20171108_1.pdf
1638,2017-11-11,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2017-11-11/600196_20171111_1.pdf
1639,2017-11-13,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2017-11-13/600196_20171113_4.pdf
1640,2017-11-13,复星医药第七届董事会第四十五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-11-13/600196_20171113_3.pdf
1641,2017-11-15,复星医药关于与苏州工业园区管理委员会签订《战略合作协议》的公告,/disclosure/listedinfo/announcement/c/2017-11-15/600196_20171115_1.pdf
1642,2017-11-21,复星医药独立非执行董事关于《上海复星医药（集团）股份有限公司第二期限制性股票激励计划（修订稿）》所涉限制性A股股票第二期解锁事项的独立意见,/disclosure/listedinfo/announcement/c/2017-11-21/600196_20171121_3.pdf
1643,2017-11-21,复星医药第七届监事会2017年第六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-11-21/600196_20171121_4.pdf
1644,2017-11-21,复星医药第七届董事会第四十六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-11-21/600196_20171121_1.pdf
1645,2017-11-21,复星医药：国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司第二期限制性股票激励计划所涉限制性A股股票第二期解锁之法律意见书,/disclosure/listedinfo/announcement/c/2017-11-21/600196_20171121_2.pdf
1646,2017-11-25,复星医药第二期激励计划所涉限制性A股股票第二期解锁暨上市的公告,/disclosure/listedinfo/announcement/c/2017-11-25/600196_20171125_1.pdf
1647,2017-11-28,复星医药对外担保公告,/disclosure/listedinfo/announcement/c/2017-11-28/600196_20171128_1.pdf
1648,2017-11-29,复星医药关于与上海市松江区人民政府签订《战略合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2017-11-29/600196_20171129_2.pdf
1649,2017-12-01,复星医药关于调整2017年日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2017-12-01/600196_20171201_2.pdf
1650,2017-12-01,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2017-12-01/600196_20171201_3.pdf
1651,2017-12-01,复星医药第七届董事会第四十七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-12-01/600196_20171201_1.pdf
1652,2017-12-05,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-12-05/600196_20171205_1.pdf
1653,2017-12-09,复星医药关于与自贡市精神卫生中心签订《投资合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2017-12-09/600196_20171209_1.pdf
1654,2017-12-12,复星医药关于控股子公司签署许可协议的公告,/disclosure/listedinfo/announcement/c/2017-12-12/600196_20171212_2.pdf
1655,2017-12-12,复星医药第七届董事会第四十八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-12-12/600196_20171212_1.pdf
1656,2017-12-16,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-12-16/600196_20171216_1.pdf
1657,2017-12-20,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2017-12-20/600196_20171220_1.pdf
1658,2017-12-21,复星医药关于与雅各臣药业（香港）有限公司签订《Licensing Framework Agreement》的公告,/disclosure/listedinfo/announcement/c/2017-12-21/600196_20171221_7.pdf
1659,2017-12-21,复星医药关于新增日常关联交易的公告,/disclosure/listedinfo/announcement/c/2017-12-21/600196_20171221_5.pdf
1660,2017-12-21,复星医药关于控股子公司增资扩股的公告,/disclosure/listedinfo/announcement/c/2017-12-21/600196_20171221_6.pdf
1661,2017-12-21,复星医药关于控股子公司获药品临床试验申请受理的公告,/disclosure/listedinfo/announcement/c/2017-12-21/600196_20171221_1.pdf
1662,2017-12-21,复星医药对外投资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2017-12-21/600196_20171221_3.pdf
1663,2017-12-21,复星医药独立非执行董事关于参与投资设立上海卓瑞综合门诊部有限公司及关于新增日常关联交易的独立意见,/disclosure/listedinfo/announcement/c/2017-12-21/600196_20171221_4.pdf
1664,2017-12-21,复星医药第七届董事会第四十九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2017-12-21/600196_20171221_2.pdf
1665,2017-12-22,复星医药关于控股子公司获药品临床试验申请受理的公告,/disclosure/listedinfo/announcement/c/2017-12-22/600196_20171222_1.pdf
1666,2017-12-27,复星医药关于控股子公司获药品临床试验申请受理的公告,/disclosure/listedinfo/announcement/c/2017-12-27/600196_20171227_1.pdf
1667,2017-12-28,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-12-28/600196_20171228_1.pdf
1668,2017-12-29,复星医药关于与徐州经济技术开发区管理委员会签订《项目投资框架协议》的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600196_20171229_5.pdf
1669,2017-12-29,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600196_20171229_4.pdf
1670,2017-12-29,复星医药H股公告,/disclosure/listedinfo/announcement/c/2017-12-29/600196_20171229_3.pdf
1671,2017-12-30,复星医药关于职工监事辞职的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600196_20171230_1.pdf
1672,2018-01-03,复星医药关于董事、高级管理人员增持本公司股份计划实施期限届满的公告,/disclosure/listedinfo/announcement/c/2018-01-03/600196_20180103_1.pdf
1673,2018-01-04,复星医药H股公告,/disclosure/listedinfo/announcement/c/2018-01-04/600196_20180104_1.pdf
1674,2018-01-09,复星医药：瑞银证券有限责任公司、德邦证券股份有限公司关于上海复星医药（集团）股份有限公司非公开发行A股股票2017年度持续督导现场检查报告,/disclosure/listedinfo/announcement/c/2018-01-09/600196_20180109_1.pdf
1675,2018-01-11,复星医药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2018-01-11/600196_20180111_1.pdf
1676,2018-01-11,复星医药对外投资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2018-01-11/600196_20180111_3.pdf
1677,2018-01-11,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2018-01-11/600196_20180111_4.pdf
1678,2018-01-11,复星医药第七届董事会第五十次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2018-01-11/600196_20180111_2.pdf
1679,2018-01-12,复星医药关于选举职工监事的公告,/disclosure/listedinfo/announcement/c/2018-01-12/600196_20180112_1.pdf
1680,2018-01-12,复星医药第七届监事会2018年第一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2018-01-12/600196_20180112_2.pdf
1681,2018-01-17,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2018-01-17/600196_20180117_1.pdf
1682,2018-01-20,复星医药关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2018-01-20/600196_20180120_3.pdf
1683,2018-01-20,复星医药对外投资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2018-01-20/600196_20180120_4.pdf
1684,2018-01-20,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2018-01-20/600196_20180120_5.pdf
1685,2018-01-20,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2018-01-20/600196_20180120_2.pdf
1686,2018-01-20,复星医药第七届董事会第五十一次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2018-01-20/600196_20180120_1.pdf
1687,2018-01-24,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2018-01-24/600196_20180124_1.pdf
1688,2018-01-25,复星医药关于控股子公司获药品临床试验批准的公告,/disclosure/listedinfo/announcement/c/2018-01-25/600196_20180125_1.pdf
1689,2018-01-30,复星医药关于控股子公司药品注册申请进展的公告,/disclosure/listedinfo/announcement/c/2018-01-30/600196_20180130_1.pdf
1690,2018-01-31,复星医药关于控股子公司获药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2018-01-31/600196_20180131_1.pdf
1691,2018-02-02,复星医药关联交易公告,/disclosure/listedinfo/announcement/c/2018-02-02/600196_20180202_4.pdf
1692,2018-02-02,复星医药对外投资暨关联交易公告,/disclosure/listedinfo/announcement/c/2018-02-02/600196_20180202_2.pdf
1693,2018-02-02,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2018-02-02/600196_20180202_3.pdf
1694,2018-02-02,复星医药独立非执行董事意见,/disclosure/listedinfo/announcement/c/2018-02-02/600196_20180202_5.pdf
1695,2018-02-02,复星医药第七届董事会第五十二次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2018-02-02/600196_20180202_1.pdf
1696,2018-02-03,复星医药H股公告,/disclosure/listedinfo/announcement/c/2018-02-03/600196_20180203_1.pdf
1697,2018-02-10,复星医药关于向合格投资者公开发行公司债券申请获中国证券监督管理委员会核准的公告,/disclosure/listedinfo/announcement/c/2018-02-10/600196_20180210_1.pdf
1698,2018-02-13,复星医药关于控股子公司获药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2018-02-13/600196_20180213_3.pdf
1699,2018-02-13,复星医药对外投资公告,/disclosure/listedinfo/announcement/c/2018-02-13/600196_20180213_2.pdf
1700,2018-02-13,复星医药第七届董事会第五十三次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2018-02-13/600196_20180213_1.pdf
1701,2018-02-14,复星医药关于控股子公司药品通过仿制药一致性评价的公告,/disclosure/listedinfo/announcement/c/2018-02-14/600196_20180214_1.pdf
1702,2018-02-14,复星医药关于控股子公司签署许可协议的公告,/disclosure/listedinfo/announcement/c/2018-02-14/600196_20180214_2.pdf
